('','webform.webform.adherence_questionnaire','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:23:\"adherence_questionnaire\";s:5:\"title\";s:37:\"Multi-Act Framework Baseline Analysis\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:41079:\"nodeid:\n  \'#type\': hidden\n  \'#title\': nodeid\n  \'#default_value\': \'0\'\n  \'#prepopulate\': true\ncriteria_1_vision_and_agenda:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 1: Vision and agenda\'\n  \'#next_button_label\': \'Criteria 2: Participatory Governance\'\n  have_you_developed_a_shared_vision_mission_for_your_initiative_:\n    \'#type\': select\n    \'#title\': \'1) Have you developed a shared vision/mission for your initiative? \'\n    \'#description\': \'Mission-Vision we mean the change you seek to achieve in the future\'\n    \'#help_display\': title_after\n    \'#options\': yes_no\n  please_provide_the_mission_statment_and_related_documents_to_the:\n    \'#type\': webform_document_file\n    \'#title\': \'1.1) Please provide the mission statement and related documents to the mission.\'\n    \'#multiple\': 5\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_developed_a_shared_vision_mission_for_your_initiative_\"]\':\n          \'!value\': \'Yes\'\n  do_you_have_an_agenda_defining_the_priority_areas_mid_term_and_l:\n    \'#type\': select\n    \'#title\': \'2) Do you have an agenda defining the priority areas, mid-term and long-term objectives and a set of actions to achieve the objectives of the initiative?\'\n    \'#options\': yes_no\n  2_1_please_provide_the_documents_related_to_the_agenda:\n    \'#type\': webform_document_file\n    \'#title\': \'2.1) Please provide the documents related to the agenda\'\n    \'#multiple\': 5\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_an_agenda_defining_the_priority_areas_mid_term_and_l\"]\':\n          \'!value\': \'Yes\'\n  could_you_please_describe_how_you_have_defined_the_common_object:\n    \'#type\': textarea\n    \'#title\': \'3) Could you please describe how you have defined the common objectives, priority areas and set of actions?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_an_agenda_defining_the_priority_areas_mid_term_and_l\"]\':\n          \'!value\': \'Yes\'\n  which_of_the_following_stakeholders_took_part_in_defining_the_ob:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'3.1) Which of the following stakeholders took part in defining the objectives, priorities and set of actions for your initiative?\'\n    \'#options\':\n      Patients: \'Patients -- (people with the diseases and affected by the diseases (i.e. relatives, caregivers))\'\n      \'Patients organizations, patient associations, advocacy organizations, etc.\': \'Patients organizations, patient associations, advocacy organizations, etc.\'\n      \'Society individual citizens, civil society organizations and networks\': \'Society individual citizens, civil society organizations and networks\'\n      \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\': \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\'\n      \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\': \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\'\n      \'Policy makers EU institutions; national, regional and local policy makers\': \'Policy makers EU institutions; national, regional and local policy makers\'\n      \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\': \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\'\n      \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\': \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\'\n    \'#other__placeholder\': \'Please specify\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_an_agenda_defining_the_priority_areas_mid_term_and_l\"]\':\n          \'!value\': \'Yes\'\n  _have_you_identified_the_intended_beneficiaries_of_your_research:\n    \'#type\': select\n    \'#title\': \'4) Have you identified the intended beneficiaries of your research initiative?\'\n    \'#options\': yes_no\n  7_please_indicate_which_of_the_following_stakeholders_are_the_in:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'4.1) Please indicate which of the following (stakeholders) are the intended beneficiaries whom you have identified\'\n    \'#options\':\n      Patients: \'Patients -- (people with the diseases and affected by the diseases (i.e. relatives, caregivers))\'\n      \'Patients organizations, patient associations, advocacy organizations, etc.\': \'Patients organizations, patient associations, advocacy organizations, etc.\'\n      \'Society individual citizens, civil society organizations and networks\': \'Society individual citizens, civil society organizations and networks\'\n      \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\': \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\'\n      \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\': \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\'\n      \'Policy makers EU institutions; national, regional and local policy makers\': \'Policy makers EU institutions; national, regional and local policy makers\'\n      \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\': \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\'\n      \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\': \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\'\n    \'#other__placeholder\': \'Please specify\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"_have_you_identified_the_intended_beneficiaries_of_your_research\"]\':\n          \'!value\': \'Yes\'\ncriteria_2_participatory_governance:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 2: Participatory Governance\'\n  \'#prev_button_label\': \'Criteria 1: Vision and agenda\'\n  \'#next_button_label\': \'Criteria 3 : effective stakeholder engagement - patient engagement\'\n  have_you_established_a_governance_structure_for_the_ms_care_unit:\n    \'#type\': select\n    \'#title\': \'5)  Have you established a governance structure for your research initiative?\'\n    \'#options\': yes_no\n  11_could_you_please_describe_the_different_bodies_in_your_govern:\n    \'#type\': textarea\n    \'#title\': \'5.1) Could you please describe the different bodies in your governance (e.g. boards committees, working groups, teams, others) in your research initiative and describe their functions and composition.\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  _10_which_of_the_following_stakeholders_are_involved_in_the_gove:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'5.2) Which of the following stakeholders are involved in the governance board?\'\n    \'#options\':\n      Patients: \'Patients -- (people with the diseases and affected by the diseases (i.e. relatives, caregivers))\'\n      \'Patients organizations, patient associations, advocacy organizations, etc.\': \'Patients organizations, patient associations, advocacy organizations, etc.\'\n      \'Society individual citizens, civil society organizations and networks\': \'Society individual citizens, civil society organizations and networks\'\n      \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\': \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\'\n      \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\': \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\'\n      \'Policy makers EU institutions; national, regional and local policy makers\': \'Policy makers EU institutions; national, regional and local policy makers\'\n      \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\': \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\'\n      \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\': \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\'\n    \'#other__placeholder\': \'Please specify\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  12_do_you_have_a_procedure_that_describes_the_roles_and_responsi:\n    \'#type\': select\n    \'#title\': \'5.3) Do you have a procedure that describes the roles and responsibilities of all (or some of the) stakeholders and decision making processes ?\'\n    \'#description\': |\n      <p class=\"question-title-container\" id=\"question-title-345309734\"><span class=\"notranslate user-generated\">documents that describe this see links:</span><br />\n      &nbsp;</p>\n      \n      <ul>\n      	<li>\n      	<p class=\"question-title-container\"><a href=\"https://www.globalreporting.org/SiteCollectionDocuments/2016/Governance%20documents/Rules%20and%20Procedures%20for%20the%20GRI%20Board%20of%20Directors.pdf\">https://www.globalreporting.org/SiteCollectionDocuments/2016/Governance%20documents/Rules%20and%20Procedures%20for%20the%20GRI%20Board%20of%20Directors.pdf</a></p>\n      	</li>\n      	<li>\n      	<p class=\"question-title-container\"><span class=\"notranslate user-generated\"><a href=\"https://www.globalreporting.org/SiteCollectionDocuments/2014/GRIs-new-governance-structure.pdf\">https://www.globalreporting.org/SiteCollectionDocuments/2014/GRIs-new-governance-structure.pdf</a>)</span></p>\n      \n      	<p>For example: if a vote is necessary, some stakeholders could have voting rights and others not (e.g. care providers have and patients do not have). Some votes may have more powers than others.&nbsp;</p>\n      	</li>\n      </ul>\n      \n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  5_3_1_please_describe_that_procedure:\n    \'#type\': textarea\n    \'#title\': \'5.3.1) Please describe that procedure\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"12_do_you_have_a_procedure_that_describes_the_roles_and_responsi\"]\':\n          \'!value\': \'Yes\'\n  or_provide_a_copy_of_that_procedure:\n    \'#type\': webform_document_file\n    \'#title\': \'or provide a copy of that procedure\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"12_do_you_have_a_procedure_that_describes_the_roles_and_responsi\"]\':\n          \'!value\': \'Yes\'\n  5_4_do_the_stakeholder_participating_in_the_governance_of_the_in:\n    \'#type\': select\n    \'#title\': \'5.4)Could the stakeholders have different decision power?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  15_please_describe:\n    \'#type\': textarea\n    \'#title\': \'5.4.1) Please describe\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"5_4_do_the_stakeholder_participating_in_the_governance_of_the_in\"]\':\n          \'!value\': \'Yes\'\n  16_when_establishing_the_governance_boards_do_you_take_into_acco:\n    \'#type\': select\n    \'#title\': \'5.5) When establishing the governance boards do you take into account diversity factors (such as gender, sector, geographical/educational background, language) ?\'\n    \'#description\': |\n      <p>e.g. They have an ethics committee, or they can have a procedure that regulates it<br />\n      Disadvantages could be: some patients with particular problems for whom it will be more difficult to be involved.&nbsp; It could be people living in remote areas, literacy issues,&hellip;<br />\n      &nbsp;</p>\n      \n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  17_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'5.5.1) Please describe the mechanisms by which you ensure a balance\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"16_when_establishing_the_governance_boards_do_you_take_into_acco\"]\':\n          \'!value\': \'Yes\'\n  or_provide_us_with_the_relevant_documentation_2:\n    \'#type\': webform_document_file\n    \'#title\': \'or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"16_when_establishing_the_governance_boards_do_you_take_into_acco\"]\':\n          \'!value\': \'Yes\'\n  18_when_establishing_the_governance_boards_do_you_ensure_the_par:\n    \'#type\': select\n    \'#title\': \'5.6) When establishing the governance boards, do you ensure the participation of disadvantaged stakeholders?\'\n    \'#description\': \'<p>(Disadvantages could be: some patients with particular problems for whom it will be more difficult to be involved. It could be people living in remote areas, literacy issues,&hellip;)</p>\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  19_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'5.6.1) Please describe the mechanisms by which you ensure a balance\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"18_when_establishing_the_governance_boards_do_you_ensure_the_par\"]\':\n          \'!value\': \'Yes\'\n  or_provide_us_with_the_relevant_documentation_:\n    \'#type\': webform_document_file\n    \'#title\': \'or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"18_when_establishing_the_governance_boards_do_you_ensure_the_par\"]\':\n          \'!value\': \'Yes\'\n  20_when_establishing_the_governance_boards_do_you_protect_the_in:\n    \'#type\': select\n    \'#title\': \'5.7) When establishing the governance boards, do you protect the integrity and multi-stakeholder nature of the initiative and ensure that self-interest of stakeholders does not prevail on collective decision-making processes?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  21_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'5.7.1) Please describe the mechanisms by which you ensure a balance\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"20_when_establishing_the_governance_boards_do_you_protect_the_in\"]\':\n          \'!value\': \'Yes\'\n  ror_provide_us_with_the_relevant_documentation_:\n    \'#type\': webform_document_file\n    \'#title\': \'or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"20_when_establishing_the_governance_boards_do_you_protect_the_in\"]\':\n          \'!value\': \'Yes\'\n  22_when_establishing_the_governance_boards_do_you_maintain_commi:\n    \'#type\': select\n    \'#title\': \'5.8) When establishing the governance boards, do you maintain commitment and ownership among the participating stakeholders?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  23_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'5.8.1) Please describe the mechanisms by which you ensure a balance\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"22_when_establishing_the_governance_boards_do_you_maintain_commi\"]\':\n          \'!value\': \'Yes\'\n  5_8_1b_or_provide_us_with_the_relevant_documentation_:\n    \'#type\': webform_document_file\n    \'#title\': \'or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"22_when_establishing_the_governance_boards_do_you_maintain_commi\"]\':\n          \'!value\': \'Yes\'\ncriteria_3_effective_stakeholder_engagement_patient_engagement:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 3 : Effective Stakeholder Engagement\'\n  \'#prev_button_label\': \'Criteria 2: Participatory Governance\'\n  \'#next_button_label\': \'Criteria 4: Efficient Management and  Coordination of the initiative\'\n  beyond_the_stakeholders_involved_in_the_governance_structure_hav:\n    \'#type\': select\n    \'#title\': \'6) Beyond the stakeholders involved in the governance structure, have you identified other stakeholders who might be influenced or might influence the initiative? \'\n    \'#options\': yes_no\n  5_1_could_you_please_describe_the_different_bodies_in_your_gover:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'6.1) Please describe these stakeholders considering the classification of Criteria 2\'\n    \'#options\':\n      Patients: \'Patients -- (people with the diseases and affected by the diseases (i.e. relatives, caregivers))\'\n      \'Patients organizations, patient associations, advocacy organizations, etc.\': \'Patients organizations, patient associations, advocacy organizations, etc.\'\n      \'Society individual citizens, civil society organizations and networks\': \'Society individual citizens, civil society organizations and networks\'\n      \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\': \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\'\n      \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\': \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\'\n      \'Policy makers EU institutions; national, regional and local policy makers\': \'Policy makers EU institutions; national, regional and local policy makers\'\n      \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\': \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\'\n      \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\': \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\'\n    \'#other__placeholder\': \'Please specify\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  27_did_you_differentiate_the_level_of_engagement_of_these_stakeh:\n    \'#type\': select\n    \'#title\': \'6.2) Did you differentiate the level of engagement of these stakeholders (i.e. involved in specific activities of the initiative such as research group, consulted, informed) according to their relevance to the initiative and other specific characteristics?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\n  28_do_you_have_a_stakeholder_engagement_strategy_in_place_both_w:\n    \'#type\': select\n    \'#title\': \'6.3) Do you have a stakeholder engagement strategy in place? (both with regard to stakeholders involved in the governance and \"external\" stakeholders)\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\n  29_describe_the_methodology_that_is_adopted_in_order_to_put_in_p:\n    \'#type\': textarea\n    \'#title\': \'6.3.1) Describe the methodology that is adopted in order to put in place a process of stakeholder engagement, and list the actions that will be undertaken for each of the steps you might identify in the engagement process\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"28_do_you_have_a_stakeholder_engagement_strategy_in_place_both_w\"]\':\n          \'!value\': \'Yes\'\n  please_provide_relevant_documents_if_any:\n    \'#type\': webform_document_file\n    \'#title\': \'Please, provide relevant documents if any\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"28_do_you_have_a_stakeholder_engagement_strategy_in_place_both_w\"]\':\n          \'!value\': \'Yes\'\n  30_did_you_perform_a_consultation_process_in_order_to_understand:\n    \'#type\': select\n    \'#title\': \'6.4) Did you perform a consultation process in order to understand the needs, expectations and challenges of the stakeholders involved in the initiative in terms of their participation in the initiative?  (both with regard to stakeholders involved in the governance and \"external\" stakeholders)\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\n  31_did_you_carry_out_an_analysis_to_identify_stakeholders_challe:\n    \'#type\': select\n    \'#title\': \'6.5) Did you carry out an analysis to identify stakeholders challenges and barriers to guarantee genuine participation?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\n  6_5_1_could_you_please_provide_the_report_of_this_analysis_:\n    \'#type\': webform_document_file\n    \'#title\': \'6.5.1) Could you please provide the report of this analysis.\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"31_did_you_carry_out_an_analysis_to_identify_stakeholders_challe\"]\':\n          \'!value\': \'Yes\'\n  33_with_regard_to_stakeholder_engagement_do_you_have_a_process_t:\n    \'#type\': select\n    \'#title\': \'6.6) With regard to stakeholder engagement, Do you have a process to guarantee a fair and equitable process that takes into account the limitations that participants might encounter (e.g. cognitive impairment, behavioral issues, fatigue)?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\n  34_please_describe:\n    \'#type\': textarea\n    \'#title\': \'6.6.1) Please describe\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"33_with_regard_to_stakeholder_engagement_do_you_have_a_process_t\"]\':\n          \'!value\': \'Yes\'\n  35_do_you_have_a_process_in_place_to_train_stakeholders_in_order:\n    \'#type\': select\n    \'#title\': \'6.7) Do you have a process in place to train stakeholders in order to allow their genuine and balanced participation?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\n  36_please_describe_the_process_of_training_stakeholders_e_g_the_:\n    \'#type\': textarea\n    \'#title\': \'6.7.1) Please describe the process of training stakeholders (e.g. the total amount of average hours per training and for informing stakeholders)\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"35_do_you_have_a_process_in_place_to_train_stakeholders_in_order\"]\':\n          \'!value\': \'Yes\'\n  7_do_you_engage_patients_in_your_research_innovation_r_i_in_one_:\n    \'#type\': select\n    \'#title\': \'7) Do you engage patients in your Research & Innovation (R&I), in one or more of the following steps: - Breaking down boundaries - Research priorities - Steering institutions - Design & plan - Research execution - Evaluation - Translation to community ?\'\n    \'#options\': yes_no\n  38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e:\n    \'#type\': checkboxes\n    \'#title\': \'7.1) Please select the steps in which you engage patiens:\'\n    \'#options\':\n      \'1. Breaking down boundaries \': \'1. Breaking down boundaries  -- (this area includes the conditions that should be set in Research Funding and Performing Organisations (RFPOs) in order to facilitate patient engagement as standard practice. Boundary refers to a physical or conceptual divide between Patient Engagement and organisations)\'\n      \'2. Research priorities\': \'2. Research priorities -- (all actions necessary to prioritize the Research Agenda and formulate its objectives. Involving patients in setting priorities implicitly implies the direct allocation of funding. Patients may be engaged to co-design research agendas, exercises of prioritization) \'\n      \'3. Steering institutions\': \'3. Steering institutions -- (all actions performed to establish steering and advisory committees and boards. An advisory committee and board is usually made up of high level stakeholders and/or experts who provide guidance on key issues such as company policy and objectives, rules and role, budgetary control, marketing strategy, resource allocation, and decisions involving large expenditures. Patients may be invited to be member of research & governance committees and boards)\'\n      \'4. Design & plan\': \'4. Design & plan -- (the design of all the activities that lead to the realization of a concept or idea and which helps to achieve the objectives set, i.e. the formulation and assignment of tasks, rules, roles and execution times in order to achieve the objectives set. Patients may be invited to co-design specific programs (e.g. design of project objectives, endpoints, work plan and related budget)\'\n      \'5. Research execution\': \'5. Research execution -- (all activities to implement a research program or a specific project in order to achieve the objectives set. Patients may be engaged in the development and monitoring of specific programs (e.g. release of call for proposals, selection of projects to be funded; monitoring of funded projects) or projects (e.g. Information and Communication Technology ICT device development).  \'\n      \'6. Evaluation\': \'6. Evaluation -- (all activities to determine the value of a research program or project, establishing their outputs and results, the degree of achievement of its objectives (process evaluation) and its impact. patients may be involved in the evaluation of the results of research programs (e.g. publications, Impact Factors, application of new parameters) or projects (e.g. evaluation of an ICT device by the user) \'\n      \'7. Translation to community\': \'7. Translation to community -- (activities to promote and facilitate the adoption of the results of research programs or projects, including all aspects of engagement in communication of results and advocacy. At project level, translation to the community includes information for regulatory authorities (e.g. medical development, ICT tools, HTA, etc.). Patients may be engaged in promoting change in society resulting from the results of research programs (e.g. development of guidelines and advocacy activities, implementation of specific care models) or projects (e.g. communication activities and advocacy to exploit the ICT device) \'\n      \'8. None of the above \': \'8. None of the above \'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"7_do_you_engage_patients_in_your_research_innovation_r_i_in_one_\"]\':\n          \'!value\': \'Yes\'\n  39_do_you_have_a_team_manager_dedicated_to_coordinate_the_patien:\n    \'#type\': select\n    \'#title\': \'8) Do you have a team/manager dedicated to coordinate the patient engagement?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e[8. None of the above ]\"]\':\n          checked: true\n  40_do_you_have_indicators_to_measure_the_return_on_patient_engag:\n    \'#type\': select\n    \'#title\': \'9) Do you have indicators to measure the “return on patient engagement” for each stakeholder involved in your initiative?\'\n    \'#description\': \'<h6>(by return on patient engagement we mean the benefit and impact resulting to performing patient engagement in R&amp;I. The more Patient engagement produces value the more the costs will be sustainable for all the stakeholders)</h6>\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e[8. None of the above ]\"]\':\n          checked: true\n  41_do_you_plan_ad_hoc_training_programs_related_to_the_patient_e:\n    \'#type\': select\n    \'#title\': \'10) Do you plan ad-hoc training programs related to the patient engagement, including scope and actions?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e[8. None of the above ]\"]\':\n          checked: true\n  42_do_you_have_mechanism_in_place_to_recognize_and_reward_patien:\n    \'#type\': select\n    \'#title\': \'11) Do you have mechanism in place to recognize and reward patients?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e[8. None of the above ]\"]\':\n          checked: true\n  43_do_you_have_dedicated_resources_budget_for_patient_engagement:\n    \'#type\': select\n    \'#title\': \'12) Do you have dedicated resources (budget) for patient engagement?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e[8. None of the above ]\"]\':\n          checked: true\n  44_do_you_perform_an_ethical_assessment_of_your_patient_engageme:\n    \'#type\': select\n    \'#title\': \'13) Do you perform an ethical assessment of your patient engagement strategy and of its implementation?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e[8. None of the above ]\"]\':\n          checked: true\ncriteria_4_efficient_management_and_coordination_of_the_initiati:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 4: Efficient Management and  Coordination of the initiative\'\n  \'#prev_button_label\': \'Criteria 3 : effective stakeholder engagement - patient engagement\'\n  \'#next_button_label\': \"Criterion 5: Co-accountability assessment\\t\\t\\t\\t\"\n  14_do_you_have_a_collective_action_plan_in_place_in_order_to_ach:\n    \'#type\': select\n    \'#title\': \'14) Do you have a collective action plan in place in order to achieve the objectives of the initiative?\'\n    \'#options\': yes_no\n  48_if_yes_do_you_have_a_plan_that_defines_the_following_please_t:\n    \'#type\': checkboxes\n    \'#title\': \'14.1) Do you have a plan that defines the following: Please tick as appropriate\'\n    \'#options\':\n      \'Specific actions that different stakeholders commit to implement in order to achieve the objectives of the initiative; \': \'Specific actions that different stakeholders commit to implement in order to achieve the objectives of the initiative; \'\n      \'Definition and composition of Working Groups, which might practically deal with the implementation of such actions\': \'Definition and composition of Working Groups, which might practically deal with the implementation of such actions\'\n      \'Definition of clear and measurable targets\': \'Definition of clear and measurable targets\'\n      \'Presentation of clear project timeline,including deadlines in order to allow participants to hold each other accountable\': \'Presentation of clear project timeline,including deadlines in order to allow participants to hold each other accountable\'\n      \'Definition of a clear internal review process, carried out on a periodical basis in order to keep  track of the achieved targets\': \'Definition of a clear internal review process, carried out on a periodical basis in order to keep  track of the achieved targets\'\n      \'Information regarding the organization \"touch points meetings\" (such as periodic events or webinars) \': \'Information regarding the organization \"touch points meetings\" (such as periodic events or webinars) \'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"14_do_you_have_a_collective_action_plan_in_place_in_order_to_ach\"]\':\n          \'!value\': \'Yes\'\n  14_2_could_you_provide_some_documentation_in_that_context_:\n    \'#type\': webform_document_file\n    \'#title\': \'14.2) Could you provide some documentation in that context?\'\n    \'#multiple\': 4\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"14_do_you_have_a_collective_action_plan_in_place_in_order_to_ach\"]\':\n          \'!value\': \'Yes\'\n  49_do_you_have_a_cost_management_process_in_place_e_g_a_defined_:\n    \'#type\': select\n    \'#title\': \'15) Do you have a cost management process in place (e.g. a defined budget, a cost analysis) that ensures that the initiative has enough resources to reach its objectives?\'\n    \'#options\': yes_no\n  50_do_you_ensure_that_the_internal_team_has_solid_skills_to_carr:\n    \'#type\': select\n    \'#title\': \'16) Do you ensure that the internal team has solid skills to carry out the activities of the initiative?\'\n    \'#options\': yes_no\n  51_do_you_maintain_accountability_over_time_keeping_track_of_exp:\n    \'#type\': select\n    \'#title\': \'17) Do you maintain accountability over time keeping track of expenses and revenues?\'\n    \'#options\': yes_no\n  52_please_describe_or_provide_documentation_:\n    \'#type\': textarea\n    \'#title\': \'17.1) Please describe\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"51_do_you_maintain_accountability_over_time_keeping_track_of_exp\"]\':\n          \'!value\': \'Yes\'\n  or_provide_documentation:\n    \'#type\': webform_document_file\n    \'#title\': \'or provide documentation\'\n    \'#multiple\': 3\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"51_do_you_maintain_accountability_over_time_keeping_track_of_exp\"]\':\n          \'!value\': \'\'\n  53_do_you_have_a_process_in_place_to_ensure_that_there_is_a_righ:\n    \'#type\': select\n    \'#title\': \'18) Do you have a process in place to ensure that there is a right balance between an efficient management process and the opportunities for engaging a wide range of participants? (examples:you have defined rules to take final decision in case a discussion among governance body\'\'s member has run aground; measures to decrease interdependency between activities, measures to increase robustness, etc.)\'\n    \'#description\': |\n      <p>E.g. Setting timelines, reducing interdependency, increase robustness???</p>\n      For example,you have defined rules to take final decision in case a discussion among governance body&#39;s member has run aground).<br />\n      We need a more genral example as this one is already ad\n      \n    \'#options\': yes_no\n  54_please_explain_:\n    \'#type\': textarea\n    \'#title\': \'18.1) Please describe\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"53_do_you_have_a_process_in_place_to_ensure_that_there_is_a_righ\"]\':\n          \'!value\': \'Yes\'\n  55_have_you_developed_a_contingency_plan_risk_management_approac:\n    \'#type\': select\n    \'#title\': \'19) Have you developed a contingency plan/risk managment approach?\'\n    \'#options\': yes_no\n  19_1_please_provide_relative_documents:\n    \'#type\': webform_document_file\n    \'#title\': \'19.1) Please provide relevant documents\'\n    \'#multiple\': 3\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"55_have_you_developed_a_contingency_plan_risk_management_approac\"]\':\n          \'!value\': \'Yes\'\ninitiativeid:\n  \'#type\': hidden\n  \'#title\': InitiativeID\n  \'#prepopulate\': true\ncriterion_5_co_accountability_assessment_:\n  \'#type\': webform_wizard_page\n  \'#title\': \"Criterion 5: Co-accountability assessment\\t\\t\\t\\t\"\n  \'#prev_button_label\': \"Criterion 4: Efficient Management and Coordination of the initiative\\t\\t\\t\\t\"\n  do_you_have_a_monitoring_system_for_the_implementation_of_the_ac:\n    \'#type\': select\n    \'#title\': \'20) Do you have a monitoring system for the implementation of the actions of the initiative and the performance of the initiative itself (ongoing) ?\'\n    \'#options\': yes_no\n  have_you_defined_an_assessment_system_that_allow_to_measure_init:\n    \'#type\': select\n    \'#title\': \'21) Have you defined an assessment system that allow to measure initiative’s \"long-term impact”(ex-post) ? \'\n    \'#options\': yes_no\n  does_this_assessment_involve_stakeholders_in_the_gathering_of_da:\n    \'#type\': select\n    \'#title\': \'21.1) Does this assessment involve stakeholders in the gathering of data and information ?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n  does_this_assessment_include_indicators_related_to_the_patient_d:\n    \'#type\': select\n    \'#title\': \'21.2) Does this assessment include indicators related to the patient dimension ?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n  are_the_monitoring_and_the_assessment_systems_and_the_related_in:\n    \'#type\': select\n    \'#title\': \'21.3) Are the monitoring and the assessment systems and the related indicators linked to the objectives of the initiative (link with criteria 1)\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n  please_describe_how_the_measurement_is_linked_to_the_objectives_:\n    \'#type\': textarea\n    \'#title\': \'21.4) Please describe how the measurement is linked to the objectives (link with criteria 1)\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n  do_you_publish_a_progress_report_:\n    \'#type\': select\n    \'#title\': \'22) Do you publish a progress report ?\'\n    \'#options\': yes_no\n  can_you_provide_any_of_those_reports_:\n    \'#type\': webform_document_file\n    \'#title\': \'22.1) Can you provide any of those reports ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_publish_a_progress_report_\"]\':\n          \'!value\': \'Yes\'\n  what_is_the_frequency_of_publishing_progress_reports_:\n    \'#type\': textarea\n    \'#title\': \'22.2) What is the frequency of publishing progress reports ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_publish_a_progress_report_\"]\':\n          \'!value\': \'Yes\'\n  do_you_communicate_with_stakeholders_about_the_progress_of_the_i:\n    \'#type\': select\n    \'#title\': \'23) Do you communicate with stakeholders about the progress of the initiative ?\'\n    \'#options\': yes_no\n  please_describe_how_you_communicate_with_the_stakeholders_on_pro:\n    \'#type\': textarea\n    \'#title\': \'23.1) Please describe how you communicate with the stakeholders on progress (e.g. Online platform, annual report, newsletters, ad-hoc communications) ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_communicate_with_stakeholders_about_the_progress_of_the_i\"]\':\n          \'!value\': \'Yes\'\n  do_you_have_a_review_process_in_place_to_improve_the_initiative_:\n    \'#type\': select\n    \'#title\': \'24) Do you have a review process in place to improve the initiative’s performance and practices (based on the results of the monitoring) ?\'\n    \'#options\': yes_no\n  is_this_review_process_strictly_internal_or_is_there_a_third_par:\n    \'#type\': textarea\n    \'#title\': \'24.1) Is this review process strictly internal or is there a third party involvement ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_a_review_process_in_place_to_improve_the_initiative_\"]\':\n          \'!value\': \'Yes\'\n  pleas_describe_the_process_provide_documentation_that_allows_the:\n    \'#type\': textarea\n    \'#title\': \'24.2 Please describe the process/provide documentation that allows the incorporation of feedbacks from consultations and reviews to revise/change objectives of the initiative in a flexible manner\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_a_review_process_in_place_to_improve_the_initiative_\"]\':\n          \'!value\': \'Yes\'\n  do_you_have_a_process_in_place_to_gather_feedback_from_external_:\n    \'#type\': select\n    \'#title\': \'25) Do you have a process in place to gather feedback from external stakeholders and the public? (For example a section on the website for public consultation, organization of specific events, etc.) ?\'\n    \'#options\': yes_no\n  please_describe3:\n    \'#type\': textarea\n    \'#title\': \'25.1) Please describe\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_a_process_in_place_to_gather_feedback_from_external_\"]\':\n          \'!value\': \'Yes\'\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:1;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:1;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:2:{s:6:\"nodeid\";s:6:\"nodeid\";s:12:\"initiativeid\";s:12:\"initiativeid\";}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:1;s:26:\"wizard_progress_percentage\";b:1;s:20:\"wizard_progress_link\";b:1;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:13:\"authenticated\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:1;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:1;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:1:{i:0;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:1:{i:0;s:9:\"anonymous\";}s:5:\"users\";a:1:{i:0;i:19;}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:1:{i:0;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:1:{i:0;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"484f620f-ed55-4f62-9b74-b6fdb7a67c74\";}'),('','webform.webform.contact','a:22:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";N;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:7:\"contact\";s:5:\"title\";s:7:\"Contact\";s:11:\"description\";s:28:\"Basic email contact webform.\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:566:\"name:\n  \'#title\': \'Your Name\'\n  \'#type\': textfield\n  \'#required\': true\n  \'#default_value\': \'[current-user:display-name]\'\nemail:\n  \'#title\': \'Your Email\'\n  \'#type\': email\n  \'#required\': true\n  \'#default_value\': \'[current-user:mail]\'\nsubject:\n  \'#title\': Subject\n  \'#type\': textfield\n  \'#required\': true\n  \'#test\': \'Testing contact webform from [site:name]\'\nmessage:\n  \'#title\': Message\n  \'#type\': textarea\n  \'#required\': true\n  \'#test\': \'Please ignore this email.\'\nactions:\n  \'#type\': webform_actions\n  \'#title\': \'Submit button(s)\'\n  \'#submit__label\': \'Send message\'\n\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:11:\"url_message\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:27:\"Your message has been sent.\";s:16:\"confirmation_url\";s:7:\"<front>\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:2:{s:18:\"email_confirmation\";a:7:{s:2:\"id\";s:5:\"email\";s:5:\"label\";s:18:\"Email confirmation\";s:10:\"handler_id\";s:18:\"email_confirmation\";s:6:\"status\";b:1;s:10:\"conditions\";a:0:{}s:6:\"weight\";i:1;s:8:\"settings\";a:27:{s:6:\"states\";a:1:{i:0;s:9:\"completed\";}s:7:\"to_mail\";s:37:\"[webform_submission:values:email:raw]\";s:10:\"to_options\";a:0:{}s:7:\"cc_mail\";s:0:\"\";s:10:\"cc_options\";a:0:{}s:8:\"bcc_mail\";s:0:\"\";s:11:\"bcc_options\";a:0:{}s:9:\"from_mail\";s:8:\"_default\";s:12:\"from_options\";a:0:{}s:9:\"from_name\";s:8:\"_default\";s:7:\"subject\";s:39:\"[webform_submission:values:subject:raw]\";s:4:\"body\";s:41:\"[webform_submission:values:message:value]\";s:17:\"excluded_elements\";a:0:{}s:13:\"ignore_access\";b:0;s:13:\"exclude_empty\";b:1;s:22:\"exclude_empty_checkbox\";b:0;s:19:\"exclude_attachments\";b:0;s:4:\"html\";b:1;s:11:\"attachments\";b:0;s:4:\"twig\";b:0;s:5:\"debug\";b:0;s:8:\"reply_to\";s:0:\"\";s:11:\"return_path\";s:0:\"\";s:11:\"sender_mail\";s:0:\"\";s:11:\"sender_name\";s:0:\"\";s:10:\"theme_name\";s:0:\"\";s:10:\"parameters\";a:0:{}}}s:18:\"email_notification\";a:7:{s:2:\"id\";s:5:\"email\";s:5:\"label\";s:18:\"Email notification\";s:10:\"handler_id\";s:18:\"email_notification\";s:6:\"status\";b:1;s:10:\"conditions\";a:0:{}s:6:\"weight\";i:2;s:8:\"settings\";a:27:{s:6:\"states\";a:1:{i:0;s:9:\"completed\";}s:7:\"to_mail\";s:8:\"_default\";s:10:\"to_options\";a:0:{}s:7:\"cc_mail\";s:0:\"\";s:10:\"cc_options\";a:0:{}s:8:\"bcc_mail\";s:0:\"\";s:11:\"bcc_options\";a:0:{}s:9:\"from_mail\";s:37:\"[webform_submission:values:email:raw]\";s:12:\"from_options\";a:0:{}s:9:\"from_name\";s:36:\"[webform_submission:values:name:raw]\";s:7:\"subject\";s:39:\"[webform_submission:values:subject:raw]\";s:4:\"body\";s:41:\"[webform_submission:values:message:value]\";s:17:\"excluded_elements\";a:0:{}s:13:\"ignore_access\";b:0;s:13:\"exclude_empty\";b:1;s:22:\"exclude_empty_checkbox\";b:0;s:19:\"exclude_attachments\";b:0;s:4:\"html\";b:1;s:11:\"attachments\";b:0;s:4:\"twig\";b:0;s:5:\"debug\";b:0;s:8:\"reply_to\";s:0:\"\";s:11:\"return_path\";s:0:\"\";s:11:\"sender_mail\";s:0:\"\";s:11:\"sender_name\";s:0:\"\";s:10:\"theme_name\";s:0:\"\";s:10:\"parameters\";a:0:{}}}}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"509b3f89-1395-461f-8c26-c40ecdf3462a\";s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"CjLyKc08W5pQDmtIk0iDWmit1eCAlCVJtOzxMdHI51Q\";}}'),('','webform.webform.demo_application','a:22:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:35:\"webform_demo_application_evaluation\";}}}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";N;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:16:\"demo_application\";s:5:\"title\";s:17:\"Demo: Application\";s:11:\"description\";s:49:\"A demonstration of a very basic application form.\";s:8:\"category\";s:4:\"Demo\";s:8:\"elements\";s:1496:\"contact:\n  \'#type\': webform_contact\n  \'#title\': Contact\n  \'#name__required\': true\n  \'#company__required\': true\n  \'#email__required\': true\n  \'#phone__required\': true\n  \'#address__required\': true\n  \'#address_2__required\': true\n  \'#city__required\': true\n  \'#state_province__required\': true\n  \'#postal_code__required\': true\n  \'#country__required\': true\napplication_status:\n  \'#type\': details\n  \'#title\': \'Application Status\'\n  \'#open\': true\n  \'#admin\': true\n  \'#access_create_roles\': {  }\n  state:\n    \'#type\': webform_buttons\n    \'#title\': \'Application State\'\n    \'#options\':\n      completed: Completed\n      in_review: \'In review\'\n      accepted: Accepted\n      rejected: Rejected\n    \'#access_create_roles\': {  }\n  completed_date:\n    \'#type\': datetime\n    \'#title\': \'Application Completed Date\'\n    \'#access_create_roles\': {  }\n    \'#access_update_roles\': {  }\n    \'#access_view_roles\':\n      - authenticated\n  in_review_date:\n    \'#type\': datetime\n    \'#title\': \'Application In Review Date\'\n    \'#access_create_roles\': {  }\n    \'#access_update_roles\': {  }\n    \'#access_view_roles\':\n      - authenticated\n  accepted_date:\n    \'#type\': datetime\n    \'#title\': \'Application Accepted Date\'\n    \'#access_create_roles\': {  }\n    \'#access_update_roles\': {  }\n    \'#access_view_roles\':\n      - authenticated\n  rejected_date:\n    \'#type\': datetime\n    \'#title\': \'Application Rejected Date\'\n    \'#access_create_roles\': {  }\n    \'#access_update_roles\': {  }\n    \'#access_view_roles\':\n      - authenticated\n\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:53:\"Application: [webform_submission:values:contact:name]\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:1:{i:0;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"71791fe0-a40a-4713-9041-af2a3aea0fc5\";s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"9oVBTGFeW-eXo3mn4Pb_ra7Dbjf1Sae7qvNAg2ZXqTs\";}}'),('','webform.webform.demo_application_evaluation','a:22:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:35:\"webform_demo_application_evaluation\";}}}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";N;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:27:\"demo_application_evaluation\";s:5:\"title\";s:28:\"Demo: Application Evaluation\";s:11:\"description\";s:132:\"A demonstration of a very basic application evaluation form. This form is attached to the \'Demo: Application\' using a Webform block.\";s:8:\"category\";s:4:\"Demo\";s:8:\"elements\";s:275:\"application_evaluation:\n  \'#type\': fieldset\n  \'#title\': \'Application evaluation\'\n  \'#attributes\':\n    style: \'background-color: #f5f5f2\'\n  rating:\n    \'#type\': webform_rating\n    \'#title\': Rating\n    \'#required\': true\n  comments:\n    \'#type\': textarea\n    \'#title\': Comments\n\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:1:\"1\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:7:\"message\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";i:1;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"8e292e39-6761-4e94-aed0-54f064fbb9e9\";s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"CS7u5MyOwCSWXlsyIy9CacB1VUWJMCG1K6_FGVIgfgY\";}}');
INSERT INTO `config` VALUES ('','webform.webform.email_reminder','a:22:{s:4:\"uuid\";s:36:\"b3f07e4c-011c-48d2-b3b7-76eb6e96916d\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:1:{s:6:\"module\";a:2:{i:0;s:11:\"ma_handlers\";i:1;s:20:\"webform_entity_print\";}}s:20:\"third_party_settings\";a:1:{s:20:\"webform_entity_print\";a:2:{s:8:\"template\";a:3:{s:6:\"header\";s:0:\"\";s:6:\"footer\";s:0:\"\";s:3:\"css\";s:0:\"\";}s:12:\"export_types\";a:1:{s:3:\"pdf\";a:3:{s:7:\"enabled\";b:1;s:9:\"link_text\";s:0:\"\";s:15:\"link_attributes\";a:0:{}}}}}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:14:\"email_reminder\";s:5:\"title\";s:14:\"Email Reminder\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:8:\"Handlers\";s:8:\"elements\";s:281:\"nid:\n  \'#type\': hidden\n  \'#title\': Nid\n  \'#default_value\': \'[current-page:node:nid]\'\npath:\n  \'#type\': hidden\n  \'#title\': Path\n  \'#default_value\': \'/node/[current-page:node:nid]\'\nactions:\n  \'#type\': webform_actions\n  \'#title\': \'Submit button(s)\'\n  \'#submit__label\': \'Email Reminder\'\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:1;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:1;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:7:\"message\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:1;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:1:{s:21:\"mail_reminder_handler\";a:7:{s:2:\"id\";s:21:\"mail_reminder_handler\";s:5:\"label\";s:21:\"Mail Reminder handler\";s:10:\"handler_id\";s:21:\"mail_reminder_handler\";s:6:\"status\";b:1;s:10:\"conditions\";a:0:{}s:6:\"weight\";i:0;s:8:\"settings\";a:0:{}}}s:8:\"variants\";a:0:{}}'),('','webform.webform.mail_invitation','a:22:{s:4:\"uuid\";s:36:\"295b8870-9867-4573-89e1-104cf19c5ec0\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:1:{s:6:\"module\";a:2:{i:0;s:11:\"ma_handlers\";i:1;s:20:\"webform_entity_print\";}}s:20:\"third_party_settings\";a:1:{s:20:\"webform_entity_print\";a:2:{s:8:\"template\";a:3:{s:6:\"header\";s:0:\"\";s:6:\"footer\";s:0:\"\";s:3:\"css\";s:0:\"\";}s:12:\"export_types\";a:1:{s:3:\"pdf\";a:3:{s:7:\"enabled\";b:1;s:9:\"link_text\";s:0:\"\";s:15:\"link_attributes\";a:0:{}}}}}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:15:\"mail_invitation\";s:5:\"title\";s:16:\"Email Invitation\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:8:\"Handlers\";s:8:\"elements\";s:283:\"nid:\n  \'#type\': hidden\n  \'#title\': Nid\n  \'#default_value\': \'[current-page:node:nid]\'\npath:\n  \'#type\': hidden\n  \'#title\': Path\n  \'#default_value\': \'/node/[current-page:node:nid]\'\nactions:\n  \'#type\': webform_actions\n  \'#title\': \'Submit button(s)\'\n  \'#submit__label\': \'Email Invitation\'\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:1;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:1;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:7:\"message\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:1;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:1:{s:23:\"mail_invitation_handler\";a:7:{s:2:\"id\";s:23:\"mail_invitation_handler\";s:5:\"label\";s:23:\"Mail Invitation handler\";s:10:\"handler_id\";s:23:\"mail_invitation_handler\";s:6:\"status\";b:1;s:10:\"conditions\";a:0:{}s:6:\"weight\";i:0;s:8:\"settings\";a:0:{}}}s:8:\"variants\";a:0:{}}'),('','webform.webform.materiality_analysis','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:6:\"closed\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:20:\"materiality_analysis\";s:5:\"title\";s:20:\"Materiality Analysis\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:4960:\"aspect_prioritization:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Aspect Selection\'\n  \'#prev_button_label\': \'Aspect Selection\'\n  aspects_selection:\n    \'#type\': webform_tableselect_sort\n    \'#title\': Economic\n    \'#multiple\': 12\n    \'#options\':\n      \'Anti-competitive behaviour\': \'Anti-competitive behaviour\'\n      Control: Control\n      \'Economic externalities\': \'Economic externalities\'\n      \'Financial performance\': \'Financial performance\'\n      \'Improvement of health services\': \'Improvement of health services\'\n      \'Intellectual property\': \'Intellectual property\'\n      Market: Market\n      \'Organizational efficiency\': \'Organizational efficiency\'\n      \'Resources allocated\': \'Resources allocated\'\n    \'#required\': true\n    \'#format\': value\n  efficacy:\n    \'#type\': webform_tableselect_sort\n    \'#title\': Efficacy\n    \'#multiple\': 12\n    \'#options\':\n      \'Drug supply to patient\': \'Drug supply to patient\'\n      Governance: Governance\n      \'Health service assessment\': \'Health service assessment\'\n      \'Health services and products accessibility\': \'Health services and products accessibility\'\n      \'Healthcare practitioners human capital\': \'Healthcare practitioners human capital\'\n      \'Improvement of health services\': \'Improvement of health services\'\n      \'Influence on patient behaviour\': \'Influence on patient behaviour\'\n      \'Patient satisfaction\': \'Patient satisfaction\'\n      \'Stakeholder engagement\': \'Stakeholder engagement\'\n    \'#required\': true\n    \'#format\': value\n  excellence:\n    \'#type\': webform_tableselect_sort\n    \'#title\': Excellence\n    \'#multiple\': 12\n    \'#options\':\n      \'Academic production\': \'Academic production\'\n      \'Anticipatory design\': \'Anticipatory design\'\n      \'Researchers\'\' human capital\': \'Researchers\'\' human capital\'\n      \'Research recognition\': \'Research recognition\'\n      \'Research partnership\': \'Research partnership\'\n      \'Products generated\': \'Products generated\'\n      \'Patient engagement & involvement\': \'Patient engagement & involvement\'\n      \'Intellectual property\': \'Intellectual property\'\n      \'Informing healthcare practice decision making\': \'Informing healthcare practice decision making\'\n      \'Influence on subsequent research\': \'Influence on subsequent research\'\n      \'Influence on public behaviour\': \'Influence on public behaviour\'\n      \'Indicate the overall aspecy that the indicator evaluates within each dimension.\': \'Indicate the overall aspecy that the indicator evaluates within each dimension.\'\n      \'Impact evaluation\': \'Impact evaluation\'\n      \'Financial resources\': \'Financial resources\'\n      \'Ethics and integrity\': \'Ethics and integrity\'\n      Compliance: Compliance\n      Communication: Communication\n      Bibliometric: Bibliometric\n      \'Resources allocated\': \'Resources allocated\'\n      \'Scientific input\': \'Scientific input\'\n    \'#required\': true\n    \'#format\': value\n  social:\n    \'#type\': webform_tableselect_sort\n    \'#title\': Social\n    \'#multiple\': 12\n    \'#options\':\n      \'Audits and certification\': \'Audits and certification\'\n      \'Ethical marketing\': \'Ethical marketing\'\n      \'Impact on communities\': \'Impact on communities\'\n      \'Labour rights\': \'Labour rights\'\n      \'Political contributions\': \'Political contributions\'\n      \'Political influence\': \'Political influence\'\n      Pollution: Pollution\n      Reputation: Reputation\n      \'Safety and security\': \'Safety and security\'\n      \'Scope and parameters of information\': \'Scope and parameters of information\'\n      \'Stakeholder engagement\': \'Stakeholder engagement\'\n      \'Sustainable consumption\': \'Sustainable consumption\'\n      \'Training and education\': \'Training and education\'\n    \'#required\': true\n    \'#format\': value\naspect_selection:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Aspect Prioritization\'\n  please_prioritize_the_selected_aspects_drag_n_drop_:\n    \'#type\': webform_section\n    \'#title\': \'Please prioritize the selected aspects (drag n drop)\'\n    priotity_aspects:\n      \'#type\': webform_table_sort\n      \'#title\': \'Aspects Priority\'\n      \'#options\':\n        \'Anti-competitive behaviour\': \'Anti-competitive behaviour\'\n        Communication: Communication\n        \'Ethical marketing\': \'Ethical marketing\'\n        \'Impact evaluation\': \'Impact evaluation\'\n        \'Improvement of health services\': \'Improvement of health services\'\n        \'Influence on subsequent research\': \'Influence on subsequent research\'\n        Labour: Labour\n        Market: Market\n        \'Political externalities\': \'Political externalities\'\n        \'Researchers\'\' human capital\': \'Researchers\'\' human capital\'\n        \'Socio-environmental impacts\': \'Socio-environmental impacts\'\n        \'Patient satisfaction\': \'Patient satisfaction\'\n        \'Informing healthcare practice decision making\': \'Informing healthcare practice decision making\'\n        \'Products generated\': \'Products generated\'\n        \'Stakeholder engagement\': \'Stakeholder engagement\'\n      \'#required\': true\n      \'#format\': value\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"7ab2d1ae-d3c2-47a2-9fb6-c390b903c7b3\";}'),('','webform.webform.mscu_ecf_2018_academic_mscu','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:6:\"closed\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:27:\"mscu_ecf_2018_academic_mscu\";s:5:\"title\";s:39:\"OLD_MSCU – ECF – 2018 Academic MSCU\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:10418:\"country:\n  \'#type\': textfield\n  \'#title\': Country\n  \'#required\': true\nprovince_state:\n  \'#type\': textfield\n  \'#title\': Province/State\nhospital_university_centre:\n  \'#type\': textfield\n  \'#title\': Hospital/University/Centre\n  \'#required\': true\nyear:\n  \'#type\': number\n  \'#title\': Year\n  \'#min\': 1945\n  \'#max\': 2020\nhorizontal_rule1:\n  \'#type\': webform_horizontal_rule\nepidemiology_in_your_country:\n  \'#type\': webform_section\n  \'#title\': \'Epidemiology: (in your country)\'\n  \'#title_tag\': h4\n  number_of_patients_of_ms_attended_in_one_year:\n    \'#type\': number\n    \'#title\': \'Incidence per 100.000 population\'\n    \'#required\': true\n  incidence_per_100_000_population_second_format_:\n    \'#type\': range\n    \'#title\': \'Incidence per 100.000 population (second format)\'\n    \'#step\': 20\n    \'#output\': above\n  prevalence_per_100_000_population:\n    \'#type\': radios\n    \'#title\': \'Prevalence per 100.000 population\'\n    \'#options\':\n      \'<50\': \'<50\'\n      51-100: 51-100\n      100-150: 100-150\n      150-200: 150-200\n      \'>200\': \'>200\'\nflexbox:\n  \'#type\': fieldset\n  \'#title\': \'Neurological Service \'\n  _which_proportion_of_ms_patients_country_are_care_for_in_tick_:\n    \'#type\': webform_section\n    \'#title\': \'Which proportion of MS patients (%) country are care for in (tick)\'\n    \'#title_tag\': h3\n    ms_clinics_in_university_hospitals1:\n      \'#type\': radios\n      \'#title\': \'MS clinics in University Hospitals\'\n      \'#options\':\n        \'< 10%\': \'< 10%\'\n        10-25%: 10-25%\n        25-50%: 25-50%\n        50-75%: 50-75%\n        \'> 75%\': \'> 75%\'\n    ms_clinics_in_non_academic_hospitals:\n      \'#type\': radios\n      \'#title\': \'MS clinics in Non-academic Hospitals\'\n      \'#options\':\n        \'< 10%\': \'< 10%\'\n        10-25%: 10-25%\n        25-50%: 25-50%\n        50-75%: 50-75%\n        \'> 75%\': \'> 75%\'\n    non_academic_hospitals_without_specific_ms_clinic:\n      \'#type\': radios\n      \'#title\': \'Non-academic hospitals without specific MS clinic\'\n      \'#options\':\n        \'< 10%\': \'< 10%\'\n        10-25%: 10-25%\n        25-50%: 25-50%\n        50-75%: 50-75%\n        \'> 75%\': \'> 75%\'\n    practising_neurologists:\n      \'#type\': checkboxes\n      \'#title\': \'Practising Neurologists\'\n      \'#multiple\': 2\n      \'#options\':\n        \'< 500\': \'< 500\'\n        500-1000: 500-1000\n        1000-1500: 1000-1500\n        1500-2000: 1500-2000\n        75-100%: 75-100%\n        \'> 2000\': \'> 2000\'\nexperience_of_the_multiple_sclerosis_care_unit_mscu_in_your_hosp:\n  \'#type\': fieldset\n  \'#title\': \'Experience of the Multiple Sclerosis Care Unit (MSCU) in your hospital – Activity/year\'\n  number_of_patients_of_ms_attended_in_one_yearn:\n    \'#type\': radios\n    \'#title\': \'Number of patients of MS attended in one year\'\n    \'#options\':\n      \'< 500\': \'< 500\'\n      500-1000: 500-1000\n      1000-1500: 1000-1500\n      1500-2000: 1500-2000\n      \'> 2000\': \'> 2000\'\n  processes_in_ms_patients_access_to_routinely_used_:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'Processes in MS patients: (access to, routinely used?)\'\n    \'#options\':\n      \'Blood tests\': \'Blood tests\'\n      \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n      MRI: MRI\n      \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n      \'OCT (optic coherence tomography)\': \'OCT (optic coherence tomography)\'\n    \'#other__option_label\': \'Other ..\'\n    \'#other__placeholder\': \'Please specify\'\nother_variables_yes_no_quantify_and_specify_year:\n  \'#type\': checkboxes\n  \'#title\': \'Other variables (Yes/No, quantify and specify)/year\'\n  \'#options\':\n    Teaching: Teaching\n    \'Continuous Medical Education\': \'Continuous Medical Education\'\n    Research: Research\n    Publications: Publications\nother_activities_carried_out_in_your_centre_:\n  \'#type\': webform_section\n  \'#title\': \'Other activities carried out in your centre \'\n  \'#format\': details-closed\n  teaching:\n    \'#type\': select\n    \'#title\': Teaching\n    \'#options\': yes_no\n  _of_overall_working_activity:\n    \'#type\': number\n    \'#title\': \'% of overall working activity\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"teaching\"]\':\n          \'!value\': \'Yes\'\n  continuous_medical_education:\n    \'#type\': select\n    \'#title\': \'Continuous Medical Education\'\n    \'#options\': yes_no\n  _of_overall_working_activity2:\n    \'#type\': number\n    \'#title\': \'% of overall working activity\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"continuous_medical_education\"]\':\n          \'!value\': \'Yes\'\n  research:\n    \'#type\': select\n    \'#title\': Research\n    \'#options\': yes_no\n  hours_years:\n    \'#type\': number\n    \'#title\': hours/year\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"research\"]\':\n          \'!value\': \'Yes\'\n  publications:\n    \'#type\': select\n    \'#title\': Publications\n    \'#options\': yes_no\n  number_of_publications_year:\n    \'#type\': number\n    \'#title\': \'Number of publications/year\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"publications\"]\':\n          \'!value\': \'Yes\'\nspecific_resources_of_the_mscu:\n  \'#type\': webform_section\n  \'#title\': \'Specific resources of the MSCU\'\n  \'#title_tag\': h5\n  _human_resources_needed_for_the_adequate_assistance_of_ms_patien:\n    \'#type\': label\n    \'#title\': \'Human resources needed for the adequate assistance of MS patients\'\n  neurologists:\n    \'#type\': checkbox\n    \'#title\': Neurologists\n  neurologists_:\n    \'#type\': number\n    \'#title\': \'Neurologists \'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"neurologists\"]\':\n          unchecked: true\n  nurses:\n    \'#type\': number\n    \'#title\': Nurses\n  physiotherapists:\n    \'#type\': number\n    \'#title\': Physiotherapists\n  testa:\n    \'#type\': processed_text\n    \'#display_on\': both\n    \'#text\': |\n      <h5>Basic formation of the members of the team (average experience in years in MS)</h5>\n      \n    \'#format\': basic_html\n  neurologists_1:\n    \'#type\': number\n    \'#title\': \'Neurologists \'\n  nurses1:\n    \'#type\': number\n    \'#title\': Nurses\n  physiotherapists1:\n    \'#type\': number\n    \'#title\': Physiotherapists\n  other_members_of_the_ms_team_:\n    \'#type\': checkboxes\n    \'#title\': \'Other members of the MS team \'\n    \'#options\':\n      \'Occupational therapist\': \'Occupational therapist\'\n      Neuropsychologist: Neuropsychologist\n      \'Speech therapist\': \'Speech therapist\'\n      \'Clinical psychologists\': \'Clinical psychologists\'\n      \'Rehabilitation neurologist\': \'Rehabilitation neurologist\'\n  specific_equipment_necessary_for_the_adequate_assistance_of_ms_p:\n    \'#type\': checkboxes\n    \'#title\': \'Specific equipment, necessary for the adequate assistance of MS patients\'\n    \'#options\':\n      \'Day hospital integrated in the MSCU or available at the centre\': \'Day hospital integrated in the MSCU or available at the centre\'\n      \'Area for extraction and manipulation of body fluids (blood, CSF)\': \'Area for extraction and manipulation of body fluids (blood, CSF)\'\n      \'Area of outpatient assistance\': \'Area of outpatient assistance\'\n      \'Sera/CSF aliquots banking facility: -70ºC\': \'Sera/CSF aliquots banking facility: -70ºC\'\n  system_of_communications_with_patients:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'System of communications with patients\'\n    \'#options\':\n      Telephone: Telephone\n      \'Mobile (SMS)\': \'Mobile (SMS)\'\n      E-mail: E-mail\n      \'Web page\': \'Web page\'\n  resources_of_other_units_or_services_apart_from_the_mscu_necessa:\n    \'#type\': checkboxes\n    \'#title\': \'Resources of other units or services apart from the MSCU, necessary for the adequate provision of care of MS patients\'\n    \'#options\':\n      \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\': \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\'\n      \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\': \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\'\n      \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\': \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\'\n      \'Service/Unit of Immunology that can perform IgG oligoclonal bands\': \'Service/Unit of Immunology that can perform IgG oligoclonal bands\'\n      \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\': \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\'\n      \'Service/Unit of Rehabilitation with experience in the management of MS patients\': \'Service/Unit of Rehabilitation with experience in the management of MS patients\'\n      \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\': \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\'\n      \'Service/Unit of Urology, with experience in the management of MS patients\': \'Service/Unit of Urology, with experience in the management of MS patients\'\n      \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\': \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\'\n      \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \': \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \'\nresources_of_other_units_or_s2:\n  \'#type\': fieldset\n  \'#title\': \'Resources of other units or services apart from the MSCU, necessary for the adequate provision of assistance care of MS patient\'\n  service_unit_of_neuroradiology_with_mri_1_5_tesla_or_more:\n    \'#type\': select\n    \'#title\': \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\'\n    \'#options\': yes_no\n  number:\n    \'#type\': number\n    \'#title\': Number\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"service_unit_of_neuroradiology_with_mri_1_5_tesla_or_more\"]\':\n          \'!value\': \'Yes\'\n    \'#min\': 0\n  service_unit_of_neurophysiology_with_the_possibility_to_perform_:\n    \'#type\': select\n    \'#title\': \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor) \'\n    \'#options\': yes_no\n  number1:\n    \'#type\': number\n    \'#title\': Number\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"service_unit_of_neurophysiology_with_the_possibility_to_perform_\"]\':\n          \'!value\': \'Yes\'\n    \'#min\': 0\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:1;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"1ce55b38-c5f5-4070-a227-8d0c1ad6929a\";}'),('','webform.webform.mscu_ecf_2018_academic_mscu_init','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:32:\"mscu_ecf_2018_academic_mscu_init\";s:5:\"title\";s:38:\"MSCU – ECF – 2018 Academic MSCU_v1\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:25500:\"general_information:\n  \'#type\': webform_wizard_page\n  \'#title\': \'GENERAL INFORMATION\'\n  general_information1:\n    \'#type\': webform_section\n    \'#title\': \'GENERAL INFORMATION\'\n    name_of_the_organization:\n      \'#type\': textfield\n      \'#title\': \'NAME OF THE ORGANIZATION\'\n    country:\n      \'#type\': select\n      \'#title\': Country\n      \'#options\': country_names\n      \'#options_display\': side_by_side\n    province_state:\n      \'#type\': textfield\n      \'#title\': Province/State\n    indicate_the_type_of_organization:\n      \'#type\': webform_radios_other\n      \'#title\': \'INDICATE THE TYPE OF ORGANIZATION\'\n      \'#options\':\n        HOSPITAL: HOSPITAL\n        UNIVERSITY: UNIVERSITY\n        \'RESEARCH CENTRE\': \'RESEARCH CENTRE\'\n        \'HEALTHCARE ORGANIZATION\': \'HEALTHCARE ORGANIZATION\'\n        \'REGIONAL AUTHORITY\': \'REGIONAL AUTHORITY\'\n      \'#other__placeholder\': \'Please specify\'\n    year:\n      \'#type\': number\n      \'#title\': Year\n      \'#min\': 1945\n      \'#max\': 2020\nms_in_your_country:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MS IN YOUR COUNTRY\'\n  ms_in_your_country1:\n    \'#type\': webform_section\n    \'#title\': \'MS IN YOUR COUNTRY\'\n    epidemiology_in_your_country:\n      \'#type\': webform_section\n      \'#title\': \'EPIDEMIOLOGY/ WHO GETS MS?\'\n      \'#title_tag\': h4\n      prevalence_per_100_000_population:\n        \'#type\': radios\n        \'#title\': \'Prevalence rates per 100.000\'\n        \'#options\':\n          \'<25\': \'<25\'\n          25-50: 25-50\n          51-100: 51-100\n          101-150: 101-150\n          151-200: 151-200\n          \'>200\': \'>200\'\n      incidence_rates_per_100_000:\n        \'#type\': radios\n        \'#title\': \'Incidence rates per 100.000\'\n        \'#options\':\n          \'<1\': \'<1\'\n          1-2: 1-2\n          3-5: 3-5\n          6-10: 6-10\n          \'>10\': \'>10\'\n    _which_proportion_of_ms_patients_country_are_care_for_in_tick_:\n      \'#type\': webform_section\n      \'#title\': \'Which proportion of MS patients (%) country are care for in\'\n      \'#title_tag\': h3\n      ms_clinics_in_university_hospitals1:\n        \'#type\': radios\n        \'#title\': \'MS clinics in University Hospitals\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n      ms_clinics_in_non_academic_hospitals:\n        \'#type\': radios\n        \'#title\': \'MS clinics in Non-academic Hospitals\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n      non_academic_hospitals_without_specific_ms_clinic:\n        \'#type\': radios\n        \'#title\': \'Non-academic hospitals without specific MS clinic\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n      practising_neurologists:\n        \'#type\': radios\n        \'#title\': \'Practising Neurologists\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\nmscu_in_your_hospital:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU IN YOUR HOSPITAL\'\n  mscu_in_your_hospital1:\n    \'#type\': webform_section\n    \'#title\': \'EXPERIENCE OF THE MULTIPLE SCLEROSIS CARE UNIT (MSCU) IN YOUR HOSPITAL – ACTIVITY/YEAR\'\n    number_of_patients_of_ms_attended_in_one_yearn:\n      \'#type\': radios\n      \'#title\': \'Number of patients of MS attended in one year\'\n      \'#options\':\n        \'< 500\': \'< 500\'\n        500-1000: 500-1000\n        1000-1500: 1000-1500\n        1500-2000: 1500-2000\n        \'> 2000\': \'> 2000\'\n    processes_in_ms_patients_access_to_routinely_used_:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'Exams for MS Patients to assess the hospital\'\n      \'#options\':\n        \'Blood tests\': \'Blood tests\'\n        \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n        MRI: MRI\n        \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n        \'OCT (optic coherence tomography)\': \'OCT (optic coherence tomography)\'\n      \'#other__option_label\': \'Other ..\'\n      \'#other__placeholder\': \'Please specify\'\n    exams_routinely_performed_for_ms_patients_in_your_hospital:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'Exams routinely performed for MS Patients in your hospital\'\n      \'#options\':\n        \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n        MRI: MRI\n        \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n        \'OCT (optic coherence tomography)\': \'OCT (optic coherence tomography)\'\n      \'#other__option_label\': \'Other ..\'\n      \'#other__placeholder\': \'Please specify\'\nother_activities_in_your_center1:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER ACTIVITIES IN YOUR CENTER\'\n  other_activities_carried_out_in_your_centre:\n    \'#type\': webform_section\n    \'#title\': \'Other activities carried out in your centre\'\n    teaching1:\n      \'#type\': checkbox\n      \'#title\': Teaching\n    _of_overall_working_activity:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"teaching1\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n    continuous_medical_education:\n      \'#type\': checkbox\n      \'#title\': \'Continuous Medical Education\'\n    _of_overall_working_activity2:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"continuous_medical_education\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n    research:\n      \'#type\': checkbox\n      \'#title\': Research\n    hours_years:\n      \'#type\': number\n      \'#title\': hours/year\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"research\"]\':\n            unchecked: true\n      \'#min\': 0\n    publications:\n      \'#type\': checkbox\n      \'#title\': Publications\n    number_of_publications_year:\n      \'#type\': number\n      \'#title\': \'Number of publications/year\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"publications\"]\':\n            unchecked: true\n      \'#min\': 0\nmscr_specific_equipments:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU SPECIFIC RESOURSES\'\n  mscr_specific_equipments1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU SPECIFIC RESOURSES\'\n    specific_resources_of_the_mscu:\n      \'#type\': webform_section\n      \'#title\': \'HEALTH CARE PROFESSIONALS NEEDED FOR THE ADEGUATE ASSISTANCE OF MS PATIENTS\'\n      neurologists:\n        \'#type\': checkbox\n        \'#title\': Neurologists\n      neurologists_1:\n        \'#type\': number\n        \'#title\': \'number of Neurologists \'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"neurologists\"]\':\n              unchecked: true\n        \'#min\': 0\n      nurses1:\n        \'#type\': checkbox\n        \'#title\': Nurses\n      nurses:\n        \'#type\': number\n        \'#title\': \'number of Nurses\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"nurses1\"]\':\n              unchecked: true\n        \'#min\': 0\n      physiotherapists11:\n        \'#type\': checkbox\n        \'#title\': Physiotherapists\n      physiotherapists:\n        \'#type\': number\n        \'#title\': \'number of Physiotherapists\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"physiotherapists11\"]\':\n              unchecked: true\n      others:\n        \'#type\': checkbox\n        \'#title\': Other\n      specialty:\n        \'#type\': textfield\n        \'#title\': Specialty\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"others\"]\':\n              unchecked: true\n      number_of_specialty:\n        \'#type\': number\n        \'#title\': \'number of Specialty\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"others\"]\':\n              unchecked: true\n      additional_health_care_professionals:\n        \'#type\': checkboxes\n        \'#title\': \'ADDITIONAL HEALTH CARE PROFESSIONALS\'\n        \'#options\':\n          \'OCCUPATIONAL THERAPIST \': \'OCCUPATIONAL THERAPIST \'\n          NEUROPSYCHOLOGIST: NEUROPSYCHOLOGIST\n          \'SPEECH THERAPIST    \': \'SPEECH THERAPIST    \'\n          \'CLINICAL PSYCHOLOGISTS \': \'CLINICAL PSYCHOLOGISTS \'\n          \'REHABILITATION NEUROLOGIST/PHYSICIAN \': \'REHABILITATION NEUROLOGIST/PHYSICIAN \'\nmscr_specific_equipments12:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n  mscr_specific_equipments11:\n    \'#type\': webform_section\n    \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n    day_hospital_integrated_in_the_mscu_or_available_at_the_centre:\n      \'#type\': select\n      \'#title\': \'DAY HOSPITAL INTEGRATED IN THE MSCU OR AVAILABLE AT THE CENTRE\'\n      \'#options\': yes_no\n    area_for_extraction_and_manipulation_of_body_fluids_blood_csf_:\n      \'#type\': select\n      \'#title\': \'AREA FOR EXTRACTION AND MANIPULATION OF BODY FLUIDS (BLOOD, CSF)\'\n      \'#options\': yes_no\n    area_of_outpatient_assistance:\n      \'#type\': select\n      \'#title\': \'AREA OF OUTPATIENT ASSISTANCE\'\n      \'#options\': yes_no\n    system_of_communications_with_patients:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'System of communications with patients\'\n      \'#options\':\n        Telephone: Telephone\n        \'Mobile (SMS)\': \'Mobile (SMS)\'\n        E-mail: E-mail\n        \'Web page\': \'Web page\'\nother_hospital_units_services:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER HOSPITAL UNITS_SERVICES\'\n  other_hospital_units_services1:\n    \'#type\': webform_section\n    \'#title\': \'RESOURCES OF OTHER UNITS OR SERVICES APART FROM THE MSCU, NECESSARY FOR THE ADEQUATE PROVISION OF CARE FOR MS PATIENTS \'\n    resources_of_other_units_or_services_apart_from_the_mscu_necessa:\n      \'#type\': checkboxes\n      \'#title\': \'Resources of other units or services apart from the MSCU, necessary for the adequate provision of care for MS patients\'\n      \'#options\':\n        \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\': \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\'\n        \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\': \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\'\n        \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\': \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\'\n        \'Service/Unit of Immunology that can perform IgG oligoclonal bands\': \'Service/Unit of Immunology that can perform IgG oligoclonal bands\'\n        \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\': \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\'\n        \'Service/Unit of Rehabilitation with experience in the management of MS patients\': \'Service/Unit of Rehabilitation with experience in the management of MS patients\'\n        \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\': \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\'\n        \'Service/Unit of Urology, with experience in the management of MS patients\': \'Service/Unit of Urology, with experience in the management of MS patients\'\n        \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\': \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\'\n        \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \': \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \'\nmscu_kpis:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n  mscu_kpis1:\n    \'#type\': webform_section\n    \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n    number_of_treatments_administered_in_the_day_hospital_outpatient:\n      \'#type\': number\n      \'#title\': \'NUMBER OF TREATMENTS ADMINISTERED IN THE DAY HOSPITAL/OUTPATIENT CLINIC.\'\n      \'#min\': 0\n    number_of_treated_exacerbations_relapses_:\n      \'#type\': number\n      \'#title\': \'NUMBER OF TREATED EXACERBATIONS (RELAPSES)\'\n      \'#min\': 0\n    number_and_severity_of_adverse_events_who_scale_qualitative_vari:\n      \'#type\': number\n      \'#title\': \'NUMBER AND SEVERITY OF ADVERSE EVENTS. WHO SCALE: QUANTITATIVE VARIABLE (NUMBER OF CASES)\'\n      \'#min\': 0\n    umber_and_severity_of_adverse:\n      \'#type\': number\n      \'#title\': \"NUMBER AND SEVERITY OF ADVERSE EVENTS. WHO SCALE:  QUALITATIVE VARIABLE (SEVERITY).\\_\"\n      \'#min\': 0\n    use_of_disability_progression_expanded_disability_status_scale_e:\n      \'#type\': checkbox\n      \'#title\': \'USE OF DISABILITY PROGRESSION, EXPANDED DISABILITY STATUS SCALE (EDSS)\'\n      \'#attributes\':\n        class:\n          - veryStrong\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    assessment_of_degree_of_satisfaction_of_users:\n      \'#type\': checkbox\n      \'#title\': \'ASSESSMENT OF DEGREE OF SATISFACTION OF USERS\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    amministrative_data:\n      \'#type\': checkbox\n      \'#title\': \'ADMINISTRATIVE DATA\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    cost_questionnaire:\n      \'#type\': checkbox\n      \'#title\': \'COST QUESTIONNAIRE\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\nmscu_registry:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU REGISTRY\'\n  mscu_registry1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU REGISTRY\'\n    does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_:\n      \'#type\': select\n      \'#title\': \'DOES MSCU HAVE A REGISTRY OF PATIENTS WITH MULTIPLE SCLEROSIS?\'\n      \'#options\': yes_no\n    please_tick_which_of_the_following_data_are_recorded_in_the_mscu:\n      \'#type\': label\n      \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    minimal_data_set_requirement:\n      \'#type\': checkboxes\n      \'#title\': \'MINIMAL DATA SET REQUIREMENT\'\n      \'#options\':\n        \'NUMBER OF PATIENT IDENTIFICATION\': \'NUMBER OF PATIENT IDENTIFICATION\'\n        \'DATE OF BIRTH\': \'DATE OF BIRTH\'\n        SEX: SEX\n        \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\': \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\'\n        \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \': \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \'\n        \'OTHER DIAGNOSIS (ICD-9-MC)\': \'OTHER DIAGNOSIS (ICD-9-MC)\'\n        \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \': \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    evoked_potentials_ep_:\n      \'#type\': checkboxes\n      \'#title\': \'Evoked potentials (EP)\'\n      \'#options\':\n        \'Visual EP\': \'Visual EP\'\n        \'Auditory EP\': \'Auditory EP\'\n        \'Somatosensory EP\': \'Somatosensory EP\'\n        \'Motor EP\': \'Motor EP\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    hospital_admissions:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'HOSPITAL ADMISSIONS\'\n      \'#options\':\n        \'DATE OF HOSPITALIZATION\': \'DATE OF HOSPITALIZATION\'\n        \'DATE HOSPITAL DISCHARGE\': \'DATE HOSPITAL DISCHARGE\'\n        \'TYPE OF HOSPITALIZATION\': \'TYPE OF HOSPITALIZATION\'\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_hospital_discharge_:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF HOSPITAL DISCHARGE \'\n      \'#options\':\n        Home: Home\n        \'Transfer to another hospital\': \'Transfer to another hospital\'\n        \'Voluntary discharge\': \'Voluntary discharge\'\n        \'Transfer to another sanitary facility \': \'Transfer to another sanitary facility \'\n        Death: Death\n        \'Service responsible of discharge. \': \'Service responsible of discharge. \'\n        \'Principal diagnosis (ICD-9-MC)\': \'Principal diagnosis (ICD-9-MC)\'\n        \'Other diagnosis (ICD-9-MC)\': \'Other diagnosis (ICD-9-MC)\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    x_ray:\n      \'#type\': checkbox\n      \'#title\': X-Ray\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n  please_tick_which_of_the_following_data2:\n    \'#type\': webform_section\n    \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY FOR OUTPATIENT VISITS?\'\n    date_of_visit:\n      \'#type\': checkbox\n      \'#title\': \'DATE OF VISIT\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF VISIT\'\n      \'#options\':\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    reason_for_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'REASON FOR VISIT\'\n      \'#options\':\n        DIAGNOSTIC: DIAGNOSTIC\n        RELAPSE: RELAPSE\n        \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\': \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests2:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_2:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri2:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_2:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\ntreatments_available:\n  \'#type\': webform_wizard_page\n  \'#title\': \'TREATMENTS AVAILABLE\'\n  treatments_available1:\n    \'#type\': webform_section\n    \'#title\': \'TREATMENTS AVAILABLE\'\n    immunomodulator_treatment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'IMMUNOMODULATOR TREATMENT\'\n      \'#options\':\n        Betaseron: Betaseron\n        Extavia: Extavia\n        Avonex: Avonex\n        Copaxone: Copaxone\n        \'Generic Glatiramer\': \'Generic Glatiramer\'\n        \'Rebif® (interferon beta-1a)\': \'Rebif® (interferon beta-1a)\'\n        \'Plegridy® (PEG-Interferon)\': \'Plegridy® (PEG-Interferon)\'\n    immunosuppressant_treatment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'IMMUNOSUPPRESSANT TREATMENT\'\n      \'#options\':\n        \'Aubagi® (teriflunmide)\': \'Aubagi® (teriflunmide)\'\n        \'Tecfidera® (dimethyl fumarate)\': \'Tecfidera® (dimethyl fumarate)\'\n        \'Tysabri® (natalizumab)\': \'Tysabri® (natalizumab)\'\n        \'Gilenya® (finglimd)\': \'Gilenya® (finglimd)\'\n        \'Lemtrada® (alemtuzumab)\': \'Lemtrada® (alemtuzumab)\'\n        \'Nvantrne® (mitxantrne) \': \'Nvantrne® (mitxantrne) \'\n        \'Mavenclad® (cladribine)\': \'Mavenclad® (cladribine)\'\n        \'crevus® (crelizumab)\': \'crevus® (crelizumab)\'\n        Rituximab: Rituximab\n        Azathiprine: Azathiprine\n        Methtrexate: Methtrexate\n        Cyclphsphamide: Cyclphsphamide\n    autologous_hematopoietic_stem_cell_transplantation_asct_:\n      \'#type\': select\n      \'#title\': \'AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT)\'\n      \'#options\': yes_no\n    other_therapeutic_procedures:\n      \'#type\': checkbox\n      \'#title\': \'OTHER THERAPEUTIC PROCEDURES\'\n    please_specify:\n      \'#type\': textarea\n      \'#title\': \'PLEASE SPECIFY\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"other_therapeutic_procedures\"]\':\n            unchecked: true\n    _adverse_effects:\n      \'#type\': checkboxes\n      \'#title\': \' ADVERSE EFFECTS\'\n      \'#options\':\n        ICD-9-MC: ICD-9-MC\n        MEDRA: MEDRA\n        \'WHO Toxicity Grading Scale\': \'WHO Toxicity Grading Scale\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:1;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:1;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:1;s:26:\"wizard_progress_percentage\";b:1;s:20:\"wizard_progress_link\";b:1;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:1;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"086d3f76-479a-45d8-be8e-ecbfd908189c\";}'),('','webform.webform.mscu_ecf_2018_non_academic_mscu','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:31:\"mscu_ecf_2018_non_academic_mscu\";s:5:\"title\";s:43:\"MSCU – ECF – 2018 Non Academic Hospital\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:23389:\"general_information:\n  \'#type\': webform_wizard_page\n  \'#title\': \'GENERAL INFORMATION\'\n  general_information1:\n    \'#type\': webform_section\n    \'#title\': \'GENERAL INFORMATION\'\n    name_of_the_organization:\n      \'#type\': textfield\n      \'#title\': \'NAME OF THE ORGANIZATION\'\n    country:\n      \'#type\': select\n      \'#title\': Country\n      \'#options\': country_names\n      \'#options_display\': side_by_side\n    province_state:\n      \'#type\': textfield\n      \'#title\': Province/State\n    indicate_the_type_of_organization:\n      \'#type\': webform_radios_other\n      \'#title\': \'INDICATE THE TYPE OF ORGANIZATION\'\n      \'#options\':\n        HOSPITAL: HOSPITAL\n        UNIVERSITY: UNIVERSITY\n        \'RESEARCH CENTRE\': \'RESEARCH CENTRE\'\n        \'HEALTHCARE ORGANIZATION\': \'HEALTHCARE ORGANIZATION\'\n        \'REGIONAL AUTHORITY\': \'REGIONAL AUTHORITY\'\n      \'#other__placeholder\': \'Please specify\'\n    year:\n      \'#type\': number\n      \'#title\': Year\n      \'#min\': 1945\n      \'#max\': 2020\nmscu_in_your_hospital:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU IN YOUR HOSPITAL\'\n  mscu_in_your_hospital1:\n    \'#type\': webform_section\n    \'#title\': \'EXPERIENCE OF THE MULTIPLE SCLEROSIS CARE UNIT (MSCU) IN YOUR HOSPITAL – ACTIVITY/YEAR\'\n    number_of_patients_of_ms_attended_in_one_yearn:\n      \'#type\': radios\n      \'#title\': \'Number of patients of MS attended in one year\'\n      \'#options\':\n        \'< 500\': \'< 500\'\n        500-1000: 500-1000\n        1000-1500: 1000-1500\n        1500-2000: 1500-2000\n        \'> 2000\': \'> 2000\'\n    processes_in_ms_patients_access_to_routinely_used_:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'Exams for MS Patients to assess the hospital\'\n      \'#options\':\n        \'Blood tests\': \'Blood tests\'\n        \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n        MRI: MRI\n        \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n        \'OCT (optic coherence tomography)\': \'OCT (optic coherence tomography)\'\n      \'#other__option_label\': \'Other ..\'\n      \'#other__placeholder\': \'Please specify\'\n    exams_routinely_performed_for_ms_patients_in_your_hospital:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'Exams routinely performed for MS Patients in your hospital\'\n      \'#options\':\n        \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n        MRI: MRI\n        \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n        \'OCT (optic coherence tomography)\': \'OCT (optic coherence tomography)\'\n      \'#other__option_label\': \'Other ..\'\n      \'#other__placeholder\': \'Please specify\'\nother_activities_in_your_center1:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER ACTIVITIES IN YOUR CENTER\'\n  other_activities_carried_out_in_your_centre:\n    \'#type\': webform_section\n    \'#title\': \'Other activities carried out in your centre\'\n    teaching1:\n      \'#type\': checkbox\n      \'#title\': Teaching\n    _of_overall_working_activity:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"teaching1\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n    continuous_medical_education:\n      \'#type\': checkbox\n      \'#title\': \'Continuous Medical Education\'\n    _of_overall_working_activity2:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"continuous_medical_education\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n    research:\n      \'#type\': checkbox\n      \'#title\': Research\n    hours_years:\n      \'#type\': number\n      \'#title\': hours/year\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"research\"]\':\n            unchecked: true\n      \'#min\': 0\n    publications:\n      \'#type\': checkbox\n      \'#title\': Publications\n    number_of_publications_year:\n      \'#type\': number\n      \'#title\': \'Number of publications/year\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"publications\"]\':\n            unchecked: true\n      \'#min\': 0\nmscr_specific_equipments:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU SPECIFIC RESOURSES\'\n  mscr_specific_equipments1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU SPECIFIC RESOURSES\'\n    specific_resources_of_the_mscu:\n      \'#type\': webform_section\n      \'#title\': \'HEALTH CARE PROFESSIONALS NEEDED FOR THE ADEGUATE ASSISTANCE OF MS PATIENTS\'\n      neurologists:\n        \'#type\': checkbox\n        \'#title\': Neurologists\n      neurologists_1:\n        \'#type\': number\n        \'#title\': \'number of Neurologists \'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"neurologists\"]\':\n              unchecked: true\n        \'#min\': 0\n      nurses1:\n        \'#type\': checkbox\n        \'#title\': Nurses\n      nurses:\n        \'#type\': number\n        \'#title\': \'number of Nurses\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"nurses1\"]\':\n              unchecked: true\n        \'#min\': 0\n      physiotherapists11:\n        \'#type\': checkbox\n        \'#title\': Physiotherapists\n      physiotherapists:\n        \'#type\': number\n        \'#title\': \'number of Physiotherapists\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"physiotherapists11\"]\':\n              unchecked: true\n      others:\n        \'#type\': checkbox\n        \'#title\': Other\n      specialty:\n        \'#type\': textfield\n        \'#title\': Specialty\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"others\"]\':\n              unchecked: true\n      number_of_specialty:\n        \'#type\': number\n        \'#title\': \'number of Specialty\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"others\"]\':\n              unchecked: true\n      additional_health_care_professionals:\n        \'#type\': checkboxes\n        \'#title\': \'ADDITIONAL HEALTH CARE PROFESSIONALS\'\n        \'#options\':\n          \'OCCUPATIONAL THERAPIST \': \'OCCUPATIONAL THERAPIST \'\n          NEUROPSYCHOLOGIST: NEUROPSYCHOLOGIST\n          \'SPEECH THERAPIST    \': \'SPEECH THERAPIST    \'\n          \'CLINICAL PSYCHOLOGISTS \': \'CLINICAL PSYCHOLOGISTS \'\n          \'REHABILITATION NEUROLOGIST/PHYSICIAN \': \'REHABILITATION NEUROLOGIST/PHYSICIAN \'\nmscr_specific_equipments12:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n  mscr_specific_equipments11:\n    \'#type\': webform_section\n    \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n    day_hospital_integrated_in_the_mscu_or_available_at_the_centre:\n      \'#type\': select\n      \'#title\': \'DAY HOSPITAL INTEGRATED IN THE MSCU OR AVAILABLE AT THE CENTRE\'\n      \'#options\': yes_no\n    area_for_extraction_and_manipulation_of_body_fluids_blood_csf_:\n      \'#type\': select\n      \'#title\': \'AREA FOR EXTRACTION AND MANIPULATION OF BODY FLUIDS (BLOOD, CSF)\'\n      \'#options\': yes_no\n    area_of_outpatient_assistance:\n      \'#type\': select\n      \'#title\': \'AREA OF OUTPATIENT ASSISTANCE\'\n      \'#options\': yes_no\n    system_of_communications_with_patients:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'System of communications with patients\'\n      \'#options\':\n        Telephone: Telephone\n        \'Mobile (SMS)\': \'Mobile (SMS)\'\n        E-mail: E-mail\n        \'Web page\': \'Web page\'\nother_hospital_units_services:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER HOSPITAL UNITS_SERVICES\'\n  other_hospital_units_services1:\n    \'#type\': webform_section\n    \'#title\': \'RESOURCES OF OTHER UNITS OR SERVICES APART FROM THE MSCU, NECESSARY FOR THE ADEQUATE PROVISION OF CARE FOR MS PATIENTS \'\n    resources_of_other_units_or_services_apart_from_the_mscu_necessa:\n      \'#type\': checkboxes\n      \'#title\': \'Resources of other units or services apart from the MSCU, necessary for the adequate provision of care for MS patients\'\n      \'#options\':\n        \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\': \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\'\n        \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\': \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\'\n        \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\': \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\'\n        \'Service/Unit of Immunology that can perform IgG oligoclonal bands\': \'Service/Unit of Immunology that can perform IgG oligoclonal bands\'\n        \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\': \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\'\n        \'Service/Unit of Rehabilitation with experience in the management of MS patients\': \'Service/Unit of Rehabilitation with experience in the management of MS patients\'\n        \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\': \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\'\n        \'Service/Unit of Urology, with experience in the management of MS patients\': \'Service/Unit of Urology, with experience in the management of MS patients\'\n        \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\': \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\'\n        \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \': \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \'\nmscu_kpis:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n  mscu_kpis1:\n    \'#type\': webform_section\n    \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n    number_of_treatments_administered_in_the_day_hospital_outpatient:\n      \'#type\': number\n      \'#title\': \'NUMBER OF TREATMENTS ADMINISTERED IN THE DAY HOSPITAL/OUTPATIENT CLINIC.\'\n      \'#min\': 0\n    number_of_treated_exacerbations_relapses_:\n      \'#type\': number\n      \'#title\': \'NUMBER OF TREATED EXACERBATIONS (RELAPSES)\'\n      \'#min\': 0\n    number_and_severity_of_adverse_events_who_scale_qualitative_vari:\n      \'#type\': number\n      \'#title\': \'NUMBER AND SEVERITY OF ADVERSE EVENTS. WHO SCALE: QUANTITATIVE VARIABLE (NUMBER OF CASES)\'\n      \'#min\': 0\n    umber_and_severity_of_adverse:\n      \'#type\': number\n      \'#title\': \"NUMBER AND SEVERITY OF ADVERSE EVENTS. WHO SCALE:  QUALITATIVE VARIABLE (SEVERITY).\\_\"\n      \'#min\': 0\n    use_of_disability_progression_expanded_disability_status_scale_e:\n      \'#type\': checkbox\n      \'#title\': \'USE OF DISABILITY PROGRESSION, EXPANDED DISABILITY STATUS SCALE (EDSS)\'\n      \'#attributes\':\n        class:\n          - veryStrong\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    assessment_of_degree_of_satisfaction_of_users:\n      \'#type\': checkbox\n      \'#title\': \'ASSESSMENT OF DEGREE OF SATISFACTION OF USERS\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    amministrative_data:\n      \'#type\': checkbox\n      \'#title\': \'ADMINISTRATIVE DATA\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    cost_questionnaire:\n      \'#type\': checkbox\n      \'#title\': \'COST QUESTIONNAIRE\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\nmscu_registry:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU REGISTRY\'\n  mscu_registry1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU REGISTRY\'\n    does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_:\n      \'#type\': select\n      \'#title\': \'DOES MSCU HAVE A REGISTRY OF PATIENTS WITH MULTIPLE SCLEROSIS?\'\n      \'#options\': yes_no\n    please_tick_which_of_the_following_data_are_recorded_in_the_mscu:\n      \'#type\': label\n      \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    minimal_data_set_requirement:\n      \'#type\': checkboxes\n      \'#title\': \'MINIMAL DATA SET REQUIREMENT\'\n      \'#options\':\n        \'NUMBER OF PATIENT IDENTIFICATION\': \'NUMBER OF PATIENT IDENTIFICATION\'\n        \'DATE OF BIRTH\': \'DATE OF BIRTH\'\n        SEX: SEX\n        \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\': \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\'\n        \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \': \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \'\n        \'OTHER DIAGNOSIS (ICD-9-MC)\': \'OTHER DIAGNOSIS (ICD-9-MC)\'\n        \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \': \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    evoked_potentials_ep_:\n      \'#type\': checkboxes\n      \'#title\': \'Evoked potentials (EP)\'\n      \'#options\':\n        \'Visual EP\': \'Visual EP\'\n        \'Auditory EP\': \'Auditory EP\'\n        \'Somatosensory EP\': \'Somatosensory EP\'\n        \'Motor EP\': \'Motor EP\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    hospital_admissions:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'HOSPITAL ADMISSIONS\'\n      \'#options\':\n        \'DATE OF HOSPITALIZATION\': \'DATE OF HOSPITALIZATION\'\n        \'DATE HOSPITAL DISCHARGE\': \'DATE HOSPITAL DISCHARGE\'\n        \'TYPE OF HOSPITALIZATION\': \'TYPE OF HOSPITALIZATION\'\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_hospital_discharge_:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF HOSPITAL DISCHARGE \'\n      \'#options\':\n        Home: Home\n        \'Transfer to another hospital\': \'Transfer to another hospital\'\n        \'Voluntary discharge\': \'Voluntary discharge\'\n        \'Transfer to another sanitary facility \': \'Transfer to another sanitary facility \'\n        Death: Death\n        \'Service responsible of discharge. \': \'Service responsible of discharge. \'\n        \'Principal diagnosis (ICD-9-MC)\': \'Principal diagnosis (ICD-9-MC)\'\n        \'Other diagnosis (ICD-9-MC)\': \'Other diagnosis (ICD-9-MC)\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    x_ray:\n      \'#type\': checkbox\n      \'#title\': X-Ray\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n  please_tick_which_of_the_following_data2:\n    \'#type\': webform_section\n    \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY FOR OUTPATIENT VISITS?\'\n    date_of_visit:\n      \'#type\': checkbox\n      \'#title\': \'DATE OF VISIT\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF VISIT\'\n      \'#options\':\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    reason_for_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'REASON FOR VISIT\'\n      \'#options\':\n        DIAGNOSTIC: DIAGNOSTIC\n        RELAPSE: RELAPSE\n        \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\': \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests2:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_2:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri2:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_2:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\ntreatments_available:\n  \'#type\': webform_wizard_page\n  \'#title\': \'TREATMENTS AVAILABLE\'\n  treatments_available1:\n    \'#type\': webform_section\n    \'#title\': \'TREATMENTS AVAILABLE\'\n    immunomodulator_treatment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'IMMUNOMODULATOR TREATMENT\'\n      \'#options\':\n        Betaseron: Betaseron\n        Extavia: Extavia\n        Avonex: Avonex\n        Copaxone: Copaxone\n        \'Generic Glatiramer\': \'Generic Glatiramer\'\n        \'Rebif® (interferon beta-1a)\': \'Rebif® (interferon beta-1a)\'\n        \'Plegridy® (PEG-Interferon)\': \'Plegridy® (PEG-Interferon)\'\n    immunosuppressant_treatment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'IMMUNOSUPPRESSANT TREATMENT\'\n      \'#options\':\n        \'Aubagi® (teriflunmide)\': \'Aubagi® (teriflunmide)\'\n        \'Tecfidera® (dimethyl fumarate)\': \'Tecfidera® (dimethyl fumarate)\'\n        \'Tysabri® (natalizumab)\': \'Tysabri® (natalizumab)\'\n        \'Gilenya® (finglimd)\': \'Gilenya® (finglimd)\'\n        \'Lemtrada® (alemtuzumab)\': \'Lemtrada® (alemtuzumab)\'\n        \'Nvantrne® (mitxantrne) \': \'Nvantrne® (mitxantrne) \'\n        \'Mavenclad® (cladribine)\': \'Mavenclad® (cladribine)\'\n        \'crevus® (crelizumab)\': \'crevus® (crelizumab)\'\n        Rituximab: Rituximab\n        Azathiprine: Azathiprine\n        Methtrexate: Methtrexate\n        Cyclphsphamide: Cyclphsphamide\n    autologous_hematopoietic_stem_cell_transplantation_asct_:\n      \'#type\': select\n      \'#title\': \'AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT)\'\n      \'#options\': yes_no\n    other_therapeutic_procedures:\n      \'#type\': checkbox\n      \'#title\': \'OTHER THERAPEUTIC PROCEDURES\'\n    please_specify:\n      \'#type\': textarea\n      \'#title\': \'PLEASE SPECIFY\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"other_therapeutic_procedures\"]\':\n            unchecked: true\n    _adverse_effects:\n      \'#type\': checkboxes\n      \'#title\': \' ADVERSE EFFECTS\'\n      \'#options\':\n        ICD-9-MC: ICD-9-MC\n        MEDRA: MEDRA\n        \'WHO Toxicity Grading Scale\': \'WHO Toxicity Grading Scale\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:1;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:1;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:1;s:26:\"wizard_progress_percentage\";b:1;s:20:\"wizard_progress_link\";b:1;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:1;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"f7df5ab8-2715-480d-8e49-f81ab6e8c0f1\";}'),('','webform.webform.mscu_ecf_2018_practising_neurolo','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:32:\"mscu_ecf_2018_practising_neurolo\";s:5:\"title\";s:44:\"MSCU – ECF – 2018 Practicing Neurologist\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:2853:\"country:\n  \'#type\': textfield\n  \'#title\': Country\nprovince_state:\n  \'#type\': textfield\n  \'#title\': Province/State\nhospital_university_centre:\n  \'#type\': textfield\n  \'#title\': Hospital/University/Centre\nyear:\n  \'#type\': number\n  \'#title\': Year\n  \'#min\': 1945\n  \'#max\': 2020\nnumber_of_patients_of_ms_attended_in_one_year:\n  \'#type\': number\n  \'#title\': \'Number of patients of MS attended in one year\'\nprocesses_in_ms_patients_access_to_routinely_used_:\n  \'#type\': checkboxes\n  \'#title\': \'Processes in MS patients: (access to, routinely used?)\'\n  \'#options\':\n    \'Blood tests\': \'Blood tests\'\n    \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n    MRI: MRI\n    \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n    \'OCT (optic coherence tomography)\': \'OCT (Optic Coherence Tomography)\'\ntreatments_available:\n  \'#type\': webform_checkboxes_other\n  \'#title\': \'Treatments available\'\n  \'#options\':\n    \'Immunomodulator treatment\': \'Immunomodulator treatment\'\n    \'Immunosuppressant treatment\': \'Immunosuppressant treatment\'\n    \'Autologous hematopoietic stem cell transplantation (ASCT)\': \'Autologous hematopoietic stem cell transplantation (ASCT)\'\n  \'#other__type\': textarea\n  \'#other__option_label\': \'Other therapeutic procedures\'\n  \'#other__placeholder\': \'Please specify\'\nimmunomodulator_treatment:\n  \'#type\': webform_checkboxes_other\n  \'#title\': \'Immunomodulator treatment\'\n  \'#options\':\n    Betaseron: Betaseron\n    Extavia: Extavia\n    Avonex: Avonex\n    Copaxone: Copaxone\n    \'Generic Glatiramer\': \'Generic Glatiramer\'\n    \'Rebif® (interferon beta-1a)\': \'Rebif® (interferon beta-1a)\'\n    PEG-Interferon: PEG-Interferon\n  \'#states\':\n    invisible-slide:\n      \':input[name=\"treatments_available[checkboxes][Immunomodulator treatment]\"]\':\n        unchecked: true\nimmunosuppressant_treatment:\n  \'#type\': webform_checkboxes_other\n  \'#title\': \'Immunosuppressant treatment\'\n  \'#options\':\n    \'Aubagio® (teriflunomide)\': \'Aubagio® (teriflunomide)\'\n    \'Tecfidera® (dimethyl fumarate)\': \'Tecfidera® (dimethyl fumarate)\'\n    \'Tysabri® (natalizumab)\': \'Tysabri® (natalizumab)\'\n    \'Gilenya® (fingolimod)\': \'Gilenya® (fingolimod)\'\n    \'Lemtrada® (alemtuzumab)\': \'Lemtrada® (alemtuzumab)\'\n    \'Novantrone® (mitoxantrone) \': \'Novantrone® (mitoxantrone) \'\n    \'Mavenclad® (cladribine)\': \'Mavenclad® (cladribine)\'\n    \'Ocrevus® (ocrelizumab)\': \'Ocrevus® (ocrelizumab)\'\n    Rituximab: Rituximab\n    Azathioprine: Azathioprine\n    Methotrexate: Methotrexate\n    Cyclophosphamide: Cyclophosphamide\n  \'#states\':\n    invisible-slide:\n      \':input[name=\"treatments_available[checkboxes][Immunosuppressant treatment]\"]\':\n        unchecked: true\nadverse_effects:\n  \'#type\': checkboxes\n  \'#title\': \'Adverse effects\'\n  \'#options\':\n    ICD-9-MC: ICD-9-MC\n    MEDRA: MEDRA\n    \'WHO Toxicity Grading Scale\': \'WHO Toxicity Grading Scale\'\n\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:4:\"both\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:1;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"ffec5877-4313-4436-bf57-710599d359ea\";}'),('','webform.webform.mscu_ecf_2020','a:22:{s:4:\"uuid\";s:36:\"b6c05124-542a-416a-915c-ecefb3b9587e\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:1:{s:6:\"module\";a:1:{i:0;s:20:\"webform_entity_print\";}}s:20:\"third_party_settings\";a:1:{s:20:\"webform_entity_print\";a:2:{s:8:\"template\";a:3:{s:6:\"header\";s:0:\"\";s:6:\"footer\";s:0:\"\";s:3:\"css\";s:0:\"\";}s:12:\"export_types\";a:1:{s:3:\"pdf\";a:3:{s:7:\"enabled\";b:1;s:9:\"link_text\";s:0:\"\";s:15:\"link_attributes\";a:0:{}}}}}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:13:\"mscu_ecf_2020\";s:5:\"title\";s:21:\"MSCU – ECF – 2020\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:29167:\"general_information:\n  \'#type\': webform_wizard_page\n  \'#title\': \'GENERAL INFORMATION\'\n  general_information1:\n    \'#type\': webform_section\n    \'#title\': \'GENERAL INFORMATION\'\n    \'#required\': true\n    name_of_the_organization:\n      \'#type\': textfield\n      \'#title\': \'Name of the organization\'\n      \'#description\': Hospital/University/Centre\n      \'#required\': true\n    country:\n      \'#type\': select\n      \'#title\': Country\n      \'#options\': country_names\n      \'#options_display\': side_by_side\n      \'#required\': true\n    province_state:\n      \'#type\': textfield\n      \'#title\': City\n      \'#required\': true\n    indicate_the_type_of_organization:\n      \'#type\': radios\n      \'#title\': \'Indicate the type of organization\'\n      \'#options\':\n        \'HEALTHCARE ORGANIZATION\': \'HEALTHCARE ORGANIZATION\'\n        HOSPITAL: HOSPITAL\n        \'REGIONAL AUTHORITY\': \'REGIONAL AUTHORITY\'\n        \'RESEARCH CENTRE\': \'RESEARCH CENTRE\'\n        \'PRIVATE PRACTITIONER\': \'PRIVATE PRACTITIONER\'\n        UNIVERSITY: UNIVERSITY\n      \'#other__placeholder\': \'Please specify\'\n      \'#required\': true\nms_in_your_country:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MS IN YOUR COUNTRY\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  ms_in_your_country1:\n    \'#type\': webform_section\n    \'#title\': \'MS IN YOUR COUNTRY\'\n    epidemiology_in_your_country:\n      \'#type\': webform_section\n      \'#title\': \'EPIDEMIOLOGY/ WHO GETS MS?\'\n      \'#title_tag\': h4\n      prevalence_per_100_000_population:\n        \'#type\': radios\n        \'#title\': \'Prevalence rates per 100.000\'\n        \'#options\':\n          \'<25\': \'<25\'\n          25-50: 25-50\n          51-100: 51-100\n          101-150: 101-150\n          151-200: 151-200\n          \'>200\': \'>200\'\n        \'#options_display\': three_columns\n        \'#required\': true\n      incidence_rates_per_100_000:\n        \'#type\': radios\n        \'#title\': \'Incidence rates per 100.000\'\n        \'#options\':\n          \'<1\': \'<1\'\n          1-2: 1-2\n          3-5: 3-5\n          6-10: 6-10\n          \'>10\': \'>10\'\n        \'#options_display\': three_columns\n        \'#required\': true\n    _which_proportion_of_ms_patients_country_are_care_for_in_tick_:\n      \'#type\': webform_section\n      \'#title\': \'In your country which proportion of MS patients are cared for ?\'\n      \'#title_tag\': h3\n      ms_clinics_in_university_hospitals1:\n        \'#type\': radios\n        \'#title\': \'MS clinics in University Hospitals\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\n        \'#required\': true\n      ms_clinics_in_non_academic_hospitals:\n        \'#type\': radios\n        \'#title\': \'MS clinics in Non-academic Hospitals\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\n        \'#required\': true\n      non_academic_hospitals_without_specific_ms_clinic:\n        \'#type\': radios\n        \'#title\': \'Non-academic hospitals without specific MS clinic\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\n        \'#required\': true\n      practising_neurologists:\n        \'#type\': radios\n        \'#title\': \'Practising Neurologists\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\n        \'#required\': true\nmscu_in_your_hospital:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU IN YOUR HOSPITAL\'\n  ms_care_experience:\n    \'#type\': webform_section\n    \'#title\': \'MS CARE EXPERIENCE\'\n    number_of_patients_of_ms_attended_in_one_yearn:\n      \'#type\': radios\n      \'#title\': \'Number of patients of MS attended in one year\'\n      \'#options\':\n        \'< 500\': \'< 500\'\n        500-1000: 500-1000\n        1000-1500: 1000-1500\n        1500-2000: 1500-2000\n        2000-2500: 2000-2500\n        2500-3000: 2500-3000\n        3000-3500: 3000-3500\n        3500-4000: 3500-4000\n        4000-4500: 4000-4500\n        4500-5000: 4500-5000\n      \'#options_display\': three_columns\n      \'#required\': true\n      \'#states\':\n        invisible:\n          \':input[name=\"indicate_the_type_of_organization\"]\':\n            value: \'PRIVATE PRACTITIONER\'\n    number_of_patients_of_ms_attended_in_one_year:\n      \'#type\': radios\n      \'#title\': \'Number of patients of MS attended in one year\'\n      \'#options\':\n        \'< 50\': \'< 50\'\n        50-100: 50-100\n        100-150: 100-150\n        150-200: 150-200\n        200-250: 200-250\n        250-300: 250-300\n        300-350: 300-350\n        350-400: 350-400\n        400-450: 400-450\n        450-500: 450-500\n      \'#options_display\': three_columns\n      \'#states\':\n        invisible:\n          \':input[name=\"indicate_the_type_of_organization\"]\':\n            \'!value\': \'PRIVATE PRACTITIONER\'\n      \'#required\': true\n    exams_routinely_performed_for_ms_patients_in_your_hospital:\n      \'#type\': checkboxes\n      \'#title\': \'Processes in MS patients: (access to, routinely used)\'\n      \'#options\':\n        \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n        MRI: MRI\n        \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n        \'OCT (optic coherence tomography)\': \'OCT (optic coherence tomography)\'\n        \'Blood tests\': \'Blood tests\'\n      \'#other__option_label\': \'Other ..\'\n      \'#other__placeholder\': \'Please specify\'\n    blood_tests213:\n      \'#type\': checkboxes\n      \'#title\': \'Blood tests\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"exams_routinely_performed_for_ms_patients_in_your_hospital[Blood tests]\"]\':\n            unchecked: true\n      \'#required\': true\nother_activities_in_your_center1:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER ACTIVITIES IN YOUR CENTER\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  other_activities_carried_out_in_your_centre:\n    \'#type\': webform_section\n    \'#title\': \'Other activities carried out in your centre\'\n    teaching1:\n      \'#type\': checkbox\n      \'#title\': Teaching\n    _of_overall_working_activity:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"teaching1\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n      \'#required\': true\n    continuous_medical_education:\n      \'#type\': checkbox\n      \'#title\': \'Continuous Medical Education\'\n    _of_overall_working_activity2:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"continuous_medical_education\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n      \'#required\': true\n    research:\n      \'#type\': checkbox\n      \'#title\': Research\n    _of_overall_working_activity3:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"research\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n      \'#required\': true\n    publications:\n      \'#type\': checkbox\n      \'#title\': Publications\n    number_of_publications_year:\n      \'#type\': radios\n      \'#title\': \'Number of publications/year\'\n      \'#options\':\n        \'<5\': \'<5\'\n        5-10: 5-10\n        10-15: 10-15\n        15-20: 15-20\n        20-25: 20-25\n        25-30: 25-30\n        30-35: 30-35\n        35-40: 35-40\n        40-45: 40-45\n        45-50: 45-50\n      \'#options_display\': three_columns\n      \'#required\': true\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"publications\"]\':\n            unchecked: true\n  is_previous_experience_needed_when_entering_the_unit:\n    \'#type\': radios\n    \'#title\': \'Is previous experience needed when entering the unit\'\n    \'#options\': yes_no\n    \'#required\': true\nmscr_specific_equipments:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU SPECIFIC RESOURSES\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscr_specific_equipments1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU SPECIFIC RESOURSES\'\n    specific_resources_of_the_mscu:\n      \'#type\': webform_section\n      \'#title\': \'HEALTH CARE PROFESSIONALS NEEDED FOR THE ADEGUATE ASSISTANCE OF MS PATIENTS\'\n      neurologists:\n        \'#type\': checkbox\n        \'#title\': Neurologists\n      neurologists_1:\n        \'#type\': number\n        \'#title\': \'number of Neurologists \'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"neurologists\"]\':\n              unchecked: true\n        \'#min\': 0\n        \'#required\': true\n      nurses1:\n        \'#type\': checkbox\n        \'#title\': Nurses\n      nurses:\n        \'#type\': number\n        \'#title\': \'number of Nurses\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"nurses1\"]\':\n              unchecked: true\n        \'#min\': 0\n        \'#required\': true\n      physiotherapists11:\n        \'#type\': checkbox\n        \'#title\': Physiotherapists\n      physiotherapists:\n        \'#type\': number\n        \'#title\': \'number of Physiotherapists\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"physiotherapists11\"]\':\n              unchecked: true\n        \'#required\': true\n      additional_health_care_professionals:\n        \'#type\': checkboxes\n        \'#title\': \'ADDITIONAL HEALTH CARE PROFESSIONALS\'\n        \'#options\':\n          \'OCCUPATIONAL THERAPIST \': \'OCCUPATIONAL THERAPIST \'\n          NEUROPSYCHOLOGIST: NEUROPSYCHOLOGIST\n          \'SPEECH THERAPIST    \': \'SPEECH THERAPIST    \'\n          \'CLINICAL PSYCHOLOGISTS \': \'CLINICAL PSYCHOLOGISTS \'\n          \'REHABILITATION NEUROLOGIST/PHYSICIAN \': \'REHABILITATION NEUROLOGIST/PHYSICIAN \'\nmscr_specific_equipments12:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscr_specific_equipments11:\n    \'#type\': webform_section\n    \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n    day_hospital_integrated_in_the_mscu_or_available_at_the_centre:\n      \'#type\': select\n      \'#title\': \'DAY HOSPITAL INTEGRATED IN THE MSCU OR AVAILABLE AT THE CENTRE\'\n      \'#options\': yes_no\n      \'#required\': true\n    area_for_extraction_and_manipulation_of_body_fluids_blood_csf_:\n      \'#type\': select\n      \'#title\': \'AREA FOR EXTRACTION AND MANIPULATION OF BODY FLUIDS (BLOOD, CSF)\'\n      \'#options\': yes_no\n      \'#required\': true\n    area_of_outpatient_assistance:\n      \'#type\': select\n      \'#title\': \'AREA OF OUTPATIENT ASSISTANCE\'\n      \'#options\': yes_no\n      \'#required\': true\n    system_of_communications_with_patients:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'System of communications with patients\'\n      \'#options\':\n        E-mail: E-mail\n        Telephone: Telephone\n        \'Mobile (SMS)\': \'Mobile (SMS)\'\n        \'Web page\': \'Web page\'\n    banking_facilities_for_sera_csf:\n      \'#type\': radios\n      \'#title\': \'Banking facilities for Sera/CSF\'\n      \'#options\': yes_no\n      \'#required\': true\nother_hospital_units_services:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER HOSPITAL UNITS_SERVICES\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  other_hospital_units_services1:\n    \'#type\': webform_section\n    \'#title\': \'RESOURCES OF OTHER UNITS OR SERVICES APART FROM THE MSCU, NECESSARY FOR THE ADEQUATE PROVISION OF CARE FOR MS PATIENTS \'\n    resources_of_other_units_or_services_apart_from_the_mscu_necessa:\n      \'#type\': checkboxes\n      \'#title\': \'Resources of other units or services apart from the MSCU, necessary for the adequate provision of care for MS patients\'\n      \'#options\':\n        \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\': \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\'\n        \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\': \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\'\n        \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\': \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\'\n        \'Service/Unit of Immunology that can perform IgG oligoclonal bands\': \'Service/Unit of Immunology that can perform IgG oligoclonal bands\'\n        \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\': \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\'\n        \'Service/Unit of Rehabilitation with experience in the management of MS patients\': \'Service/Unit of Rehabilitation with experience in the management of MS patients\'\n        \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\': \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\'\n        \'Service/Unit of Urology, with experience in the management of MS patients\': \'Service/Unit of Urology, with experience in the management of MS patients\'\n        \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\': \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\'\n        \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \': \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \'\nmscu_kpis:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscu_kpis1:\n    \'#type\': webform_section\n    \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n    number_of_treatments_administered_in_day_hospital_outpatient:\n      \'#type\': radios\n      \'#title\': \'NUMBER OF TREATMENTS ADMINISTERED IN THE DAY HOSPITAL/OUTPATIENT CLINIC. (Oral or IV)\'\n      \'#options\':\n        0-200: 0-200\n        200-400: 200-400\n        400-600: 400-600\n        600-800: 600-800\n        800-1000: 800-1000\n        1000-1200: 1000-1200\n        1200-1400: 1200-1400\n        1400-1600: 1400-1600\n        1600-1800: 1600-1800\n        1800-2000: 1800-2000\n        2000-2200: 2000-2200\n        2200-2400: 2200-2400\n        2400-2600: 2400-2600\n        2600-2800: 2600-2800\n        2800-3000: 2800-3000\n      \'#options_display\': three_columns\n      \'#required\': true\n    number_of_treated_exacerbations_relapses_:\n      \'#type\': radios\n      \'#title\': \'NUMBER OF TREATED EXACERBATIONS (RELAPSES)\'\n      \'#options\':\n        0-50: 0-50\n        50-100: 50-100\n        100-150: 100-150\n        150-200: 150-200\n        200-250: 200-250\n        250-300: 250-300\n        300-350: 300-350\n        350-400: 350-400\n        400-450: 400-450\n        450-500: 450-500\n      \'#options_display\': three_columns\n      \'#required\': true\n    number_of_severe_adverse_events1:\n      \'#type\': radios\n      \'#title\': \'NUMBER OF SEVERE ADVERSE EVENTS\'\n      \'#options\':\n        0-50: 0-50\n        50-100: 50-100\n        100-150: 100-150\n        150-200: 150-200\n      \'#options_display\': three_columns\n      \'#required\': true\n    use_of_disability_progression_expanded_disability_status_scale_e:\n      \'#type\': checkbox\n      \'#title\': \'USE OF DISABILITY PROGRESSION, EXPANDED DISABILITY STATUS SCALE (EDSS)\'\n      \'#attributes\':\n        class:\n          - veryStrong\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    assessment_of_degree_of_satisfaction_of_users:\n      \'#type\': checkbox\n      \'#title\': \'ASSESSMENT OF DEGREE OF SATISFACTION OF USERS\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    amministrative_data:\n      \'#type\': checkbox\n      \'#title\': \'ADMINISTRATIVE DATA\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    do_you_have_cost_accountability:\n      \'#type\': radios\n      \'#title\': \'Do you have cost accountability\'\n      \'#options\': yes_no\n      \'#required\': true\nmscu_registry:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU REGISTRY\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscu_registry1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU REGISTRY\'\n    does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_:\n      \'#type\': select\n      \'#title\': \'DOES MSCU HAVE A REGISTRY OF PATIENTS WITH MULTIPLE SCLEROSIS?\'\n      \'#options\': yes_no\n      \'#required\': true\n    minimal_data_set_requirement:\n      \'#type\': checkboxes\n      \'#title\': \'MINIMAL DATA SET REQUIREMENT\'\n      \'#options\':\n        \'NUMBER OF PATIENT IDENTIFICATION\': \'NUMBER OF PATIENT IDENTIFICATION\'\n        \'DATE OF BIRTH\': \'DATE OF BIRTH\'\n        SEX: SEX\n        \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\': \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\'\n        \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \': \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \'\n        \'OTHER DIAGNOSIS (ICD-9-MC)\': \'OTHER DIAGNOSIS (ICD-9-MC)\'\n        \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \': \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    evoked_potentials_ep_:\n      \'#type\': checkboxes\n      \'#title\': \'Evoked potentials (EP)\'\n      \'#options\':\n        \'Visual EP\': \'Visual EP\'\n        \'Auditory EP\': \'Auditory EP\'\n        \'Somatosensory EP\': \'Somatosensory EP\'\n        \'Motor EP\': \'Motor EP\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    hospital_admissions:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'HOSPITAL ADMISSIONS\'\n      \'#options\':\n        \'DATE OF HOSPITALIZATION\': \'DATE OF HOSPITALIZATION\'\n        \'DATE HOSPITAL DISCHARGE\': \'DATE HOSPITAL DISCHARGE\'\n        \'TYPE OF HOSPITALIZATION\': \'TYPE OF HOSPITALIZATION\'\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_hospital_discharge_:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF HOSPITAL DISCHARGE \'\n      \'#options\':\n        Home: Home\n        \'Transfer to another hospital\': \'Transfer to another hospital\'\n        \'Voluntary discharge\': \'Voluntary discharge\'\n        \'Transfer to another sanitary facility \': \'Transfer to another sanitary facility \'\n        Death: Death\n        \'Service responsible of discharge. \': \'Service responsible of discharge. \'\n        \'Principal diagnosis (ICD-9-MC)\': \'Principal diagnosis (ICD-9-MC)\'\n        \'Other diagnosis (ICD-9-MC)\': \'Other diagnosis (ICD-9-MC)\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    x_ray:\n      \'#type\': checkbox\n      \'#title\': X-Ray\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    please_tick_which_of_the_following_data_are_recorded_in_themscu:\n      \'#type\': webform_section\n      \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY\'\n      \'#states\':\n        invisible:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'\': \'\'\n  please_tick_which_of_the_following_data2:\n    \'#type\': webform_section\n    \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY FOR OUTPATIENT VISITS?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n          \'!value\': \'Yes\'\n    date_of_visit:\n      \'#type\': checkbox\n      \'#title\': \'DATE OF VISIT\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF VISIT\'\n      \'#options\':\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    reason_for_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'REASON FOR VISIT\'\n      \'#options\':\n        DIAGNOSTIC: DIAGNOSTIC\n        RELAPSE: RELAPSE\n        \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\': \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests2:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_2:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri2:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_2:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\ntreatments_available:\n  \'#type\': webform_wizard_page\n  \'#title\': \'TREATMENTS AVAILABLE\'\n  treatments_available1:\n    \'#type\': webform_section\n    \'#title\': \'TREATMENTS AVAILABLE\'\n    immunomodulator_treatment:\n      \'#type\': checkboxes\n      \'#title\': \'IMMUNOMODULATOR TREATMENT\'\n      \'#options\':\n        Betaseron: Betaseron\n        Extavia: Extavia\n        Avonex: Avonex\n        Copaxone: Copaxone\n        \'Generic Glatiramer\': \'Generic Glatiramer\'\n        \'Rebif® (interferon beta-1a)\': \'Rebif® (interferon beta-1a)\'\n        \'Plegridy® (PEG-Interferon)\': \'Plegridy® (PEG-Interferon)\'\n        Plasmapheresis: Plasmapheresis\n        \'Vumerity ® (Diroximel fumarate)\': \'Vumerity ® (Diroximel fumarate)\'\n    immunosuppressant_treatment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'IMMUNOSUPPRESSANT TREATMENT\'\n      \'#options\':\n        \'Aubagi® (teriflunmide)\': \'Aubagi® (teriflunmide)\'\n        \'Tecfidera® (dimethyl fumarate)\': \'Tecfidera® (dimethyl fumarate)\'\n        \'Tysabri® (natalizumab)\': \'Tysabri® (natalizumab)\'\n        \'Gilenya® (finglimd)\': \'Gilenya® (finglimd)\'\n        \'Lemtrada® (alemtuzumab)\': \'Lemtrada® (alemtuzumab)\'\n        \'Nοvantrne® (mitxantrne) \': \'Nοvantrne® (mitxantrne) \'\n        \'Mavenclad® (cladribine)\': \'Mavenclad® (cladribine)\'\n        \'Οcrevus® (crelizumab)\': \'Οcrevus® (crelizumab)\'\n        Rituximab: Rituximab\n        Azathiprine: Azathiprine\n        Methοtrexate: Methοtrexate\n        Cyclοphsphamide: Cyclοphsphamide\n    autologous_hematopoietic_stem_cell_transplantation_asct_:\n      \'#type\': select\n      \'#title\': \'AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT)\'\n      \'#options\': yes_no\n      \'#required\': true\n    other_therapeutic_procedures:\n      \'#type\': checkbox\n      \'#title\': \'OTHER THERAPEUTIC PROCEDURES\'\n    please_specify:\n      \'#type\': textarea\n      \'#title\': \'PLEASE SPECIFY\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"other_therapeutic_procedures\"]\':\n            unchecked: true\n      \'#required\': true\n    _adverse_effects:\n      \'#type\': checkboxes\n      \'#title\': \' ADVERSE EFFECTS\'\n      \'#options\':\n        ICD-9-MC: ICD-9-MC\n        MEDRA: MEDRA\n        \'WHO Toxicity Grading Scale\': \'WHO Toxicity Grading Scale\'\n      \'#other__placeholder\': \'Please Specify\'\nemail:\n  \'#type\': email\n  \'#title\': Email\n  \'#wrapper_attributes\':\n    class:\n      - none\n  \'#access_view_roles\':\n    - anonymous\n    - administrator\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:1;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:1;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:1;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:1;s:26:\"wizard_progress_percentage\";b:1;s:20:\"wizard_progress_link\";b:1;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:1;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:11:\"url_message\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:20:\"Confirmation message\";s:16:\"confirmation_url\";s:10:\"[site:url]\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:1;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:2:{i:0;s:13:\"administrator\";i:1;s:13:\"webform_admin\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}}'),('','webform.webform.mscu_ecf_2020_for_check_','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:24:\"mscu_ecf_2020_for_check_\";s:5:\"title\";s:33:\"MSCU – ECF – 2020 (for check)\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:28207:\"general_information:\n  \'#type\': webform_wizard_page\n  \'#title\': \'GENERAL INFORMATION\'\n  general_information1:\n    \'#type\': webform_section\n    \'#title\': \'GENERAL INFORMATION\'\n    name_of_the_organization:\n      \'#type\': textfield\n      \'#title\': \'Name of the organization\'\n      \'#description\': Hospital/University/Centre\n    country:\n      \'#type\': select\n      \'#title\': Country\n      \'#options\': country_names\n      \'#options_display\': side_by_side\n    province_state:\n      \'#type\': textfield\n      \'#title\': City\n    indicate_the_type_of_organization:\n      \'#type\': radios\n      \'#title\': \'Indicate the type of organization\'\n      \'#options\':\n        \'HEALTHCARE ORGANIZATION\': \'HEALTHCARE ORGANIZATION\'\n        HOSPITAL: HOSPITAL\n        \'REGIONAL AUTHORITY\': \'REGIONAL AUTHORITY\'\n        \'RESEARCH CENTRE\': \'RESEARCH CENTRE\'\n        \'PRIVATE PRACTITIONER\': \'PRIVATE PRACTITIONER\'\n        UNIVERSITY: UNIVERSITY\n      \'#other__placeholder\': \'Please specify\'\nms_in_your_country:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MS IN YOUR COUNTRY\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  ms_in_your_country1:\n    \'#type\': webform_section\n    \'#title\': \'MS IN YOUR COUNTRY\'\n    epidemiology_in_your_country:\n      \'#type\': webform_section\n      \'#title\': \'EPIDEMIOLOGY/ WHO GETS MS?\'\n      \'#title_tag\': h4\n      prevalence_per_100_000_population:\n        \'#type\': radios\n        \'#title\': \'Prevalence rates per 100.000\'\n        \'#options\':\n          \'<25\': \'<25\'\n          25-50: 25-50\n          51-100: 51-100\n          101-150: 101-150\n          151-200: 151-200\n          \'>200\': \'>200\'\n        \'#options_display\': three_columns\n      incidence_rates_per_100_000:\n        \'#type\': radios\n        \'#title\': \'Incidence rates per 100.000\'\n        \'#options\':\n          \'<1\': \'<1\'\n          1-2: 1-2\n          3-5: 3-5\n          6-10: 6-10\n          \'>10\': \'>10\'\n        \'#options_display\': three_columns\n    _which_proportion_of_ms_patients_country_are_care_for_in_tick_:\n      \'#type\': webform_section\n      \'#title\': \'In your country which proportion of MS patients are cared for ?\'\n      \'#title_tag\': h3\n      ms_clinics_in_university_hospitals1:\n        \'#type\': radios\n        \'#title\': \'MS clinics in University Hospitals\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\n      ms_clinics_in_non_academic_hospitals:\n        \'#type\': radios\n        \'#title\': \'MS clinics in Non-academic Hospitals\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\n      non_academic_hospitals_without_specific_ms_clinic:\n        \'#type\': radios\n        \'#title\': \'Non-academic hospitals without specific MS clinic\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\n      practising_neurologists:\n        \'#type\': radios\n        \'#title\': \'Practising Neurologists\'\n        \'#options\':\n          \'< 10%\': \'< 10%\'\n          10-25%: 10-25%\n          25-50%: 25-50%\n          50-75%: 50-75%\n          \'> 75%\': \'> 75%\'\n        \'#options_display\': three_columns\nmscu_in_your_hospital:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU IN YOUR HOSPITAL\'\n  ms_care_experience:\n    \'#type\': webform_section\n    \'#title\': \'MS CARE EXPERIENCE\'\n    number_of_patients_of_ms_attended_in_one_yearn:\n      \'#type\': radios\n      \'#title\': \'Number of patients of MS attended in one year\'\n      \'#options\':\n        \'< 500\': \'< 500\'\n        500-1000: 500-1000\n        1000-1500: 1000-1500\n        1500-2000: 1500-2000\n        2000-2500: 2000-2500\n        2500-3000: 2500-3000\n        3000-3500: 3000-3500\n        3500-4000: 3500-4000\n        4000-4500: 4000-4500\n        4500-5000: 4500-5000\n      \'#options_display\': three_columns\n      \'#states\':\n        invisible:\n          \':input[name=\"indicate_the_type_of_organization\"]\':\n            value: \'PRIVATE PRACTITIONER\'\n    number_of_patients_of_ms_attended_in_one_year:\n      \'#type\': radios\n      \'#title\': \'Number of patients of MS attended in one year\'\n      \'#options\':\n        \'< 50\': \'< 50\'\n        50-100: 50-100\n        100-150: 100-150\n        150-200: 150-200\n        200-250: 200-250\n        250-300: 250-300\n        300-350: 300-350\n        350-400: 350-400\n        400-450: 400-450\n        450-500: 450-500\n      \'#options_display\': three_columns\n      \'#states\':\n        invisible:\n          \':input[name=\"indicate_the_type_of_organization\"]\':\n            \'!value\': \'PRIVATE PRACTITIONER\'\n    exams_routinely_performed_for_ms_patients_in_your_hospital:\n      \'#type\': checkboxes\n      \'#title\': \'Processes in MS patients: (access to, routinely used)\'\n      \'#options\':\n        \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n        MRI: MRI\n        \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n        \'OCT (optic coherence tomography)\': \'OCT (optic coherence tomography)\'\n        \'Blood tests\': \'Blood tests\'\n      \'#other__option_label\': \'Other ..\'\n      \'#other__placeholder\': \'Please specify\'\n    blood_tests213:\n      \'#type\': checkboxes\n      \'#title\': \'Blood tests\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"exams_routinely_performed_for_ms_patients_in_your_hospital[Blood tests]\"]\':\n            unchecked: true\nother_activities_in_your_center1:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER ACTIVITIES IN YOUR CENTER\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  other_activities_carried_out_in_your_centre:\n    \'#type\': webform_section\n    \'#title\': \'Other activities carried out in your centre\'\n    teaching1:\n      \'#type\': checkbox\n      \'#title\': Teaching\n    _of_overall_working_activity:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"teaching1\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n    continuous_medical_education:\n      \'#type\': checkbox\n      \'#title\': \'Continuous Medical Education\'\n    _of_overall_working_activity2:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"continuous_medical_education\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n    research:\n      \'#type\': checkbox\n      \'#title\': Research\n    _of_overall_working_activity3:\n      \'#type\': number\n      \'#title\': \'% of overall working activity\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"research\"]\':\n            unchecked: true\n      \'#min\': 0\n      \'#max\': 100\n    publications:\n      \'#type\': checkbox\n      \'#title\': Publications\n    number_of_publications_year:\n      \'#type\': radios\n      \'#title\': \'Number of publications/year\'\n      \'#options\':\n        \'<5\': \'<5\'\n        5-10: 5-10\n        10-15: 10-15\n        15-20: 15-20\n        20-25: 20-25\n        25-30: 25-30\n        30-35: 30-35\n        35-40: 35-40\n        40-45: 40-45\n        45-50: 45-50\n      \'#options_display\': three_columns\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"publications\"]\':\n            unchecked: true\n  is_previous_experience_needed_when_entering_the_unit:\n    \'#type\': radios\n    \'#title\': \'Is previous experience needed when entering the unit\'\n    \'#options\': yes_no\nmscr_specific_equipments:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU SPECIFIC RESOURSES\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscr_specific_equipments1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU SPECIFIC RESOURSES\'\n    specific_resources_of_the_mscu:\n      \'#type\': webform_section\n      \'#title\': \'HEALTH CARE PROFESSIONALS NEEDED FOR THE ADEGUATE ASSISTANCE OF MS PATIENTS\'\n      neurologists:\n        \'#type\': checkbox\n        \'#title\': Neurologists\n      neurologists_1:\n        \'#type\': number\n        \'#title\': \'number of Neurologists \'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"neurologists\"]\':\n              unchecked: true\n        \'#min\': 0\n      nurses1:\n        \'#type\': checkbox\n        \'#title\': Nurses\n      nurses:\n        \'#type\': number\n        \'#title\': \'number of Nurses\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"nurses1\"]\':\n              unchecked: true\n        \'#min\': 0\n      physiotherapists11:\n        \'#type\': checkbox\n        \'#title\': Physiotherapists\n      physiotherapists:\n        \'#type\': number\n        \'#title\': \'number of Physiotherapists\'\n        \'#states\':\n          invisible-slide:\n            \':input[name=\"physiotherapists11\"]\':\n              unchecked: true\n      additional_health_care_professionals:\n        \'#type\': checkboxes\n        \'#title\': \'ADDITIONAL HEALTH CARE PROFESSIONALS\'\n        \'#options\':\n          \'OCCUPATIONAL THERAPIST \': \'OCCUPATIONAL THERAPIST \'\n          NEUROPSYCHOLOGIST: NEUROPSYCHOLOGIST\n          \'SPEECH THERAPIST    \': \'SPEECH THERAPIST    \'\n          \'CLINICAL PSYCHOLOGISTS \': \'CLINICAL PSYCHOLOGISTS \'\n          \'REHABILITATION NEUROLOGIST/PHYSICIAN \': \'REHABILITATION NEUROLOGIST/PHYSICIAN \'\nmscr_specific_equipments12:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscr_specific_equipments11:\n    \'#type\': webform_section\n    \'#title\': \'MSCR SPECIFIC EQUIPMENT\'\n    day_hospital_integrated_in_the_mscu_or_available_at_the_centre:\n      \'#type\': select\n      \'#title\': \'DAY HOSPITAL INTEGRATED IN THE MSCU OR AVAILABLE AT THE CENTRE\'\n      \'#options\': yes_no\n    area_for_extraction_and_manipulation_of_body_fluids_blood_csf_:\n      \'#type\': select\n      \'#title\': \'AREA FOR EXTRACTION AND MANIPULATION OF BODY FLUIDS (BLOOD, CSF)\'\n      \'#options\': yes_no\n    area_of_outpatient_assistance:\n      \'#type\': select\n      \'#title\': \'AREA OF OUTPATIENT ASSISTANCE\'\n      \'#options\': yes_no\n    system_of_communications_with_patients:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'System of communications with patients\'\n      \'#options\':\n        E-mail: E-mail\n        Telephone: Telephone\n        \'Mobile (SMS)\': \'Mobile (SMS)\'\n        \'Web page\': \'Web page\'\n    banking_facilities_for_sera_csf:\n      \'#type\': radios\n      \'#title\': \'Banking facilities for Sera/CSF\'\n      \'#options\': yes_no\nother_hospital_units_services:\n  \'#type\': webform_wizard_page\n  \'#title\': \'OTHER HOSPITAL UNITS_SERVICES\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  other_hospital_units_services1:\n    \'#type\': webform_section\n    \'#title\': \'RESOURCES OF OTHER UNITS OR SERVICES APART FROM THE MSCU, NECESSARY FOR THE ADEQUATE PROVISION OF CARE FOR MS PATIENTS \'\n    resources_of_other_units_or_services_apart_from_the_mscu_necessa:\n      \'#type\': checkboxes\n      \'#title\': \'Resources of other units or services apart from the MSCU, necessary for the adequate provision of care for MS patients\'\n      \'#options\':\n        \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\': \'Service/Unit of Neuroradiology with MRI 1.5 tesla or more\'\n        \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\': \'Service/Unit of Neurophysiology, with the possibility to perform EP (visual, brainstem, somatosensory and motor)\'\n        \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\': \'Service/Unit of Nuclear Medicine, with SPECT or PET available, needed in some cases for differential diagnosis\'\n        \'Service/Unit of Immunology that can perform IgG oligoclonal bands\': \'Service/Unit of Immunology that can perform IgG oligoclonal bands\'\n        \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\': \'Service/Unit of Immunology that can perform Neurofilament Light in blood (Simoa)\'\n        \'Service/Unit of Rehabilitation with experience in the management of MS patients\': \'Service/Unit of Rehabilitation with experience in the management of MS patients\'\n        \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\': \'Service/Unit of Ophthalmology, able to perform OCT and with experience in the management of MS patients\'\n        \'Service/Unit of Urology, with experience in the management of MS patients\': \'Service/Unit of Urology, with experience in the management of MS patients\'\n        \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\': \'Service/Unit of Genetics, with possibility for banking of DNA/RNA samples\'\n        \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \': \'Availability of a Haematology Unit for autologous hematopoietic stem cell transplantation (aHSCT) \'\nmscu_kpis:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscu_kpis1:\n    \'#type\': webform_section\n    \'#title\': \'Indicators of processes and clinical results of the MSCU/year\'\n    number_of_treatments_administered_in_the_day_hospital_outptient:\n      \'#type\': radios\n      \'#title\': \'NUMBER OF TREATMENTS ADMINISTERED IN THE DAY HOSPITAL/OUTPATIENT CLINIC. (Oral or IV)\'\n      \'#options\':\n        0-200: 0-200\n        200-400: 200-400\n        400-600: 400-600\n        600-800: 600-800\n        800-1000: 800-1000\n        1000-1200: 1000-1200\n        1200-1400: 1200-1400\n        1400-1600: 1400-1600\n        1600-1800: 1600-1800\n        1800-2000: 1800-2000\n        2000-2200: 2000-2200\n        2200-2400: 2200-2400\n        2400-2600: 2400-2600\n        2600-2800: 2600-2800\n        2800-3000: 2800-3000\n      \'#options_display\': three_columns\n    number_of_treated_exacerbations_relapses_:\n      \'#type\': radios\n      \'#title\': \'NUMBER OF TREATED EXACERBATIONS (RELAPSES)\'\n      \'#options\':\n        0-50: 0-50\n        50-100: 50-100\n        100-150: 100-150\n        150-200: 150-200\n        200-250: 200-250\n        250-300: 250-300\n        300-350: 300-350\n        350-400: 350-400\n        400-450: 400-450\n        450-500: 450-500\n      \'#options_display\': three_columns\n    number_of_severe_adverse_events1:\n      \'#type\': radios\n      \'#title\': \'NUMBER OF SEVERE ADVERSE EVENTS\'\n      \'#options\':\n        0-50: 0-50\n        50-100: 50-100\n        100-150: 100-150\n        150-200: 150-200\n      \'#options_display\': three_columns\n    use_of_disability_progression_expanded_disability_status_scale_e:\n      \'#type\': checkbox\n      \'#title\': \'USE OF DISABILITY PROGRESSION, EXPANDED DISABILITY STATUS SCALE (EDSS)\'\n      \'#attributes\':\n        class:\n          - veryStrong\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    assessment_of_degree_of_satisfaction_of_users:\n      \'#type\': checkbox\n      \'#title\': \'ASSESSMENT OF DEGREE OF SATISFACTION OF USERS\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    amministrative_data:\n      \'#type\': checkbox\n      \'#title\': \'ADMINISTRATIVE DATA\'\n      \'#label_attributes\':\n        class:\n          - veryStrong\n    do_you_have_cost_accountability:\n      \'#type\': radios\n      \'#title\': \'Do you have cost accountability\'\n      \'#options\': yes_no\nmscu_registry:\n  \'#type\': webform_wizard_page\n  \'#title\': \'MSCU REGISTRY\'\n  \'#states\':\n    invisible:\n      \':input[name=\"indicate_the_type_of_organization\"]\':\n        value: \'PRIVATE PRACTITIONER\'\n  mscu_registry1:\n    \'#type\': webform_section\n    \'#title\': \'MSCU REGISTRY\'\n    does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_:\n      \'#type\': select\n      \'#title\': \'DOES MSCU HAVE A REGISTRY OF PATIENTS WITH MULTIPLE SCLEROSIS?\'\n      \'#options\': yes_no\n    minimal_data_set_requirement:\n      \'#type\': checkboxes\n      \'#title\': \'MINIMAL DATA SET REQUIREMENT\'\n      \'#options\':\n        \'NUMBER OF PATIENT IDENTIFICATION\': \'NUMBER OF PATIENT IDENTIFICATION\'\n        \'DATE OF BIRTH\': \'DATE OF BIRTH\'\n        SEX: SEX\n        \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\': \'AUTONOMOUS COMMUNITY-STATE -PROVINCE OF RESIDENCE\'\n        \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \': \'DATE OF DIAGNOSIS AND DATE OF EXACERBATIONS (RELAPSES) \'\n        \'OTHER DIAGNOSIS (ICD-9-MC)\': \'OTHER DIAGNOSIS (ICD-9-MC)\'\n        \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \': \'DIAGNOSTIC PROCEDURES USED IN THE PATIENT (ICD-9-MC) TYPES OF PROCEDURES AND DATE OF SAME \'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    evoked_potentials_ep_:\n      \'#type\': checkboxes\n      \'#title\': \'Evoked potentials (EP)\'\n      \'#options\':\n        \'Visual EP\': \'Visual EP\'\n        \'Auditory EP\': \'Auditory EP\'\n        \'Somatosensory EP\': \'Somatosensory EP\'\n        \'Motor EP\': \'Motor EP\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    hospital_admissions:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'HOSPITAL ADMISSIONS\'\n      \'#options\':\n        \'DATE OF HOSPITALIZATION\': \'DATE OF HOSPITALIZATION\'\n        \'DATE HOSPITAL DISCHARGE\': \'DATE HOSPITAL DISCHARGE\'\n        \'TYPE OF HOSPITALIZATION\': \'TYPE OF HOSPITALIZATION\'\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_hospital_discharge_:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF HOSPITAL DISCHARGE \'\n      \'#options\':\n        Home: Home\n        \'Transfer to another hospital\': \'Transfer to another hospital\'\n        \'Voluntary discharge\': \'Voluntary discharge\'\n        \'Transfer to another sanitary facility \': \'Transfer to another sanitary facility \'\n        Death: Death\n        \'Service responsible of discharge. \': \'Service responsible of discharge. \'\n        \'Principal diagnosis (ICD-9-MC)\': \'Principal diagnosis (ICD-9-MC)\'\n        \'Other diagnosis (ICD-9-MC)\': \'Other diagnosis (ICD-9-MC)\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    x_ray:\n      \'#type\': checkbox\n      \'#title\': X-Ray\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    please_tick_which_of_the_following_data_are_recorded_in_themscu:\n      \'#type\': webform_section\n      \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY\'\n      \'#states\':\n        invisible:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'\': \'\'\n  please_tick_which_of_the_following_data2:\n    \'#type\': webform_section\n    \'#title\': \'PLEASE TICK WHICH OF THE FOLLOWING DATA ARE RECORDED IN THE MSCU REGISTRY FOR OUTPATIENT VISITS?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n          \'!value\': \'Yes\'\n    date_of_visit:\n      \'#type\': checkbox\n      \'#title\': \'DATE OF VISIT\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    type_of_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'TYPE OF VISIT\'\n      \'#options\':\n        URGENT: URGENT\n        PROGRAMMED: PROGRAMMED\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    reason_for_visit:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'REASON FOR VISIT\'\n      \'#options\':\n        DIAGNOSTIC: DIAGNOSTIC\n        RELAPSE: RELAPSE\n        \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\': \'INITIATION OR MONITORING OF DISEASE MODIFYING THERAPY\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    clinical_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'CLINICAL ASSESSMENT\'\n      \'#options\':\n        EDSS: EDSS\n        MSFC: MSFC\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    patient_reported_outcome_assessment2:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'PATIENT REPORTED OUTCOME ASSESSMENT\'\n      \'#options\':\n        \'QoL MEASURE\': \'QoL MEASURE\'\n        \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\': \'FATIGUE: MODIFIED FATIGUE IMPACT SCALE OR OTHER\'\n        \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \': \'ANXIETY/DEPRESSION: HOSPITAL ANXIETY AND DEPRESSION SCALE \'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    blood_tests2:\n      \'#type\': checkboxes\n      \'#title\': \'BLOOD TESTS\'\n      \'#options\':\n        \'IMMUNOLOGY SEROLOGICAL PROFILE\': \'IMMUNOLOGY SEROLOGICAL PROFILE\'\n        NfL: NfL\n        AQ4A: AQ4A\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    csf_studies_cerebrospinal_fluid_2:\n      \'#type\': checkboxes\n      \'#title\': \'CSF STUDIES (CEREBROSPINAL FLUID)\'\n      \'#options\':\n        \'IT Synthesis of IgG\': \'IT Synthesis of IgG\'\n        \'IgG OB\': \'IgG OB\'\n        \'IgM OB\': \'IgM OB\'\n      \'#other__placeholder\': \'Please Specify\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    mri2:\n      \'#type\': checkbox\n      \'#title\': MRI\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\n    oct_optic_coherence_tomography_2:\n      \'#type\': checkbox\n      \'#title\': \'OCT (optic coherence tomography)\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"does_mscu_have_a_registry_of_patients_with_multiple_sclerosis_\"]\':\n            \'!value\': \'Yes\'\ntreatments_available:\n  \'#type\': webform_wizard_page\n  \'#title\': \'TREATMENTS AVAILABLE\'\n  treatments_available1:\n    \'#type\': webform_section\n    \'#title\': \'TREATMENTS AVAILABLE\'\n    immunomodulator_treatment:\n      \'#type\': checkboxes\n      \'#title\': \'IMMUNOMODULATOR TREATMENT\'\n      \'#options\':\n        Betaseron: Betaseron\n        Extavia: Extavia\n        Avonex: Avonex\n        Copaxone: Copaxone\n        \'Generic Glatiramer\': \'Generic Glatiramer\'\n        \'Rebif® (interferon beta-1a)\': \'Rebif® (interferon beta-1a)\'\n        \'Plegridy® (PEG-Interferon)\': \'Plegridy® (PEG-Interferon)\'\n        Plasmapheresis: Plasmapheresis\n        \'Vumerity ® (Diroximel fumarate)\': \'Vumerity ® (Diroximel fumarate)\'\n    immunosuppressant_treatment:\n      \'#type\': webform_checkboxes_other\n      \'#title\': \'IMMUNOSUPPRESSANT TREATMENT\'\n      \'#options\':\n        \'Aubagio® (teriflunmide)\': \'Aubagio® (teriflunmide)\'\n        \'Tecfidera® (dimethyl fumarate)\': \'Tecfidera® (dimethyl fumarate)\'\n        \'Tysabri® (natalizumab)\': \'Tysabri® (natalizumab)\'\n        \'Gilenya® (finglimd)\': \'Gilenya® (finglimd)\'\n        \'Lemtrada® (alemtuzumab)\': \'Lemtrada® (alemtuzumab)\'\n        \'Novantrne® (mitxantrne) \': \'Novantrne® (mitxantrne) \'\n        \'Mavenclad® (cladribine)\': \'Mavenclad® (cladribine)\'\n        \'Ocrevus® (crelizumab)\': \'Ocrevus® (crelizumab)\'\n        Rituximab: Rituximab\n        Azathiprine: Azathiprine\n        Methotrexate: Methotrexate\n        Cyclophsphamide: Cyclophsphamide\n    autologous_hematopoietic_stem_cell_transplantation_asct_:\n      \'#type\': select\n      \'#title\': \'AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT)\'\n      \'#options\': yes_no\n    other_therapeutic_procedures:\n      \'#type\': checkbox\n      \'#title\': \'OTHER THERAPEUTIC PROCEDURES\'\n    please_specify:\n      \'#type\': textarea\n      \'#title\': \'PLEASE SPECIFY\'\n      \'#states\':\n        invisible-slide:\n          \':input[name=\"other_therapeutic_procedures\"]\':\n            unchecked: true\n    _adverse_effects:\n      \'#type\': checkboxes\n      \'#title\': \' ADVERSE EFFECTS\'\n      \'#options\':\n        ICD-9-MC: ICD-9-MC\n        MEDRA: MEDRA\n        \'WHO Toxicity Grading Scale\': \'WHO Toxicity Grading Scale\'\n      \'#other__placeholder\': \'Please Specify\'\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:1;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:1;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:1;s:26:\"wizard_progress_percentage\";b:1;s:20:\"wizard_progress_link\";b:1;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:1;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"5389b669-9c98-46e0-aa0d-f57f68288b2e\";}'),('','webform.webform.multi_act_framework_baseline_ana','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:6:\"closed\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:32:\"multi_act_framework_baseline_ana\";s:5:\"title\";s:45:\"Multi-act framework baseline analysis (Templ)\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:35872:\"nodeid:\n  \'#type\': hidden\n  \'#title\': nodeid\n  \'#default_value\': \'0\'\n  \'#prepopulate\': true\ncriteria_1_vision_and_agenda:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 1: Vision and agenda\'\n  \'#next_button_label\': \'Criteria 2: Participatory Governance\'\n  please_provide_supporting_dcoument:\n    \'#type\': webform_document_file\n    \'#title\': \'Please provide supporting document\'\n  document_annotation:\n    \'#type\': webform_term_checkboxes\n    \'#title\': \'Document Annotation\'\n    \'#vocabulary\': content_annotation\n    \'#breadcrumb\': true\n    \'#breadcrumb_delimiter\': \'\'\n    \'#tree_delimiter\': \'\'\n  have_you_developed_a_shared_vision_mission_for_your_initiative_:\n    \'#type\': select\n    \'#title\': \'1. Have you developed a shared vision/mission for your initiative? \'\n    \'#help_display\': title_after\n    \'#options\': yes_no\n  do_you_have_an_agenda_defining_the_priority_areas_mid_term_and_l:\n    \'#type\': select\n    \'#title\': \'2. Do you have an agenda defining the priority areas, mid-term and long-term objectives and a set of actions to achieve the objectives of the initiative?\'\n    \'#options\': yes_no\n  _if_so_can_you_please_provide_the_documents_related_to_the_visio:\n    \'#type\': select\n    \'#title\': \'3. Can you please provide the documents related to the vision/mission and/or agenda?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible:\n        \':input[name=\"do_you_have_an_agenda_defining_the_priority_areas_mid_term_and_l\"]\':\n          \'!value\': \'Yes\'\n  could_you_please_describe_how_you_have_defined_the_common_object:\n    \'#type\': textarea\n    \'#title\': \'4. Could you please describe how you have defined the common objectives, priority areas and set of actions?\'\n  which_of_the_following_stakeholders_took_part_in_defining_the_ob:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'5. Which of the following stakeholders took part in defining the objectives, priorities and set of actions for your initiative? please tick if appropriate\'\n    \'#options\':\n      Patients: \'Patients -- (people with the diseases and affected by the diseases (i.e. relatives, caregivers))\'\n      \'Patients organizations, patient associations, advocacy organizations, etc.\': \'Patients organizations, patient associations, advocacy organizations, etc.\'\n      \'Society individual citizens, civil society organizations and networks\': \'Society individual citizens, civil society organizations and networks\'\n      \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\': \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\'\n      \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\': \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\'\n      \'Policy makers EU institutions; national, regional and local policy makers\': \'Policy makers EU institutions; national, regional and local policy makers\'\n      \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\': \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\'\n      \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\': \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\'\n    \'#other__placeholder\': \'Please specify\'\n  _have_you_identified_the_intended_beneficiaries_of_your_research:\n    \'#type\': select\n    \'#title\': \'6. Have you identified the intended beneficiaries of your research initiative?\'\n    \'#options\': yes_no\n  7_please_indicate_which_of_the_following_stakeholders_are_the_in:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'7. Please indicate which of the following (stakeholders) are the intended beneficiaries whom you have identified\'\n    \'#options\':\n      Patients: \'Patients -- (people with the diseases and affected by the diseases (i.e. relatives, caregivers))\'\n      \'Patients organizations, patient associations, advocacy organizations, etc.\': \'Patients organizations, patient associations, advocacy organizations, etc.\'\n      \'Society individual citizens, civil society organizations and networks\': \'Society individual citizens, civil society organizations and networks\'\n      \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\': \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\'\n      \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\': \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\'\n      \'Policy makers EU institutions; national, regional and local policy makers\': \'Policy makers EU institutions; national, regional and local policy makers\'\n      \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\': \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\'\n      \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\': \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\'\n    \'#other__placeholder\': \'Please specify\'\n    \'#states\':\n      invisible:\n        \':input[name=\"_have_you_identified_the_intended_beneficiaries_of_your_research\"]\':\n          \'!value\': \'Yes\'\ncriteria_2_participatory_governance:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 2: Participatory Governance\'\n  \'#prev_button_label\': \'Criteria 1: Vision and agenda\'\n  \'#next_button_label\': \'Criteria 3 : effective stakeholder engagement - patient engagement\'\n  have_you_established_a_governance_structure_for_the_ms_care_unit:\n    \'#type\': select\n    \'#title\': \'9. Have you established a governance structure for the MS Care Unit?\'\n    \'#options\': yes_no\n  _10_which_of_the_following_stakeholders_are_involved_in_the_gove:\n    \'#type\': webform_checkboxes_other\n    \'#title\': \'10. Which of the following stakeholders are involved in the governance board?\'\n    \'#options\':\n      Patients: \'Patients -- (people with the diseases and affected by the diseases (i.e. relatives, caregivers))\'\n      \'Patients organizations, patient associations, advocacy organizations, etc.\': \'Patients organizations, patient associations, advocacy organizations, etc.\'\n      \'Society individual citizens, civil society organizations and networks\': \'Society individual citizens, civil society organizations and networks\'\n      \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\': \'Payers and purchasers, public or private entities responsible for underwriting the costs of health care\'\n      \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\': \'Care providers, health and social care organizations and professionals (doctors, nurses, etc.)\'\n      \'Policy makers EU institutions; national, regional and local policy makers\': \'Policy makers EU institutions; national, regional and local policy makers\'\n      \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\': \'Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector\'\n      \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\': \'Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects\'\n    \'#other__placeholder\': \'Please specify\'\n  11_could_you_please_describe_the_different_bodies_in_your_govern:\n    \'#type\': textarea\n    \'#title\': \'11. Could you please describe the different bodies in your governance (e.g. boards committees, working groups, teams, others) in the MS Care Unit and describe their functions and composition.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"have_you_established_a_governance_structure_for_the_ms_care_unit\"]\':\n          \'!value\': \'Yes\'\n  12_do_you_have_a_procedure_that_describes_the_roles_and_responsi:\n    \'#type\': select\n    \'#title\': \'12. Do you have a procedure that describes the roles and responsibilities of all (or some of the) stakeholders and decision making processes ?\'\n    \'#description\': |\n      <h6 class=\"question-title-container\" id=\"question-title-345309734\"><span class=\"notranslate user-generated\">documents that describe this see links:</span><br />\n      &nbsp;</h6>\n      \n      <ul>\n      	<li>\n      	<h6 class=\"question-title-container\"><a href=\"https://www.globalreporting.org/SiteCollectionDocuments/2016/Governance%20documents/Rules%20and%20Procedures%20for%20the%20GRI%20Board%20of%20Directors.pdf\">https://www.globalreporting.org/SiteCollectionDocuments/2016/Governance%20documents/Rules%20and%20Procedures%20for%20the%20GRI%20Board%20of%20Directors.pdf</a></h6>\n      	</li>\n      	<li>\n      	<h6 class=\"question-title-container\"><span class=\"notranslate user-generated\"><a href=\"https://www.globalreporting.org/SiteCollectionDocuments/2014/GRIs-new-governance-structure.pdf\">https://www.globalreporting.org/SiteCollectionDocuments/2014/GRIs-new-governance-structure.pdf</a>)</span></h6>\n      	</li>\n      </ul>\n      \n    \'#options\': yes_no\n  13_if_so_describe_or_provide_a_copy_of_that_procedure_:\n    \'#type\': textarea\n    \'#title\': \'13. If so, describe or provide a copy of that procedure.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"12_do_you_have_a_procedure_that_describes_the_roles_and_responsi\"]\':\n          value: \'No\'\n  14_could_the_stakeholders_have_different_decision_power_:\n    \'#type\': select\n    \'#title\': \'14. Could the stakeholders have different decision power?\'\n    \'#description\': \'<h6><span class=\"notranslate user-generated\"><em>(For example: if a vote is necessary, some stakeholders could have voting rights and others not (e.g. care providers have and patients do not have). Some votes may have more power than others).</em></span></h6>\'\n    \'#options\': yes_no\n  15_please_describe:\n    \'#type\': textarea\n    \'#title\': \'15. please describe\'\n    \'#states\':\n      invisible:\n        \':input[name=\"14_could_the_stakeholders_have_different_decision_power_\"]\':\n          \'!value\': \'Yes\'\n  16_when_establishing_the_governance_boards_do_you_take_into_acco:\n    \'#type\': select\n    \'#title\': \'16. When establishing the governance boards, Do you take into account diversity factors (such as gender, sector, geographical/educational background, language)? (e.g. an ethics committee or a procedure that regulates this aspect.)\'\n    \'#options\': yes_no\n  17_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'17. please describe the mechanisms by which you ensure a balance or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"16_when_establishing_the_governance_boards_do_you_take_into_acco\"]\':\n          \'!value\': \'Yes\'\n  18_when_establishing_the_governance_boards_do_you_ensure_the_par:\n    \'#type\': select\n    \'#title\': \'18. When establishing the governance boards, do you ensure the participation of disadvantaged stakeholders?\'\n    \'#description\': \'<h6>(Disadvantages could be: some patients with particular problems for whom it will be more difficult to be involved. It could be people living in remote areas, literacy issues,&hellip;)</h6>\'\n    \'#options\': yes_no\n  19_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'19. Please describe the mechanisms by which you ensure a balance or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"18_when_establishing_the_governance_boards_do_you_ensure_the_par\"]\':\n          \'!value\': \'Yes\'\n  20_when_establishing_the_governance_boards_do_you_protect_the_in:\n    \'#type\': select\n    \'#title\': \'20. When establishing the governance boards, do you protect the integrity and multi-stakeholder nature of the initiative and ensure that self-interest of stakeholders does not prevail on collective decision-making processes?\'\n    \'#options\': yes_no\n  21_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'21. Please describe the mechanisms by which you ensure a balance or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"20_when_establishing_the_governance_boards_do_you_protect_the_in\"]\':\n          \'!value\': \'Yes\'\n  22_when_establishing_the_governance_boards_do_you_maintain_commi:\n    \'#type\': select\n    \'#title\': \'22. When establishing the governance boards, do you maintain commitment and ownership among the participating stakeholders?\'\n    \'#options\': yes_no\n  23_please_describe_the_mechanisms_by_which_you_ensure_a_balance_:\n    \'#type\': textarea\n    \'#title\': \'23. Please describe the mechanisms by which you ensure a balance or provide us with the relevant documentation.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"22_when_establishing_the_governance_boards_do_you_maintain_commi\"]\':\n          \'!value\': \'Yes\'\ncriteria_3_effective_stakeholder_engagement_patient_engagement:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 3 : effective stakeholder engagement - patient engagement\'\n  \'#prev_button_label\': \'Criteria 2: Participatory Governance\'\n  \'#next_button_label\': \'Criteria 4: Efficient Management and  Coordination of the initiative\'\n  beyond_the_stakeholders_involved_in_the_governance_structure_hav:\n    \'#type\': select\n    \'#title\': \'25. Beyond the stakeholders involved in the governance structure, have you identified other stakeholders who might be influenced or might influence the initiative? \'\n    \'#options\': yes_no\n  26_if_so_please_describe_these_stakeholders_considering_the_clas:\n    \'#type\': textarea\n    \'#title\': \'26. Please describe these stakeholders considering the classification of Criteria 2\'\n    \'#description\': |\n      <h6 class=\"question-title-container\" id=\"question-title-338899957\"><span class=\"notranslate user-generated\">- Patients (people with the diseases and affected by the diseases (i.e. relatives, caregivers))<br />\n      - Patients organizations, patient associations, advocacy organizations, etc.<br />\n      - Society individual citizens, civil society organizations and networks<br />\n      - Payers and purchasers, public or private entities responsible for underwriting the costs of health care<br />\n      - Care providers, health and social care organizations and professionals (doctors, nurses, etc.)<br />\n      - Policy makers EU institutions; national, regional and local policy makers<br />\n      - Industry companies developing and selling health products (drugs, devices, applications, etc.) and services sector<br />\n      - Research and education organizations Research organizations; Universities; Education providers; Foundations; Other research projects</span></h6>\n      \n    \'#help_title\': Help\n    \'#states\':\n      invisible:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\n  27_did_you_differentiate_the_level_of_engagement_of_these_stakeh:\n    \'#type\': select\n    \'#title\': \'27. Did you differentiate the level of engagement of these stakeholders (i.e. involved in specific activities of the initiative such as research group, consulted, informed) according to their relevance to the initiative and other specific characteristics?\'\n    \'#options\': yes_no\n  28_do_you_have_a_stakeholder_engagement_strategy_in_place_both_w:\n    \'#type\': select\n    \'#title\': \'28. Do you have a stakeholder engagement strategy in place? (both with regard to stakeholders involved in the governance and \"external\" stakeholders)\'\n    \'#options\': yes_no\n  29_describe_the_methodology_that_is_adopted_in_order_to_put_in_p:\n    \'#type\': textarea\n    \'#title\': \'29. Describe the methodology that is adopted in order to put in place a process of stakeholder engagement, and list the actions that will be undertaken for each of the steps you might identify in the engagement process Please, provide relevant documents if any\'\n    \'#states\':\n      invisible:\n        \':input[name=\"28_do_you_have_a_stakeholder_engagement_strategy_in_place_both_w\"]\':\n          value: \'No\'\n  30_did_you_perform_a_consultation_process_in_order_to_understand:\n    \'#type\': select\n    \'#title\': \'30. Did you perform a consultation process in order to understand the needs, expectations and challenges of the stakeholders involved in the initiative in terms of their participation in the initiative?  (both with regard to stakeholders involved in the governance and \"external\" stakeholders)\'\n    \'#options\': yes_no\n  31_did_you_carry_out_an_analysis_to_identify_stakeholders_challe:\n    \'#type\': select\n    \'#title\': \'31. Did you carry out an analysis to identify stakeholders challenges and barriers to guarantee genuine participation?\'\n    \'#options\': yes_no\n  32_could_you_please_provide_the_report_of_this_analysis_:\n    \'#type\': textarea\n    \'#title\': \'32. Could you please provide the report of this analysis.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"31_did_you_carry_out_an_analysis_to_identify_stakeholders_challe\"]\':\n          \'!value\': \'Yes\'\n  33_with_regard_to_stakeholder_engagement_do_you_have_a_process_t:\n    \'#type\': select\n    \'#title\': \'33. With regard to stakeholder engagement, Do you have a process to guarantee a fair and equitable process that takes into account the limitations that participants might encounter (e.g. cognitive impairment, behavioral issues, fatigue)?\'\n    \'#options\': yes_no\n  34_please_describe:\n    \'#type\': textarea\n    \'#title\': \'34. Please describe\'\n    \'#states\':\n      invisible:\n        \':input[name=\"33_with_regard_to_stakeholder_engagement_do_you_have_a_process_t\"]\':\n          \'!value\': \'Yes\'\n  35_do_you_have_a_process_in_place_to_train_stakeholders_in_order:\n    \'#type\': select\n    \'#title\': \'35. Do you have a process in place to train stakeholders in order to allow their genuine and balanced participation?\'\n    \'#options\': yes_no\n  36_please_describe_the_process_of_training_stakeholders_e_g_the_:\n    \'#type\': textarea\n    \'#title\': \'36. Please describe the process of training stakeholders (e.g. the total amount of average hours per training and for informing stakeholders)\'\n    \'#states\':\n      invisible:\n        \':input[name=\"35_do_you_have_a_process_in_place_to_train_stakeholders_in_order\"]\':\n          \'!value\': \'Yes\'\ncriteria_4_efficient_management_and_coordination_of_the_initiati:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 4: Efficient Management and  Coordination of the initiative\'\n  \'#prev_button_label\': \'Criteria 3 : effective stakeholder engagement - patient engagement\'\n  \'#next_button_label\': \"Criterion 5: Co-accountability assessment\\t\\t\\t\\t\"\n  38_in_which_of_the_7_steps_research_innovation_r_i_path_do_you_e:\n    \'#type\': checkboxes\n    \'#title\': \'38. In which of the 7-steps Research & Innovation (R&I) path do you engage patients? (please tick as appropriate)\'\n    \'#options\':\n      \'1. Breaking down boundaries \': \'1. Breaking down boundaries  -- (this area includes the conditions that should be set in Research Funding and Performing Organisations (RFPOs) in order to facilitate patient engagement as standard practice. Boundary refers to a physical or conceptual divide between Patient Engagement and organisations)\'\n      \'2. Research priorities\': \'2. Research priorities -- (all actions necessary to prioritize the Research Agenda and formulate its objectives. Involving patients in setting priorities implicitly implies the direct allocation of funding. Patients may be engaged to co-design research agendas, exercises of prioritization) \'\n      \'3. Steering institutions\': \'3. Steering institutions -- (all actions performed to establish steering and advisory committees and boards. An advisory committee and board is usually made up of high level stakeholders and/or experts who provide guidance on key issues such as company policy and objectives, rules and role, budgetary control, marketing strategy, resource allocation, and decisions involving large expenditures. Patients may be invited to be member of research & governance committees and boards)\'\n      \'4. Design & plan\': \'4. Design & plan -- (the design of all the activities that lead to the realization of a concept or idea and which helps to achieve the objectives set, i.e. the formulation and assignment of tasks, rules, roles and execution times in order to achieve the objectives set. Patients may be invited to co-design specific programs (e.g. design of project objectives, endpoints, work plan and related budget)\'\n      \'5. Research execution\': \'5. Research execution -- (all activities to implement a research program or a specific project in order to achieve the objectives set. Patients may be engaged in the development and monitoring of specific programs (e.g. release of call for proposals, selection of projects to be funded; monitoring of funded projects) or projects (e.g. Information and Communication Technology ICT device development).  \'\n      \'6. Evaluation\': \'6. Evaluation -- (all activities to determine the value of a research program or project, establishing their outputs and results, the degree of achievement of its objectives (process evaluation) and its impact. patients may be involved in the evaluation of the results of research programs (e.g. publications, Impact Factors, application of new parameters) or projects (e.g. evaluation of an ICT device by the user) \'\n      \'7. Translation to community\': \'7. Translation to community -- (activities to promote and facilitate the adoption of the results of research programs or projects, including all aspects of engagement in communication of results and advocacy. At project level, translation to the community includes information for regulatory authorities (e.g. medical development, ICT tools, HTA, etc.). Patients may be engaged in promoting change in society resulting from the results of research programs (e.g. development of guidelines and advocacy activities, implementation of specific care models) or projects (e.g. communication activities and advocacy to exploit the ICT device) \'\n      \'8. None of the above \': \'8. None of the above \'\n  39_do_you_have_a_team_manager_dedicated_to_coordinate_the_patien:\n    \'#type\': select\n    \'#title\': \'39. Do you have a team/manager dedicated to coordinate the patient engagement?\'\n    \'#options\': yes_no\n  40_do_you_have_indicators_to_measure_the_return_on_patient_engag:\n    \'#type\': select\n    \'#title\': \'40. Do you have indicators to measure the “return on patient engagement” for each stakeholder involved in your initiative?\'\n    \'#description\': \'<h6>(by return on patient engagement we mean the benefit and impact resulting to performing patient engagement in R&amp;I. The more Patient engagement produces value the more the costs will be sustainable for all the stakeholders)</h6>\'\n    \'#options\': yes_no\n  41_do_you_plan_ad_hoc_training_programs_related_to_the_patient_e:\n    \'#type\': select\n    \'#title\': \'41. Do you plan ad-hoc training programs related to the patient engagement, including scope and actions?\'\n    \'#options\': yes_no\n  42_do_you_have_mechanism_in_place_to_recognize_and_reward_patien:\n    \'#type\': select\n    \'#title\': \'42. Do you have mechanism in place to recognize and reward patients?\'\n    \'#options\': yes_no\n  43_do_you_have_dedicated_resources_budget_for_patient_engagement:\n    \'#type\': select\n    \'#title\': \'43. Do you have dedicated resources (budget) for patient engagement?\'\n    \'#options\': yes_no\n  44_do_you_perform_an_ethical_assessment_of_your_patient_engageme:\n    \'#type\': select\n    \'#title\': \'44. Do you perform an ethical assessment of your patient engagement strategy and of its implementation?\'\n    \'#options\': yes_no\n  47_could_you_provide_some_documentation_in_that_context_:\n    \'#type\': select\n    \'#title\': \'47. Could you provide some documentation in that context?\'\n    \'#options\': yes_no\n  48_if_yes_do_you_have_a_plan_that_defines_the_following_please_t:\n    \'#type\': checkboxes\n    \'#title\': \'48. If yes, do you have a plan that defines the following: Please tick as appropriate\'\n    \'#options\':\n      \'Specific actions that different stakeholders commit to implement in order to achieve the objectives of the initiative; \': \'Specific actions that different stakeholders commit to implement in order to achieve the objectives of the initiative; \'\n      \'Definition and composition of Working Groups, which might practically deal with the implementation of such actions; \': \'Definition and composition of Working Groups, which might practically deal with the implementation of such actions; \'\n      \' Definition of clear and measurable targets; \': \' Definition of clear and measurable targets; \'\n      \' Presentation of clear project timeline,including deadlines in order to allow participants to \': \' Presentation of clear project timeline,including deadlines in order to allow participants to \'\n      \'hold each other accountable; \': \'hold each other accountable; \'\n      \' Definition of a clear internal review process, carried out on a periodical basis in order to keep \': \' Definition of a clear internal review process, carried out on a periodical basis in order to keep \'\n      \' track of the achieved targets; \': \' track of the achieved targets; \'\n      \' Information regarding the organization \"touch points meetings\" (such as periodic events or webinars) \': \' Information regarding the organization \"touch points meetings\" (such as periodic events or webinars) \'\n  49_do_you_have_a_cost_management_process_in_place_e_g_a_defined_:\n    \'#type\': select\n    \'#title\': \'49. Do you have a cost management process in place (e.g. a defined budget, a cost analysis) that ensures that the initiative has enough resources to reach its objectives?\'\n    \'#options\': yes_no\n  50_do_you_ensure_that_the_internal_team_has_solid_skills_to_carr:\n    \'#type\': select\n    \'#title\': \'50. Do you ensure that the internal team has solid skills to carry out the activities of the initiative?\'\n    \'#options\': yes_no\n  51_do_you_maintain_accountability_over_time_keeping_track_of_exp:\n    \'#type\': select\n    \'#title\': \'51. Do you maintain accountability over time keeping track of expenses and revenues?\'\n    \'#options\': yes_no\n  52_please_describe_or_provide_documentation_:\n    \'#type\': textarea\n    \'#title\': \'52. Please describe or provide documentation.\'\n    \'#states\':\n      invisible:\n        \':input[name=\"51_do_you_maintain_accountability_over_time_keeping_track_of_exp\"]\':\n          \'!value\': \'Yes\'\n  53_do_you_have_a_process_in_place_to_ensure_that_there_is_a_righ:\n    \'#type\': select\n    \'#title\': \'53. Do you have a process in place to ensure that there is a right balance between an efficient management process and the opportunities for engaging a wide range of participants? (examples:you have defined rules to take final decision in case a discussion among governance body\'\'s member has run aground; measures to decrease interdependency between activities, measures to increase robustness, etc.)\'\n    \'#options\': yes_no\n  54_please_explain_:\n    \'#type\': textarea\n    \'#title\': \'54. Please explain \'\n    \'#states\':\n      invisible:\n        \':input[name=\"53_do_you_have_a_process_in_place_to_ensure_that_there_is_a_righ\"]\':\n          \'!value\': \'Yes\'\n  55_have_you_developed_a_contingency_plan_risk_management_approac:\n    \'#type\': select\n    \'#title\': \'55. Have you developed a contingency plan/risk management approach ?  (A contingency plan is essentially a “Plan B.” It’s a backup plan in place for when things go differently than expected. It is a defined, actionable plan to be enacted if an identified risk becomes a reality. For example: a key supplier goes bankrupt; key staff has to leave the project, etc.) \'\n    \'#options\': yes_no\n  56_can_you_provide_documents_:\n    \'#type\': textarea\n    \'#title\': \'56. Can you provide documents?\'\n    \'#states\':\n      invisible:\n        \':input[name=\"55_have_you_developed_a_contingency_plan_risk_management_approac\"]\':\n          \'!value\': \'Yes\'\ninitiativeid:\n  \'#type\': hidden\n  \'#title\': InitiativeID\n  \'#prepopulate\': true\ncriterion_5_co_accountability_assessment_:\n  \'#type\': webform_wizard_page\n  \'#title\': \"Criterion 5: Co-accountability assessment\\t\\t\\t\\t\"\n  \'#prev_button_label\': \"Criterion 4: Efficient Management and Coordination of the initiative\\t\\t\\t\\t\"\n  do_you_have_a_monitoring_system_for_the_implementation_of_the_ac:\n    \'#type\': select\n    \'#title\': \'20) Do you have a monitoring system for the implementation of the actions of the initiative and the performance of the initiative itself (ongoing) ?\'\n    \'#options\': yes_no\n  have_you_defined_an_assessment_system_that_allow_to_measure_init:\n    \'#type\': select\n    \'#title\': \'21) Have you defined an assessment system that allow to measure initiative’s \"long-term impact”(ex-post) ? \'\n    \'#options\': yes_no\n  does_this_assessment_involve_stakeholders_in_the_gathering_of_da:\n    \'#type\': select\n    \'#title\': \'21.1) Does this assessment involve stakeholders in the gathering of data and information ?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n        \':input[name=\"does_this_assessment_involve_stakeholders_in_the_gathering_of_da\"]\':\n          \'!value\': \'Yes\'\n  does_this_assessment_include_indicators_related_to_the_patient_d:\n    \'#type\': select\n    \'#title\': \'21.2) Does this assessment include indicators related to the patient dimension ?\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n        \':input[name=\"does_this_assessment_involve_stakeholders_in_the_gathering_of_da\"]\':\n          \'!value\': \'Yes\'\n  are_the_monitoring_and_the_assessment_systems_and_the_related_in:\n    \'#type\': select\n    \'#title\': \'21.3) Are the monitoring and the assessment systems and the related indicators linked to the objectives of the initiative (link with criteria 1)\'\n    \'#options\': yes_no\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n        \':input[name=\"does_this_assessment_involve_stakeholders_in_the_gathering_of_da\"]\':\n          \'!value\': \'Yes\'\n  please_describe_how_the_measurement_is_linked_to_the_objectives_:\n    \'#type\': textarea\n    \'#title\': \'21.4) Please describe how the measurement is linked to the objectives (link with criteria 1)\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"have_you_defined_an_assessment_system_that_allow_to_measure_init\"]\':\n          \'!value\': \'Yes\'\n        \':input[name=\"does_this_assessment_involve_stakeholders_in_the_gathering_of_da\"]\':\n          \'!value\': \'Yes\'\n  do_you_publish_a_progress_report_:\n    \'#type\': select\n    \'#title\': \'22) Do you publish a progress report ?\'\n    \'#options\': yes_no\n  can_you_provide_any_of_those_reports_:\n    \'#type\': webform_document_file\n    \'#title\': \'22.1) Can you provide any of those reports ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_publish_a_progress_report_\"]\':\n          \'!value\': \'Yes\'\n  what_is_the_frequency_of_publishing_progress_reports_:\n    \'#type\': textarea\n    \'#title\': \'22.2) What is the frequency of publishing progress reports ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_publish_a_progress_report_\"]\':\n          \'!value\': \'Yes\'\n  do_you_communicate_with_stakeholders_about_the_progress_of_the_i:\n    \'#type\': select\n    \'#title\': \'23) Do you communicate with stakeholders about the progress of the initiative ?\'\n    \'#options\': yes_no\n  please_describe_how_you_communicate_with_the_stakeholders_on_pro:\n    \'#type\': textarea\n    \'#title\': \'23.1) Please describe how you communicate with the stakeholders on progress (e.g. Online platform, annual report, newsletters, ad-hoc communications) ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_communicate_with_stakeholders_about_the_progress_of_the_i\"]\':\n          \'!value\': \'Yes\'\n  do_you_have_a_review_process_in_place_to_improve_the_initiative_:\n    \'#type\': select\n    \'#title\': \'24) Do you have a review process in place to improve the initiative’s performance and practices (based on the results of the monitoring) ?\'\n    \'#options\': yes_no\n  is_this_review_process_strictly_internal_or_is_there_a_third_par:\n    \'#type\': textarea\n    \'#title\': \'24.1) Is this review process strictly internal or is there a third party involvement ?\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_a_review_process_in_place_to_improve_the_initiative_\"]\':\n          \'!value\': \'Yes\'\n  pleas_describe_the_process_provide_documentation_that_allows_the:\n    \'#type\': textarea\n    \'#title\': \'24.2 Please describe the process/provide documentation that allows the incorporation of feedbacks from consultations and reviews to revise/change objectives of the initiative in a flexible manner\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"do_you_have_a_review_process_in_place_to_improve_the_initiative_\"]\':\n          \'!value\': \'Yes\'\n  do_you_have_a_process_in_place_to_gather_feedback_from_external_:\n    \'#type\': select\n    \'#title\': \'25) Do you have a process in place to gather feedback from external stakeholders and the public? (For example a section on the website for public consultation, organization of specific events, etc.) ?\'\n    \'#options\': yes_no\n  please_describe3:\n    \'#type\': textarea\n    \'#title\': \'Please describe\'\n    \'#states\':\n      invisible-slide:\n        \':input[name=\"beyond_the_stakeholders_involved_in_the_governance_structure_hav\"]\':\n          \'!value\': \'Yes\'\ncriteria_6_patient_engagement:\n  \'#type\': webform_wizard_page\n  \'#title\': \'Criteria 6: Patient Engagement\'\n  in_which_of_the_7_steps_r_i_path_do_you_engage_patients_:\n    \'#type\': checkboxes\n    \'#title\': \'In which of the 7-steps R&I path do you engage patients ?\'\n    \'#options\':\n      \' BREAKING DOWN BOUNDARIES\': \' BREAKING DOWN BOUNDARIES\'\n      \'RESEARCH PRIORITIES\': \'RESEARCH PRIORITIES\'\n      \'STEERING INSTITUTIONS\': \'STEERING INSTITUTIONS\'\n      \'DESIGN & PLAN\': \'DESIGN & PLAN\'\n      \'RESEARCH EXECUTION\': \'RESEARCH EXECUTION\'\n      EVALUATION: EVALUATION\n      \'TRANSLATION TO COMMUNITY\': \'TRANSLATION TO COMMUNITY\'\n      \'None of the above\': \'None of the above\'\n  do_you_have_a_team_manager_dedicated_to_coordinate_the_patient_e:\n    \'#type\': select\n    \'#title\': \'Do you have a team/manager dedicated to coordinate the patient engagement ?\'\n    \'#options\': yes_no\n  do_you_have_indicators_to_measure_the_return_on_patient_engageme:\n    \'#type\': select\n    \'#title\': \'Do you have indicators to measure the “return on patient engagement” for each stakeholder involved in your initiative ?\'\n    \'#options\': yes_no\n  do_you_plan_ad_hoc_training_programs_related_to_the_patient_enga:\n    \'#type\': select\n    \'#title\': \'Do you plan ad-hoc training programs related to the patient engagement, including scope and actions ?\'\n    \'#options\': yes_no\n  do_you_have_mechanism_in_place_to_recognize_and_reward_patients_:\n    \'#type\': select\n    \'#title\': \'Do you have mechanism in place to recognize and reward patients ?\'\n    \'#options\': yes_no\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:0:\"\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:1;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:1;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:1;s:26:\"wizard_progress_percentage\";b:1;s:20:\"wizard_progress_link\";b:1;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:13:\"authenticated\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:1;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:1;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:1:{i:0;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:1:{i:0;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:1:{i:0;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"77c39168-4450-4be4-883e-805b759071d9\";}'),('','webform.webform.open','a:21:{s:4:\"uuid\";s:36:\"2923ca0d-ea9c-465a-a40c-3ee5506df5e2\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:4:\"open\";s:5:\"title\";s:4:\"Open\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:91:\"actions:\n  \'#type\': webform_actions\n  \'#title\': \'Submit button(s)\'\n  \'#submit__label\': Open\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:1;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}}'),('','webform.webform.submission_list','a:21:{s:4:\"uuid\";s:36:\"848d88a1-182c-40ff-8f68-c98aaa6005b2\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:4:\"open\";s:12:\"dependencies\";a:1:{s:6:\"module\";a:1:{i:0;s:11:\"ma_handlers\";}}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:15:\"submission_list\";s:5:\"title\";s:15:\"Submission List\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:93:\"actions:\n  \'#type\': webform_actions\n  \'#title\': \'Submit button(s)\'\n  \'#submit__label\': Submit\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:4:\"both\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:0:{}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:7:\"message\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:0;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:1:{s:22:\"add_submission_handler\";a:7:{s:2:\"id\";s:19:\"mail_addsub_handler\";s:5:\"label\";s:22:\"Add submission handler\";s:10:\"handler_id\";s:22:\"add_submission_handler\";s:6:\"status\";b:1;s:10:\"conditions\";a:0:{}s:6:\"weight\";i:0;s:8:\"settings\";a:0:{}}}s:8:\"variants\";a:0:{}}'),('','webform.webform.variables_to_be_included_in_the_','a:21:{s:8:\"langcode\";s:2:\"en\";s:6:\"status\";s:6:\"closed\";s:12:\"dependencies\";a:0:{}s:4:\"open\";N;s:5:\"close\";N;s:6:\"weight\";i:0;s:3:\"uid\";i:1;s:8:\"template\";b:0;s:7:\"archive\";b:0;s:2:\"id\";s:32:\"variables_to_be_included_in_the_\";s:5:\"title\";s:87:\"Variables to be included in the enquiry of MSCU – ECF – 2018 Practising Neurologist\";s:11:\"description\";s:0:\"\";s:8:\"category\";s:0:\"\";s:8:\"elements\";s:2852:\"country:\n  \'#type\': textfield\n  \'#title\': Country\nprovince_state:\n  \'#type\': textfield\n  \'#title\': Province/State\nhospital_university_centre:\n  \'#type\': textfield\n  \'#title\': Hospital/University/Centre\nyear:\n  \'#type\': number\n  \'#title\': Year\n  \'#min\': 1945\n  \'#max\': 2020\nnumber_of_patients_of_ms_attended_in_one_year:\n  \'#type\': number\n  \'#title\': \'Number of patients of MS attended in one year\'\nprocesses_in_ms_patients_access_to_routinely_used_:\n  \'#type\': checkboxes\n  \'#title\': \'Processes in MS patients: (access to, routinely used?)\'\n  \'#options\':\n    \'Blood tests\': \'Blood tests\'\n    \'CSF studies (cerebrospinal fluid)\': \'CSF studies (cerebrospinal fluid)\'\n    MRI: MRI\n    \'Evoked potentials (EP)\': \'Evoked potentials (EP)\'\n    \'OCT (optic coherence tomography)\': \'OCT (Optic Coherence Tomography)\'\ntreatments_available:\n  \'#type\': webform_checkboxes_other\n  \'#title\': \'Treatments available\'\n  \'#options\':\n    \'Immunomodulator treatment\': \'Immunomodulator treatment\'\n    \'Immunosuppressant treatment\': \'Immunosuppressant treatment\'\n    \'Autologous hematopoietic stem cell transplantation (ASCT)\': \'Autologous hematopoietic stem cell transplantation (ASCT)\'\n  \'#other__type\': textarea\n  \'#other__option_label\': \'Other therapeutic procedures\'\n  \'#other__placeholder\': \'Please specify\'\nimmunomodulator_treatment:\n  \'#type\': webform_checkboxes_other\n  \'#title\': \'Immunomodulator treatment\'\n  \'#options\':\n    Betaseron: Betaseron\n    Extavia: Extavia\n    Avonex: Avonex\n    Copaxone: Copaxone\n    \'Generic Glatiramer\': \'Generic Glatiramer\'\n    \'Rebif® (interferon beta-1a)\': \'Rebif® (interferon beta-1a)\'\n    PEG-Interferon: PEG-Interferon\n  \'#states\':\n    invisible-slide:\n      \':input[name=\"treatments_available[checkboxes][Immunomodulator treatment]\"]\':\n        unchecked: true\nimmunosuppressant_treatment:\n  \'#type\': webform_checkboxes_other\n  \'#title\': \'Immunosuppressant treatment\'\n  \'#options\':\n    \'Aubagio® (teriflunomide)\': \'Aubagio® (teriflunomide)\'\n    \'Tecfidera® (dimethyl fumarate)\': \'Tecfidera® (dimethyl fumarate)\'\n    \'Tysabri® (natalizumab)\': \'Tysabri® (natalizumab)\'\n    \'Gilenya® (fingolimod)\': \'Gilenya® (fingolimod)\'\n    \'Lemtrada® (alemtuzumab)\': \'Lemtrada® (alemtuzumab)\'\n    \'Novantrone® (mitoxantrone) \': \'Novantrone® (mitoxantrone) \'\n    \'Mavenclad® (cladribine)\': \'Mavenclad® (cladribine)\'\n    \'Ocrevus® (ocrelizumab)\': \'Ocrevus® (ocrelizumab)\'\n    Rituximab: Rituximab\n    Azathioprine: Azathioprine\n    Methotrexate: Methotrexate\n    Cyclophosphamide: Cyclophosphamide\n  \'#states\':\n    invisible-slide:\n      \':input[name=\"treatments_available[checkboxes][Immunosuppressant treatment]\"]\':\n        unchecked: true\nadverse_effects:\n  \'#type\': checkboxes\n  \'#title\': \'Adverse effects\'\n  \'#options\':\n    ICD-9-MC: ICD-9-MC\n    MEDRA: MEDRA\n    \'WHO Toxicity Grading Scale\': \'WHO Toxicity Grading Scale\'\";s:3:\"css\";s:0:\"\";s:10:\"javascript\";s:0:\"\";s:8:\"settings\";a:127:{s:4:\"ajax\";b:0;s:15:\"ajax_scroll_top\";s:4:\"form\";s:18:\"ajax_progress_type\";s:0:\"\";s:11:\"ajax_effect\";s:0:\"\";s:10:\"ajax_speed\";N;s:4:\"page\";b:1;s:16:\"page_submit_path\";s:0:\"\";s:17:\"page_confirm_path\";s:0:\"\";s:15:\"page_theme_name\";s:0:\"\";s:10:\"form_title\";s:21:\"source_entity_webform\";s:16:\"form_submit_once\";b:0;s:22:\"form_exception_message\";s:0:\"\";s:17:\"form_open_message\";s:0:\"\";s:18:\"form_close_message\";s:0:\"\";s:25:\"form_previous_submissions\";b:1;s:17:\"form_confidential\";b:0;s:25:\"form_confidential_message\";s:0:\"\";s:16:\"form_remote_addr\";b:1;s:22:\"form_convert_anonymous\";b:0;s:16:\"form_prepopulate\";b:0;s:30:\"form_prepopulate_source_entity\";b:0;s:39:\"form_prepopulate_source_entity_required\";b:0;s:35:\"form_prepopulate_source_entity_type\";s:0:\"\";s:10:\"form_reset\";b:0;s:25:\"form_disable_autocomplete\";b:0;s:15:\"form_novalidate\";b:0;s:26:\"form_disable_inline_errors\";b:0;s:13:\"form_required\";b:0;s:12:\"form_unsaved\";b:0;s:17:\"form_disable_back\";b:0;s:16:\"form_submit_back\";b:0;s:14:\"form_autofocus\";b:0;s:19:\"form_details_toggle\";b:0;s:18:\"form_access_denied\";s:7:\"default\";s:24:\"form_access_denied_title\";s:0:\"\";s:26:\"form_access_denied_message\";s:0:\"\";s:29:\"form_access_denied_attributes\";a:0:{}s:15:\"form_file_limit\";s:0:\"\";s:5:\"share\";b:0;s:10:\"share_node\";b:0;s:16:\"share_theme_name\";s:0:\"\";s:11:\"share_title\";b:1;s:26:\"share_page_body_attributes\";a:0:{}s:16:\"submission_label\";s:0:\"\";s:14:\"submission_log\";b:0;s:16:\"submission_views\";a:0:{}s:24:\"submission_views_replace\";a:2:{s:14:\"webform_routes\";a:0:{}s:11:\"node_routes\";a:0:{}}s:23:\"submission_user_columns\";a:0:{}s:25:\"submission_user_duplicate\";b:0;s:24:\"submission_access_denied\";s:7:\"default\";s:30:\"submission_access_denied_title\";s:0:\"\";s:32:\"submission_access_denied_message\";s:0:\"\";s:35:\"submission_access_denied_attributes\";a:0:{}s:28:\"submission_exception_message\";s:0:\"\";s:25:\"submission_locked_message\";s:0:\"\";s:28:\"submission_excluded_elements\";a:0:{}s:24:\"submission_exclude_empty\";b:0;s:33:\"submission_exclude_empty_checkbox\";b:0;s:27:\"previous_submission_message\";s:0:\"\";s:28:\"previous_submissions_message\";s:0:\"\";s:8:\"autofill\";b:0;s:16:\"autofill_message\";s:0:\"\";s:26:\"autofill_excluded_elements\";a:0:{}s:19:\"wizard_progress_bar\";b:1;s:21:\"wizard_progress_pages\";b:0;s:26:\"wizard_progress_percentage\";b:0;s:20:\"wizard_progress_link\";b:0;s:22:\"wizard_progress_states\";b:0;s:19:\"wizard_auto_forward\";b:1;s:36:\"wizard_auto_forward_hide_next_button\";b:0;s:15:\"wizard_keyboard\";b:1;s:18:\"wizard_start_label\";s:0:\"\";s:19:\"wizard_preview_link\";b:0;s:19:\"wizard_confirmation\";b:1;s:25:\"wizard_confirmation_label\";s:0:\"\";s:12:\"wizard_track\";s:0:\"\";s:24:\"wizard_prev_button_label\";s:0:\"\";s:24:\"wizard_next_button_label\";s:0:\"\";s:13:\"wizard_toggle\";b:0;s:24:\"wizard_toggle_show_label\";s:0:\"\";s:24:\"wizard_toggle_hide_label\";s:0:\"\";s:7:\"preview\";i:0;s:13:\"preview_label\";s:0:\"\";s:13:\"preview_title\";s:0:\"\";s:15:\"preview_message\";s:0:\"\";s:18:\"preview_attributes\";a:0:{}s:25:\"preview_excluded_elements\";a:0:{}s:21:\"preview_exclude_empty\";b:1;s:30:\"preview_exclude_empty_checkbox\";b:0;s:5:\"draft\";s:4:\"none\";s:14:\"draft_multiple\";b:0;s:15:\"draft_auto_save\";b:0;s:19:\"draft_saved_message\";s:0:\"\";s:20:\"draft_loaded_message\";s:0:\"\";s:28:\"draft_pending_single_message\";s:0:\"\";s:30:\"draft_pending_multiple_message\";s:0:\"\";s:17:\"confirmation_type\";s:4:\"page\";s:18:\"confirmation_title\";s:0:\"\";s:20:\"confirmation_message\";s:0:\"\";s:16:\"confirmation_url\";s:0:\"\";s:23:\"confirmation_attributes\";a:0:{}s:17:\"confirmation_back\";b:1;s:23:\"confirmation_back_label\";s:0:\"\";s:28:\"confirmation_back_attributes\";a:0:{}s:26:\"confirmation_exclude_query\";b:0;s:26:\"confirmation_exclude_token\";b:0;s:19:\"confirmation_update\";b:0;s:11:\"limit_total\";N;s:20:\"limit_total_interval\";N;s:19:\"limit_total_message\";s:0:\"\";s:18:\"limit_total_unique\";b:0;s:10:\"limit_user\";N;s:19:\"limit_user_interval\";N;s:18:\"limit_user_message\";s:0:\"\";s:17:\"limit_user_unique\";b:0;s:18:\"entity_limit_total\";N;s:27:\"entity_limit_total_interval\";N;s:17:\"entity_limit_user\";N;s:26:\"entity_limit_user_interval\";N;s:5:\"purge\";s:4:\"none\";s:10:\"purge_days\";N;s:16:\"results_disabled\";b:0;s:23:\"results_disabled_ignore\";b:0;s:17:\"results_customize\";b:0;s:10:\"token_view\";b:0;s:12:\"token_update\";b:1;s:15:\"serial_disabled\";b:0;}s:6:\"access\";a:11:{s:6:\"create\";a:3:{s:5:\"roles\";a:2:{i:0;s:9:\"anonymous\";i:1;s:13:\"authenticated\";}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:1:{i:0;i:19;}s:11:\"permissions\";a:0:{}}s:10:\"update_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:9:\"purge_any\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:8:\"view_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"update_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"delete_own\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:10:\"administer\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:4:\"test\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}s:13:\"configuration\";a:3:{s:5:\"roles\";a:0:{}s:5:\"users\";a:0:{}s:11:\"permissions\";a:0:{}}}s:8:\"handlers\";a:0:{}s:8:\"variants\";a:0:{}s:4:\"uuid\";s:36:\"6aa0570e-d430-499f-9c08-b36de53d51d8\";}'),('','webform.webform_options.country_codes','a:10:{s:4:\"uuid\";s:36:\"c912780c-2b6f-4309-be72-d2542772c4a1\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"adQ16YGDPk7QfUKrfrC35o2sKdHEozdNtdpiH7CftQQ\";}s:2:\"id\";s:13:\"country_codes\";s:5:\"label\";s:13:\"Country codes\";s:8:\"category\";s:10:\"Geographic\";s:6:\"likert\";b:0;s:7:\"options\";s:0:\"\";}'),('','webform.webform_options.country_names','a:10:{s:4:\"uuid\";s:36:\"4392bc2f-42f9-48e4-a8ac-8fb99c68f776\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"zsfFP124dAM-sJkuEfnwaA7DN6o3-IsaXLgdNmObbYg\";}s:2:\"id\";s:13:\"country_names\";s:5:\"label\";s:13:\"Country names\";s:8:\"category\";s:10:\"Geographic\";s:6:\"likert\";b:0;s:7:\"options\";s:0:\"\";}'),('','webform.webform_options.days','a:10:{s:4:\"uuid\";s:36:\"b7f4300c-818c-4abd-87eb-544bce5d2690\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"YNrKbYrWWjeubUUM8AsQ19KnX7cU1elACR14CZJHmdg\";}s:2:\"id\";s:4:\"days\";s:5:\"label\";s:4:\"Days\";s:8:\"category\";s:13:\"Date and time\";s:6:\"likert\";b:0;s:7:\"options\";s:121:\"Sunday: Sunday\nMonday: Monday\nTuesday: Tuesday\nWednesday: Wednesday\nThursday: Thursday\nFriday: Friday\nSaturday: Saturday\n\";}'),('','webform.webform_options.education','a:10:{s:4:\"uuid\";s:36:\"a91cb6a7-500a-44eb-beec-7b459f33ec3a\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"mII4acOv33s-j8PINywrCag4OITbeJGxdPO373dnHHw\";}s:2:\"id\";s:9:\"education\";s:5:\"label\";s:9:\"Education\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:152:\"High School: High School\nAssociate Degree: Associate Degree\nGraduate or Professional Degree: Graduate or Professional Degree\nSome College: Some College\n\";}'),('','webform.webform_options.employment_status','a:10:{s:4:\"uuid\";s:36:\"1e3c17d1-caff-475a-afae-3cf1ee877bd9\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"8MCmsz_csdJkVItxI8g_s4zp2PM285YqCy_gWTzOLPw\";}s:2:\"id\";s:17:\"employment_status\";s:5:\"label\";s:17:\"Employment status\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:113:\"\'Full Time\': \'Full Time\'\n\'Part Time\': \'Part Time\'\n\'Military\': \'Military\'\nUnemployed: Unemployed\nRetired: Retired\n\";}'),('','webform.webform_options.ethnicity','a:10:{s:4:\"uuid\";s:36:\"c2d06902-ab34-4b8e-a7cf-daf6b85fe709\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"pIPgrAC82wE2GAk1mOv2UvMYv71YQe4VT8667QIYdvI\";}s:2:\"id\";s:9:\"ethnicity\";s:5:\"label\";s:9:\"Ethnicity\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:200:\"Caucasian: Caucasian\n\'Latino/Hispanic\': \'Latino/Hispanic\'\n\'Middle Eastern\': \'Middle Eastern\'\nAfrican: African\nCaribbean: Caribbean\n\'South Asian\': \'South Asian\'\n\'East Asian\': \'East Asian\'\nMixed: Mixed\n\";}'),('','webform.webform_options.gender','a:10:{s:4:\"uuid\";s:36:\"d164ec8e-1c29-4416-8b73-3bf91fab466b\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"K8qTfK5-87DpwTQBkqhgTMR4P0Zz8Z9aNI7OnMlTb0Q\";}s:2:\"id\";s:6:\"gender\";s:5:\"label\";s:6:\"Gender\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:26:\"Male: Male\nFemale: Female\n\";}'),('','webform.webform_options.industry','a:10:{s:4:\"uuid\";s:36:\"1fa5c23b-252c-4847-abe2-d1b4b584734f\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"s_SXZn2HbRGvTex-TLOCxz2oOnMYqtEZh8HD4_318QI\";}s:2:\"id\";s:8:\"industry\";s:5:\"label\";s:8:\"Industry\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:1425:\"Accounting/Finance: Accounting/Finance\nAdvertising/Public Relations: Advertising/Public Relations\nAerospace/Aviation: Aerospace/Aviation\nArts/Entertainment/Publishing: Arts/Entertainment/Publishing\nAutomotive: Automotive\nBanking/Mortgage: Banking/Mortgage\nBusiness Development: Business Development\nBusiness Opportunity: Business Opportunity\nClerical/Administrative: Clerical/Administrative\nConstruction/Facilities: Construction/Facilities\nConsumer Goods: Consumer Goods\nCustomer Service: Customer Service\nEducation/Training: Education/Training\nEnergy/Utilities: Energy/Utilities\nEngineering: Engineering\nGovernment/Military: Government/Military\nHealthcare: Healthcare\nHospitality/Travel: Hospitality/Travel\nHuman Resources: Human Resources\nInstallation/Maintenance: Installation/Maintenance\nInsurance: Insurance\nInternet: Internet\nLaw Enforcement/Security: Law Enforcement/Security\nLegal: Legal\nManagement/Executive: Management/Executive\nManufacturing/Operations: Manufacturing/Operations\nMarketing: Marketing\nNon-Profit/Volunteer: Non-Profit/Volunteer\nPharmaceutical/Biotech: Pharmaceutical/Biotech\nProfessional Services: Professional Services\nReal Estate: Real Estate\nRestaurant/Food Service: Restaurant/Food Service\nRetail: Retail\nSales: Sales\nScience/Research: Science/Research\nSkilled Labor: Skilled Labor\nTechnology: Technology\nTelecommunications: Telecommunications\nTransportation/Logistics: Transportation/Logistics\n\";}'),('','webform.webform_options.languages','a:10:{s:4:\"uuid\";s:36:\"c9bd8601-37e8-43c4-ab09-e94a8022adb0\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"mYH14Vi65Ixj10c_GFa7CipxU3D0Bt9wgo8zE8zjOfE\";}s:2:\"id\";s:9:\"languages\";s:5:\"label\";s:9:\"Languages\";s:8:\"category\";s:8:\"Language\";s:6:\"likert\";b:0;s:7:\"options\";s:0:\"\";}'),('','webform.webform_options.likert_agreement','a:10:{s:4:\"uuid\";s:36:\"e51fa40b-f4f8-446e-8b6b-20c95b1291b6\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"-NQROvgYPm-rqn_e6mytSaxmdhSViUinffVfQhp7APs\";}s:2:\"id\";s:16:\"likert_agreement\";s:5:\"label\";s:17:\"Likert: Agreement\";s:8:\"category\";s:6:\"Likert\";s:6:\"likert\";b:1;s:7:\"options\";s:94:\"1: \'Much Worse\'\n2: \'Somewhat Worse\'\n3: \'About the Same\'\n4: \'Somewhat Better\'\n5: \'Much Better\'\n\";}'),('','webform.webform_options.likert_comparison','a:10:{s:4:\"uuid\";s:36:\"d3a3bf6d-dc69-441c-acbd-cef0b94cc000\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"gZCLESMdXmEZxHqnQFx7a0rUefrkVuFzHSMnWe0qioM\";}s:2:\"id\";s:17:\"likert_comparison\";s:5:\"label\";s:18:\"Likert: Comparison\";s:8:\"category\";s:6:\"Likert\";s:6:\"likert\";b:1;s:7:\"options\";s:71:\"1: Strongly Disagree\n2: Disagree\n3: Neutral\n4: Agree\n5: Strongly Agree\n\";}'),('','webform.webform_options.likert_importance','a:10:{s:4:\"uuid\";s:36:\"6e584bb3-fd52-495c-b4c2-2ebe74267c1e\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"Hbc8n5HtVZVs5fSBSpSbuY07CVvqkKP76csvRHN9pK8\";}s:2:\"id\";s:17:\"likert_importance\";s:5:\"label\";s:18:\"Likert: Importance\";s:8:\"category\";s:6:\"Likert\";s:6:\"likert\";b:1;s:7:\"options\";s:88:\"1: Not at all Important\n2: Somewhat Important\n3: Neutral\n4: Important\n5: Very Important\n\";}'),('','webform.webform_options.likert_quality','a:10:{s:4:\"uuid\";s:36:\"82e4a64f-43f0-441e-a310-822f78ce989d\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"swmYtBVUbwq7aHJWWDN7ODByuvur9vMkexDC9h64NZ8\";}s:2:\"id\";s:14:\"likert_quality\";s:5:\"label\";s:15:\"Likert: Quality\";s:8:\"category\";s:6:\"Likert\";s:6:\"likert\";b:1;s:7:\"options\";s:50:\"1: Poor\n2: Fair\n3: Good\n4: Very good\n5: Excellent\n\";}'),('','webform.webform_options.likert_satisfaction','a:10:{s:4:\"uuid\";s:36:\"852eb691-51f8-44ae-9c4a-3cc10cd05361\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"AKE2SNwCpl6Mu_cmbq9ZM2_cXxCikCVj1vcPE9oHWTs\";}s:2:\"id\";s:19:\"likert_satisfaction\";s:5:\"label\";s:20:\"Likert: Satisfaction\";s:8:\"category\";s:6:\"Likert\";s:6:\"likert\";b:1;s:7:\"options\";s:77:\"1: Very Unsatisfied\n2: Unsatisfied\n3: Neutral\n4: Satisfied\n5: Very Satisfied\n\";}'),('','webform.webform_options.likert_ten_scale','a:10:{s:4:\"uuid\";s:36:\"d5915d0c-8b0d-4ebd-a182-66c9810b699c\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"zEZX8JSVqznnFtqFfpuC593h3t1JDAZhF0Q3pvA229o\";}s:2:\"id\";s:16:\"likert_ten_scale\";s:5:\"label\";s:17:\"Likert: Ten Scale\";s:8:\"category\";s:6:\"Likert\";s:6:\"likert\";b:1;s:7:\"options\";s:52:\"1: 1\n2: 2\n3: 3\n4: 4\n5: 5\n6: 6\n7: 7\n8: 8\n9: 9\n10: 10\n\";}'),('','webform.webform_options.likert_would_you','a:10:{s:4:\"uuid\";s:36:\"56ab80d5-b651-4211-8019-be8ae1c54e8a\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"qBS2TmfAJB37Qn3TnrNM8x4AWimmDapcizzRllgo0fo\";}s:2:\"id\";s:16:\"likert_would_you\";s:5:\"label\";s:17:\"Likert: Would You\";s:8:\"category\";s:6:\"Likert\";s:6:\"likert\";b:1;s:7:\"options\";s:72:\"1: Definitely Not\n2: Probably Not\n3: Not Sure\n4: Probably\n5: Definitely\n\";}'),('','webform.webform_options.marital_status','a:10:{s:4:\"uuid\";s:36:\"31ee6bbb-62a6-4c2a-9a94-02aa398e480b\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"cjVDbAE5BlopGrY-tfxsxMoyEibwBBNgdQwDdxOSkow\";}s:2:\"id\";s:14:\"marital_status\";s:5:\"label\";s:14:\"Marital status\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:68:\"Single: Single\nMarried: Married\nDivorced: Divorced\nWidowed: Widowed\n\";}'),('','webform.webform_options.months','a:10:{s:4:\"uuid\";s:36:\"ff2c5c68-2bc1-4149-a60a-3ad785bc303e\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"pZJnuQkh9afNML5IcMuKTUC__vmHMFn66Qr5IWtedZ4\";}s:2:\"id\";s:6:\"months\";s:5:\"label\";s:6:\"Months\";s:8:\"category\";s:13:\"Date and time\";s:6:\"likert\";b:0;s:7:\"options\";s:184:\"January: January\nFebruary: February\nMarch: March\nApril: April\nMay: May\nJune: June\nJuly: July\nAugust: August\nSeptember: September\nOctober: October\nNovember: November\nDecember: December\n\";}'),('','webform.webform_options.phone_types','a:10:{s:4:\"uuid\";s:36:\"600ab312-1912-44c7-92a0-c4e2ae629343\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"LkO63Zl2cP_l9YdjzWI8dWoD9uD0pytkPiUiUM2bo9A\";}s:2:\"id\";s:11:\"phone_types\";s:5:\"label\";s:10:\"Phone type\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:37:\"Home: Home\nOffice: Office\nCell: Cell\n\";}'),('','webform.webform_options.relationship','a:10:{s:4:\"uuid\";s:36:\"8bda710d-5177-4541-9ebe-905bc49d3bbc\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"4J2RPG4JmsD4Fm1NlIQY0JHkrJ08UUl0qTF0_EjUxvw\";}s:2:\"id\";s:12:\"relationship\";s:5:\"label\";s:12:\"Relationship\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:101:\"Parent: Parent\n\'Significant Other\': \'Significant Other\'\nSibling: Sibling\nChild: Child\nFriend: Friend\n\";}'),('','webform.webform_options.size','a:10:{s:4:\"uuid\";s:36:\"6093fd0e-b9a2-4f3f-bea8-f51879734c66\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"RKkc6tf1VudvYiOtwPCf3Tp_EoA6fov6BFC34D7gMoQ\";}s:2:\"id\";s:4:\"size\";s:5:\"label\";s:4:\"Size\";s:8:\"category\";s:7:\"General\";s:6:\"likert\";b:0;s:7:\"options\";s:91:\"Extra Small: Extra Small\nSmall: Small\nMedium: Medium\nLarge: Large\nExtra Large: Extra Large\n\";}'),('','webform.webform_options.state_codes','a:10:{s:4:\"uuid\";s:36:\"6a055ae5-3120-49bb-a5c4-97d2dcb52d15\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"8mYO8ewsZX3LVfNga69jXa0RNO0LNN8-EGkXLhSAMBU\";}s:2:\"id\";s:11:\"state_codes\";s:5:\"label\";s:11:\"State codes\";s:8:\"category\";s:10:\"Geographic\";s:6:\"likert\";b:0;s:7:\"options\";s:728:\"AL: Alabama\nAK: Alaska\nAZ: Arizona\nAR: Arkansas\nCA: California\nCO: Colorado\nCT: Connecticut\nDE: Delaware\nDC: \'District of Columbia\'\nFL: Florida\nGA: Georgia\nGU: Guam\nHI: Hawaii\nID: Idaho\nIL: Illinois\nIN: Indiana\nIA: Iowa\nKS: Kansas\nKY: Kentucky\nLA: Louisiana\nME: Maine\nMD: Maryland\nMA: Massachusetts\nMI: Michigan\nMN: Minnesota\nMS: Mississippi\nMO: Missouri\nMT: Montana\nNE: Nebraska\nNV: Nevada\nNH: \'New Hampshire\'\nNJ: \'New Jersey\'\nNM: \'New Mexico\'\nNY: \'New York\'\nNC: \'North Carolina\'\nND: \'North Dakota\'\nOH: Ohio\nOK: Oklahoma\nOR: Oregon\nPA: Pennsylvania\nRI: \'Rhode Island\'\nSC: \'South Carolina\'\nSD: \'South Dakota\'\nTN: Tennessee\nTX: Texas\nUT: Utah\nVT: Vermont\nVA: Virginia\nWA: Washington\nWV: \'West Virginia\'\nWI: Wisconsin\nWY: Wyoming\n\";}'),('','webform.webform_options.state_names','a:10:{s:4:\"uuid\";s:36:\"1fc4f168-1781-4ff4-90bd-f20683f17f9c\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"KfYqMSrFJ5iGtDzvy_rGUeRUJ4KyM7Xt-tWtYx9WjiM\";}s:2:\"id\";s:11:\"state_names\";s:5:\"label\";s:11:\"State names\";s:8:\"category\";s:10:\"Geographic\";s:6:\"likert\";b:0;s:7:\"options\";s:1081:\"Alabama: Alabama\nAlaska: Alaska\nArizona: Arizona\nArkansas: Arkansas\nCalifornia: California\nColorado: Colorado\nConnecticut: Connecticut\nDelaware: Delaware\n\'District of Columbia\': \'District of Columbia\'\nFlorida: Florida\nGeorgia: Georgia\nHawaii: Hawaii\nIdaho: Idaho\nIllinois: Illinois\nIndiana: Indiana\nIowa: Iowa\nKansas: Kansas\nKentucky: Kentucky\nLouisiana: Louisiana\nMaine: Maine\nMaryland: Maryland\nMassachusetts: Massachusetts\nMichigan: Michigan\nMinnesota: Minnesota\nMississippi: Mississippi\nMissouri: Missouri\nMontana: Montana\nNebraska: Nebraska\nNevada: Nevada\n\'New Hampshire\': \'New Hampshire\'\n\'New Jersey\': \'New Jersey\'\n\'New Mexico\': \'New Mexico\'\n\'New York\': \'New York\'\n\'North Carolina\': \'North Carolina\'\n\'North Dakota\': \'North Dakota\'\nOhio: Ohio\nOklahoma: Oklahoma\nOregon: Oregon\nPennsylvania: Pennsylvania\n\'Rhode Island\': \'Rhode Island\'\n\'South Carolina\': \'South Carolina\'\n\'South Dakota\': \'South Dakota\'\nTennessee: Tennessee\nTexas: Texas\nUtah: Utah\nVermont: Vermont\nVirginia: Virginia\nWashington: Washington\n\'West Virginia\': \'West Virginia\'\nWisconsin: Wisconsin\nWyoming: Wyoming\n\";}'),('','webform.webform_options.state_province_codes','a:10:{s:4:\"uuid\";s:36:\"88be9bf4-979b-4237-8a21-bbda23df1ecf\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"osj7RxUDLyQlfj_sIQ-YoeJf-rDrAjMBWlxpoUaSvz0\";}s:2:\"id\";s:20:\"state_province_codes\";s:5:\"label\";s:20:\"State/Province codes\";s:8:\"category\";s:10:\"Geographic\";s:6:\"likert\";b:0;s:7:\"options\";s:1004:\"AL: Alabama\nAK: Alaska\nAS: \'American Samoa\'\nAZ: Arizona\nAR: Arkansas\nAE: \'Armed Forces (Canada, Europe, Africa, or Middle East)\'\nAA: \'Armed Forces Americas\'\nAP: \'Armed Forces Pacific\'\nCA: California\nCO: Colorado\nCT: Connecticut\nDE: Delaware\nDC: \'District of Columbia\'\nFM: \'Federated States of Micronesia\'\nFL: Florida\nGA: Georgia\nGU: Guam\nHI: Hawaii\nID: Idaho\nIL: Illinois\nIN: Indiana\nIA: Iowa\nKS: Kansas\nKY: Kentucky\nLA: Louisiana\nME: Maine\nMH: \'Marshall Islands\'\nMD: Maryland\nMA: Massachusetts\nMI: Michigan\nMN: Minnesota\nMS: Mississippi\nMO: Missouri\nMT: Montana\nNE: Nebraska\nNV: Nevada\nNH: \'New Hampshire\'\nNJ: \'New Jersey\'\nNM: \'New Mexico\'\nNY: \'New York\'\nNC: \'North Carolina\'\nND: \'North Dakota\'\nMP: \'Northern Mariana Islands\'\nOH: Ohio\nOK: Oklahoma\nOR: Oregon\nPW: Palau\nPA: Pennsylvania\nPR: \'Puerto Rico\'\nRI: \'Rhode Island\'\nSC: \'South Carolina\'\nSD: \'South Dakota\'\nTN: Tennessee\nTX: Texas\nUT: Utah\nVT: Vermont\nVI: \'Virgin Islands\'\nVA: Virginia\nWA: Washington\nWV: \'West Virginia\'\nWI: Wisconsin\nWY: Wyoming\n\";}'),('','webform.webform_options.state_province_names','a:10:{s:4:\"uuid\";s:36:\"f6c24a71-754f-4dbe-97ac-76e6725c8c7a\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"v5hSmubCKajaV9shdCW9fgP5-X03SuIjHbb0ODElqI0\";}s:2:\"id\";s:20:\"state_province_names\";s:5:\"label\";s:20:\"State/Province names\";s:8:\"category\";s:10:\"Geographic\";s:6:\"likert\";b:0;s:7:\"options\";s:1574:\"Alabama: Alabama\nAlaska: Alaska\n\'American Samoa\': \'American Samoa\'\nArizona: Arizona\nArkansas: Arkansas\n\'Armed Forces (Canada, Europe, Africa, or Middle East)\': \'Armed Forces (Canada, Europe, Africa, or Middle East)\'\n\'Armed Forces Americas\': \'Armed Forces Americas\'\n\'Armed Forces Pacific\': \'Armed Forces Pacific\'\nCalifornia: California\nColorado: Colorado\nConnecticut: Connecticut\nDelaware: Delaware\n\'District of Columbia\': \'District of Columbia\'\n\'Federated States of Micronesia\': \'Federated States of Micronesia\'\nFlorida: Florida\nGeorgia: Georgia\nGuam: Guam\nHawaii: Hawaii\nIdaho: Idaho\nIllinois: Illinois\nIndiana: Indiana\nIowa: Iowa\nKansas: Kansas\nKentucky: Kentucky\nLouisiana: Louisiana\nMaine: Maine\n\'Marshall Islands\': \'Marshall Islands\'\nMaryland: Maryland\nMassachusetts: Massachusetts\nMichigan: Michigan\nMinnesota: Minnesota\nMississippi: Mississippi\nMissouri: Missouri\nMontana: Montana\nNebraska: Nebraska\nNevada: Nevada\n\'New Hampshire\': \'New Hampshire\'\n\'New Jersey\': \'New Jersey\'\n\'New Mexico\': \'New Mexico\'\n\'New York\': \'New York\'\n\'North Carolina\': \'North Carolina\'\n\'North Dakota\': \'North Dakota\'\n\'Northern Mariana Islands\': \'Northern Mariana Islands\'\nOhio: Ohio\nOklahoma: Oklahoma\nOregon: Oregon\nPalau: Palau\nPennsylvania: Pennsylvania\n\'Puerto Rico\': \'Puerto Rico\'\n\'Rhode Island\': \'Rhode Island\'\n\'South Carolina\': \'South Carolina\'\n\'South Dakota\': \'South Dakota\'\nTennessee: Tennessee\nTexas: Texas\nUtah: Utah\nVermont: Vermont\n\'Virgin Islands\': \'Virgin Islands\'\nVirginia: Virginia\nWashington: Washington\n\'West Virginia\': \'West Virginia\'\nWisconsin: Wisconsin\nWyoming: Wyoming\n\";}'),('','webform.webform_options.time_zones','a:10:{s:4:\"uuid\";s:36:\"9e71f4ec-a4e6-4d82-8ff8-d670c9a72f36\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"8rVcRXLnTAEoWs7zl8du-7RIUnayqUcGYnvb3JT21-o\";}s:2:\"id\";s:10:\"time_zones\";s:5:\"label\";s:10:\"Time zones\";s:8:\"category\";s:13:\"Date and time\";s:6:\"likert\";b:0;s:7:\"options\";s:0:\"\";}'),('','webform.webform_options.titles','a:10:{s:4:\"uuid\";s:36:\"d6371d43-f163-44ff-9378-c82de12073cb\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"PEUoedWrfYEX7oZ8CcOukfBTVxar1cPSROX8534esuU\";}s:2:\"id\";s:6:\"titles\";s:5:\"label\";s:6:\"Titles\";s:8:\"category\";s:11:\"Demographic\";s:6:\"likert\";b:0;s:7:\"options\";s:41:\"Miss: Miss\nMs: Ms\nMr: Mr\nMrs: Mrs\nDr: Dr\n\";}'),('','webform.webform_options.translations','a:10:{s:4:\"uuid\";s:36:\"c81a2233-c323-4e62-87de-91499407ab42\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"Mb_L3vE-0IBZH5s2rjpk2LNn0QHClQP9AARQdCmVLt4\";}s:2:\"id\";s:12:\"translations\";s:5:\"label\";s:12:\"Translations\";s:8:\"category\";s:8:\"Language\";s:6:\"likert\";b:0;s:7:\"options\";s:0:\"\";}'),('','webform.webform_options.yes_no','a:10:{s:4:\"uuid\";s:36:\"16a38c60-054d-4f07-9a6d-4c1ddbf18893\";s:8:\"langcode\";s:2:\"en\";s:6:\"status\";b:1;s:12:\"dependencies\";a:1:{s:8:\"enforced\";a:1:{s:6:\"module\";a:1:{i:0;s:7:\"webform\";}}}s:5:\"_core\";a:1:{s:19:\"default_config_hash\";s:43:\"W88NYg31DbaVNQx1Uir_dwwXHVtF09QOq4VBGsH1Snk\";}s:2:\"id\";s:6:\"yes_no\";s:5:\"label\";s:6:\"Yes/No\";s:8:\"category\";s:7:\"General\";s:6:\"likert\";b:0;s:7:\"options\";s:16:\"Yes: Yes\nNo: No\n\";}');

--
